https://pharmacountry.com/insights/reports/hormone-therapy-linked-to-16-lower-alzheimer-risk-in-postmenopausal-women-uk-study-finds 2026-09-13T17:50:49.824Z weekly 0.7 https://pharmacountry.com/insights/news/purepain-ointment-offers-relief-for-anal-fissure-and-hemorrhoids 2026-09-13T17:50:49.672Z weekly 0.7 https://pharmacountry.com/insights/news/purepain-ointment-offers-symptom-relief-for-anal-fissure-and-hemorrhoids 2026-09-13T17:50:49.531Z weekly 0.7 https://pharmacountry.com/insights/reports/aerobic-exercise-boosts-executive-function-in-postmenopausal-women-study-shows 2026-09-13T17:50:49.420Z weekly 0.7 https://pharmacountry.com/insights/news/elderly-patients-should-not-delay-dental-implants-solely-due-to-age 2026-09-13T17:50:49.193Z weekly 0.7 https://pharmacountry.com/insights/news/café-yeondu-store-in-gwangju-showcases-farmfresh-tomato-stew-partnered-with-pharmacist-forum 2026-09-13T12:50:46.068Z weekly 0.7 https://pharmacountry.com/insights/regulatory/government-tuition-scholarship-for-regional-universities-excludes-pharmacy-students 2026-09-13T12:50:45.919Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-opens-2026-specialized-pharmacist-training-applications 2026-09-13T12:50:45.746Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-turn-focus-to-korean-parliament-over-remote-prescription-drug-delivery 2026-09-13T12:50:45.596Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-launches-emergency-committee-to-counter-expanded-telemedicine-drug-delivery 2026-09-13T12:50:45.470Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-launches-new-review-system-to-cut-new-drug-approval-time-to-240-days 2026-09-13T12:50:45.311Z weekly 0.7 https://pharmacountry.com/insights/reports/telemedicine-and-pharmacy-encounters-reveal-hidden-patient-information-in-korea 2026-09-13T12:50:45.119Z weekly 0.7 https://pharmacountry.com/insights/analysis/cgrp-targeted-migraine-drugs-expand-in-korea-with-new-formulations 2026-09-13T12:50:44.954Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-government-proposes-nationwide-telemedicine-prescription-delivery-freemedicalcare-movement-calls-for-immediate-halt 2026-09-13T09:51:04.221Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacists-caution-over-unfulfilled-hospital-tenancy-promises-in-new-pharmacy-openings 2026-09-13T09:51:04.129Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-pharmacists-association-finds-strong-support-for-continued-policy-leadership-course 2026-09-13T09:51:04.029Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-pharmacists-association-raises-concerns-over-lee-so-youngs-nomination-and-telemedicine-drug-delivery-policy 2026-09-13T09:51:03.930Z weekly 0.7 https://pharmacountry.com/insights/regulatory/movement-headquarters-criticizes-lee-jaemyung-govts-144-health-insurance-treasury-support 2026-09-13T09:51:03.830Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-governments-plan-to-expand-telemedicine-drug-delivery-faces-political-opposition 2026-09-13T09:51:03.730Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-government-sets-2027-health-insurance-treasury-support-at-138-trillion-krw-union-claims-effective-cut 2026-09-13T09:51:03.633Z weekly 0.7 https://pharmacountry.com/insights/news/south-korea-2027-budget-expands-community-care-adds-30-new-centers 2026-09-13T09:51:03.513Z weekly 0.7 https://pharmacountry.com/insights/news/women-lawmakers-hold-luncheon-ahead-of-parliament-session 2026-09-13T07:50:59.505Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-disease-control-agency-allocates-1435-trillion-krw-for-2027-budget-expands-vaccine-and-ai-rd-funding 2026-09-13T07:50:59.397Z weekly 0.7 https://pharmacountry.com/insights/regulatory/consumer-group-urges-safety-review-of-telemedicine-drug-delivery 2026-09-13T07:50:59.306Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-084640-for-diphen-oral-elixir-usl-pharma 2026-09-13T07:50:59.131Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-southwest-infertility-pregnancy-psychological-counseling-center-opens-at-ewha-mokdong-hospital 2026-09-13T06:50:54.735Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-diphenhydramine-hydrochloride-injection-anda083533-as-discontinued 2026-09-13T06:50:54.622Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda081213-for-estropipate-oral-tablet 2026-09-13T06:50:54.500Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda089706-for-hydrocortisone-1-cream-discontinued 2026-09-13T06:50:54.335Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-sets-2027-budget-of-88-bn-krw-emphasizes-aidriven-drug-approval-and-global-regulatory-support 2026-09-13T05:51:23.447Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-anda089313-for-chorionic-gonadotropin-injection-discontinued 2026-09-13T05:51:23.299Z weekly 0.7 https://pharmacountry.com/insights/reports/yuyu-pharmaceutical-to-automate-omega-soft-gelatin-capsule-packaging-with-ai-vision-and-robots 2026-09-13T05:51:23.186Z weekly 0.7 https://pharmacountry.com/insights/reports/hecto-group-develops-ai-device-for-early-lung-cancer-detection-and-recurrence-prediction 2026-09-13T05:51:23.054Z weekly 0.7 https://pharmacountry.com/insights/news/gc-green-cross-wellbeing-partners-with-japan-bio-products-to-develop-collagen-skin-booster 2026-09-13T05:51:22.948Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084144-for-proparacaine-hydrochloride-ophthalmic-solution 2026-09-13T04:51:21.924Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-reserpine-and-hydroflumethiazide-tablet-anda-088932 2026-09-13T04:51:21.744Z weekly 0.7 https://pharmacountry.com/insights/reports/il-dong-bioscience-publishes-idcc-1201-gut-health-study-in-nutrients 2026-09-13T04:51:21.563Z weekly 0.7 https://pharmacountry.com/insights/reports/kimco-foundation-and-ai-new-drug-institute-join-2026-pharma-bio-venture-collaboration-project 2026-09-13T04:51:21.373Z weekly 0.7 https://pharmacountry.com/insights/reports/arcgen-bio-selected-as-lead-institute-for-govt-pharmabio-venture-collaboration-project 2026-09-13T04:51:21.155Z weekly 0.7 https://pharmacountry.com/insights/reports/k-폴드-ai-모델-소개-및-활용-세미나-한국제약바이오협회-ai신약연구원-9월-1일-개최 2026-09-13T03:51:30.666Z weekly 0.7 https://pharmacountry.com/insights/regulatory/대한약사회-국민건강권-사수-비상대책위원회-구성-결의 2026-09-13T03:51:30.509Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-tevas-triphed-oral-tablet-as-discontinued-anda088630 2026-09-13T03:51:30.346Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078598-for-ciprofloxacin-hydrochloride-ophthalmic-solution 2026-09-13T03:51:30.216Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fougera-pharms-receives-fda-approval-for-calcipotriene-topical-solution-anda-078305 2026-09-13T03:51:30.094Z weekly 0.7 https://pharmacountry.com/insights/news/korea-pfizer-launches-oral-cgrp-antagonist-nutec-75mg-for-acute-and-preventive-migraine 2026-09-13T02:51:26.905Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-cipla-esomeprazole-magnesium-anda078003 2026-09-13T02:51:26.781Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-teva-methylphenidate-hydrochloride-er-capsules-anda-077707 2026-09-13T02:51:26.611Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cipla-anda-077411-for-lamivudine-and-zidovudine-tablet-approved-by-fda 2026-09-13T02:51:26.415Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-077105-for-valproic-acid-oral-syrup 2026-09-13T01:51:23.749Z weekly 0.7 https://pharmacountry.com/insights/news/digitalrx-solution-launches-regular-pharmacy-store-with-points-and-prize-incentives 2026-09-13T01:51:23.663Z weekly 0.7 https://pharmacountry.com/insights/analysis/teva-to-acquire-bioxcel-therapeutics-neuroscience-assets-for-up-to-125m 2026-09-13T01:51:23.484Z weekly 0.7 https://pharmacountry.com/insights/regulatory/relay-protest-marks-348-days-demanding-hanyaksa-licensing-reform-in-south-korea 2026-09-13T01:51:23.295Z weekly 0.7 https://pharmacountry.com/insights/reports/biontechgenentech-personalized-mrna-cancer-vaccine-phase-2-halted-over-safety-concerns 2026-09-13T00:52:12.867Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharma-research-faces-2-month-advertising-suspension-for-rejuran-derma-hiller-por-tightening-ampoule 2026-09-13T00:52:12.764Z weekly 0.7 https://pharmacountry.com/insights/news/goyang-city-pharmaceutical-association-grants-4-m-krw-scholarship-to-eight-local-high-school-students 2026-09-13T00:52:12.596Z weekly 0.7 https://pharmacountry.com/insights/regulatory/opposition-grows-to-pharmacy-law-amendment-requiring-employers-to-provide-free-emergency-medicines 2026-09-12T23:51:33.456Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076815-for-diazepam-injectable 2026-09-12T23:51:33.361Z weekly 0.7 https://pharmacountry.com/insights/regulatory/teva-pharms-simvastatin-tablet-anda-076532-receives-tentative-fda-approval 2026-09-12T23:51:33.230Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-cosmetics-theft-leads-to-suspended-6-month-sentence 2026-09-12T22:52:10.286Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ani-pharms-diflorasone-diacetate-cream-anda076263-discontinued 2026-09-12T22:52:10.113Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-manufacturing-and-labeling-submissions-for-mellarils-oral-suspension-nda-017923 2026-09-12T22:52:09.937Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-supplemental-manufacturing-submissions-for-discontinued-sodium-chloride-045-irrigation-solution 2026-09-12T21:51:38.827Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078902-for-paroxetine-hydrochloride-tablets 2026-09-12T21:51:38.664Z weekly 0.7 https://pharmacountry.com/insights/news/bayer-korea-holds-womens-symposium-on-personalized-treatment-strategies 2026-09-12T20:52:42.421Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-widens-insurance-coverage-for-rare-disease-cancer-drugs 2026-09-12T20:52:42.252Z weekly 0.7 https://pharmacountry.com/insights/reports/geoyoung-partners-with-ad-cure-to-launch-voice-ai-solution-h2v 2026-09-12T20:52:42.098Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kada-marks-1-year-of-fair-play-ground-antidoping-center 2026-09-12T19:51:31.862Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-insurance-false-claims-detected-at-839-korean-clinics-and-pharmacies-over-four-years 2026-09-12T19:51:31.683Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-koreas-health-ministry-reaffirms-no-final-decision-on-expanding-telemedicine-drug-delivery 2026-09-12T19:51:31.483Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077545-for-ondansetron-hydrochloride-tablets 2026-09-12T18:51:32.208Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-teva-generic-olanzapine-anda-077243 2026-09-12T18:51:32.090Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076942-for-ketoconazole-2-topical-shampoo 2026-09-12T17:51:32.069Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-osteoscan-nda-017454-as-radiopharmaceutical-injection 2026-09-12T17:51:31.895Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nda017421-for-dial-topical-solution-containing-025-hexachlorophene 2026-09-12T16:51:28.763Z weekly 0.7 https://pharmacountry.com/insights/news/kypg-networking-day-2026-summer-jazz-talk-draws-100-young-pharmacists-in-seoul 2026-09-12T16:51:28.639Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lee-chang-hoon-appointed-director-of-korea-medical-dispute-mediation-agency 2026-09-12T16:51:28.215Z weekly 0.7 https://pharmacountry.com/insights/news/waxing-can-cause-skin-redness-pharmacist-advises-cooling-and-moisturising 2026-09-12T15:51:27.759Z weekly 0.7 https://pharmacountry.com/insights/reports/inhaled-engineered-trna-restores-protein-function-in-cystic-fibrosis-mouse-model 2026-09-12T15:51:27.579Z weekly 0.7 https://pharmacountry.com/insights/reports/ucsf-researchers-map-protein-interactions-to-identify-new-autism-drug-targets 2026-09-12T15:51:27.388Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-and-rems-submissions-for-discontinued-oxymorphone-hydrochloride-er-tablets-anda-079046 2026-09-12T14:51:28.333Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-oral-chlorpheniramine-maleate-tablet-anda080786 2026-09-12T14:51:28.221Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-for-oreton-buccal-tablet-methyltestosterone-10-mg-anda080281 2026-09-12T14:51:28.041Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-zenaras-aminocaproic-acid-injection-anda215374 2026-09-12T13:51:26.816Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-assigns-nda-214937-for-helium-inhalation-product-by-westair-gases 2026-09-12T13:51:26.617Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sagent-pharmaceuticals-ephedrine-sulfate-injection-anda214528 2026-09-12T13:51:26.373Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda214126-approval-for-sugammadex-sodium-intravenous-solutions 2026-09-12T12:51:26.874Z weekly 0.7 https://pharmacountry.com/insights/regulatory/laurus-labs-ltd-submits-new-combination-nda-213696-to-fda 2026-09-12T12:51:26.783Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-phytonadione-vitamin-k-generic-anda213336 2026-09-12T12:51:26.657Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-expands-mounjaro-use-to-reduce-cardiovascular-risk-in-type-2-diabetes 2026-09-12T11:51:33.329Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-priovants-brepocitinib-lisraya-for-adult-dermatomyositis 2026-09-12T11:51:33.165Z weekly 0.7 https://pharmacountry.com/insights/reports/mcgill-study-finds-20minute-exercise-preserves-memory-comparable-to-90minute-nap 2026-09-12T10:52:25.988Z weekly 0.7 https://pharmacountry.com/insights/news/knee-pain-risks-rise-as-exercise-resumes-with-cooler-weather 2026-09-12T10:52:25.853Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-call-for-deregulation-of-telemedicine-and-platform-sectors-in-employment-policy-debate 2026-09-12T10:52:25.715Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda212957-for-fosaprepitant-dimeglumine-discontinued-product 2026-09-12T09:51:29.069Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-aurobindo-pharmas-pirfenidone-oral-tablets-anda-212596 2026-09-12T09:51:28.918Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-prochlorperazine-edisylate-injection-anda212257 2026-09-12T09:51:28.746Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-bans-telemedicine-prescriptions-for-newly-reimbursed-fintepla-and-dayvigo-insomnia-drug 2026-09-12T08:52:05.127Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda216216-for-metolazone-tablets 2026-09-12T08:52:05.005Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-arthrotec-diclofenac-sodium-and-misoprostol 2026-09-12T08:52:04.846Z weekly 0.7 https://pharmacountry.com/insights/regulatory/yuyu-pharmaceutical-receives-15day-manufacturing-suspension-after-premature-rerelease-of-recalled-products 2026-09-12T07:51:33.565Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-announces-stepwise-drug-price-reevaluation-plan-over-four-years 2026-09-12T07:51:33.378Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacies-consider-restocking-covid19-selftest-kits-as-cases-rise 2026-09-12T06:51:31.800Z weekly 0.7 https://pharmacountry.com/insights/analysis/daewoong-and-jongkundang-end-joint-sales-of-pcab-drug-pexuclu-amid-rising-competition 2026-09-12T06:51:31.624Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nda020675-for-urso-250-and-urso-forte-ursodiol-tablets 2026-09-12T05:51:37.551Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-078408-for-vinorelbine-tartrate-injection-by-ebewe-pharma 2026-09-12T04:51:32.060Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-bedford-ciprofloxacin-injection-anda078114 2026-09-12T04:51:31.873Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-cvmp-gives-positive-opinion-on-cirbloc-for-pig-immunisation 2026-09-12T03:51:59.696Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-tolectin-oral-tolmetin-products-nda017628 2026-09-12T03:51:59.528Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-retin-a-tretinoin-topical-gel-nda-017579 2026-09-12T03:51:59.361Z weekly 0.7 https://pharmacountry.com/insights/analysis/copromotion-contracts-end-for-major-drugs-prompting-distribution-shift-in-korea 2026-09-12T02:51:02.856Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacists-hidden-workload-and-emotional-labor-in-korean-pharmacies 2026-09-12T02:51:02.722Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-announces-special-pricing-adjustment-rules-for-innovative-and-semiinnovative-drugs 2026-09-12T01:52:30.494Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-expands-pharmacy-based-crisis-household-detection-nationwide 2026-09-12T01:52:30.335Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-government-considers-expanding-telemedicine-prescription-delivery-raising-pharmacy-sector-concerns 2026-09-12T01:52:30.152Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nipride-sodium-nitroprusside-injection-nda-017546 2026-09-12T00:51:02.527Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076914-for-tramadol-hydrochloride-and-acetaminophen-tablet 2026-09-12T00:51:02.357Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gurogu-pharmaceutical-association-collects-inappropriate-telemedicine-prescription-cases-ahead-of-dec-24-rollout 2026-09-11T23:51:44.353Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nesher-pharms-metoprolol-succinate-extendedrelease-anda076640 2026-09-11T23:51:44.241Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-updates-for-generic-levofloxacin-tablets-anda-076361 2026-09-11T23:51:44.141Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-students-launch-volunteer-group-to-support-elderly-living-alone-in-south-korea 2026-09-11T22:51:02.366Z weekly 0.7 https://pharmacountry.com/insights/news/daewoong-pharmaceutical-wins-1st-seoul-biohealth-award 2026-09-11T22:51:02.221Z weekly 0.7 https://pharmacountry.com/insights/news/il-yang-pharmaceutical-launches-wizer-alpha-highdose-gi-digestive-aid 2026-09-11T22:51:02.066Z weekly 0.7 https://pharmacountry.com/insights/news/baim-holds-2026-jupiter-gyeongju-symposium-on-juvelook-pdlla-biostimulator 2026-09-11T21:51:01.765Z weekly 0.7 https://pharmacountry.com/insights/regulatory/oncogenic-therapeutics-secures-us-patent-for-new-crystal-form-and-manufacturing-method-of-nesuparib 2026-09-11T21:51:01.559Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda206517-for-aztreonam-injectable-products 2026-09-11T20:51:03.439Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda206097-for-linezolid-oral-tablet 2026-09-11T20:51:03.286Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda-approval-for-pharmascience-inc-anda205757 2026-09-11T19:50:59.830Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda205336-for-diphenhydramine-hydrochloride-injectable 2026-09-11T19:50:59.647Z weekly 0.7 https://pharmacountry.com/insights/regulatory/caplin-paricalcitol-iv-solutions-discontinued-fda-anda204910 2026-09-11T19:50:59.506Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda204552-for-aspirin-and-dipyridamole-extended-release-capsules 2026-09-11T18:51:01.417Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sun-pharma-zolpidem-tartrate-extendedrelease-tablets-anda-204170 2026-09-11T18:51:01.241Z weekly 0.7 https://pharmacountry.com/insights/analysis/jw중외제약-프렌즈-인공눈물-브랜드를-식품으로-확장-아이크런치-캔디-출시 2026-09-11T17:51:05.020Z weekly 0.7 https://pharmacountry.com/insights/reports/huons-lab-secures-patents-for-hydiffuze-antibody-sc-formulations-including-pembrolizumab-and-bevacizumab 2026-09-11T17:51:04.845Z weekly 0.7 https://pharmacountry.com/insights/analysis/skylabs-partners-with-iem-gmbh-to-launch-ringtype-blood-pressure-monitor-in-europe 2026-09-11T16:52:22.610Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-lawmaker-proposes-amendment-to-expand-nightholiday-pediatric-care 2026-09-11T16:52:22.492Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-health-ministry-appoints-kim-eunyoung-as-basic-living-security-department-manager 2026-09-11T16:52:22.340Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-clozapine-submissions-all-listed-tablet-products-discontinued 2026-09-11T15:51:01.623Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-kazano-alogliptinmetformin-tablets-nda-203414 2026-09-11T15:51:01.483Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-alkem-labs-triamcinolone-acetonide-creams-anda207651 2026-09-11T14:51:04.087Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sevelamer-carbonate-oral-suspension-anda207291 2026-09-11T14:51:03.874Z weekly 0.7 https://pharmacountry.com/insights/news/celltrion-announces-1-trillion-krw-share-buyback-under-new-shareholder-return-policy 2026-09-11T13:51:09.039Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-merck-healthcares-pergoberis-pen-added-to-health-insurance-coverage 2026-09-11T12:51:03.986Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggido-pharmaceutical-association-delivers-6-m-krw-humanitarian-medicines-to-south-sudan 2026-09-11T12:51:03.837Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda206918-approval-for-fondaparinux-sodium-injection 2026-09-11T11:51:03.345Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approval-history-for-cylert-nda-017703 2026-09-11T11:51:03.229Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-hikma-deferoxamine-mesylate-injectable-anda078086 2026-09-11T10:51:32.451Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-risperidone-tablet-anda077784-submitted-by-ratipharm 2026-09-11T10:51:32.302Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ohm-laboratories-generic-valsartan-anda-077492 2026-09-11T09:51:32.969Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077183-for-amlodipine-besylate-and-benazepril-hydrochloride 2026-09-11T09:51:32.825Z weekly 0.7 https://pharmacountry.com/insights/news/rising-covid-19-cases-in-asia-prompt-reassessment-of-testing-and-treatment-for-highrisk-patients 2026-09-11T08:51:37.951Z weekly 0.7 https://pharmacountry.com/insights/news/esc-2026-hfpef-guideline-recommends-finerenone-as-core-treatment-option 2026-09-11T07:51:32.769Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-bars-private-qualifications-using-pharmacy-related-titles 2026-09-11T07:51:32.575Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-chartwell-rx-levofloxacin-oral-tablets-anda-076890 2026-09-11T06:52:19.415Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076336-for-mirtazapine-oral-tablets 2026-09-11T06:52:19.256Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076609-for-propoxyphene-napyslateacetaminophen-tablet 2026-09-11T05:52:23.597Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sun-pharma-epoprostenol-injection-anda210473 2026-09-11T05:52:23.468Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-cardizem-cd-diltiazem-hydrochloride-extendedrelease-capsules 2026-09-11T05:52:23.320Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lupins-doxercalciferol-injection-anda210801 2026-09-11T04:52:12.503Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-protest-government-push-for-expanded-drug-delivery-via-telemedicine 2026-09-11T04:52:12.394Z weekly 0.7 https://pharmacountry.com/insights/analysis/samsung-biologics-announces-3-trillion-krw-capital-increase-to-fund-expansion 2026-09-11T04:52:12.265Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-revises-pharmaceutical-pregmp-evaluation-manual-adds-newdrug-and-singapore-gmp-provisions 2026-09-11T03:52:13.875Z weekly 0.7 https://pharmacountry.com/insights/news/sk-바이오팜-opacalym-도입-및-자사주-매입으로-차세대-성장-전략-강조 2026-09-11T03:52:13.723Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-steglatro-ertugliflozin-under-nda209803 2026-09-11T02:51:33.226Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-reports-discontinuation-of-multiple-thorazine-products 2026-09-11T02:51:33.034Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-pharmacists-plan-rally-against-expanded-telemedicine-prescription-delivery 2026-09-11T01:52:38.559Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda209102-for-generic-baclofen-tablets 2026-09-11T01:52:38.433Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda208756-for-dexmethylphenidate-tablets-rhodes-pharm 2026-09-11T01:52:38.284Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-varubi-rolapitant-intravenous-emulsion-under-nda-208399 2026-09-11T00:51:31.692Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-over-the-counter-lansoprazole-tablet-nda-208025 2026-09-11T00:51:31.516Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-proposes-amendment-to-require-employers-to-stock-emergency-medicines-at-workplaces 2026-09-10T23:51:29.429Z weekly 0.7 https://pharmacountry.com/insights/analysis/korean-health-functional-food-association-hosts-overseas-buyer-counseling-at-k-health-conference-2026 2026-09-10T23:51:29.265Z weekly 0.7 https://pharmacountry.com/insights/news/korean-association-of-pharmacist-nutrition-opens-2nd-cancer-clinical-nutrition-expert-course 2026-09-10T23:51:29.108Z weekly 0.7 https://pharmacountry.com/insights/news/korean-heart-association-to-host-free-public-walking-event-on-sep-19-for-heart-health 2026-09-10T22:51:33.570Z weekly 0.7 https://pharmacountry.com/insights/news/jonggeundang-expands-modecol-line-with-six-new-softcapsule-cold-medicines 2026-09-10T22:51:33.377Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda207613-for-midodrine-hydrochloride-tablets 2026-09-10T21:51:53.823Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-leucovorin-calcium-anda207241 2026-09-10T21:51:53.722Z weekly 0.7 https://pharmacountry.com/insights/regulatory/teva-canada-recalls-novogesic-forte-500-mg-acetaminophen-over-potential-foreign-material 2026-09-10T21:51:53.568Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sevelamer-hydrochloride-generic-anda-206883-by-macleods-pharmaceuticals 2026-09-10T20:51:52.338Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090935-for-warfarin-sodium-tablets-by-exelan-pharmaceuticals 2026-09-10T20:51:52.193Z weekly 0.7 https://pharmacountry.com/insights/news/sanofi-korea-hosts-team-care-symposium-on-insulin-therapy-for-diabetes 2026-09-10T19:50:29.711Z weekly 0.7 https://pharmacountry.com/insights/reports/seoul-asan-hospital-hosts-acis-2026-cancer-symposium-focused-on-ai-and-precision-oncology 2026-09-10T19:50:29.551Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ge-healthcare-alerts-on-two-potential-issues-in-centricity-high-acuity-systems-2 2026-09-10T19:50:29.321Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ge-healthcare-alerts-on-two-potential-issues-in-centricity-high-acuity-systems 2026-09-10T19:50:29.083Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmaker-to-host-forum-on-innovative-drug-value-assessment-sep-4 2026-09-10T18:53:21.105Z weekly 0.7 https://pharmacountry.com/insights/news/elevated-blood-cell-counts-may-indicate-myeloproliferative-neoplasm 2026-09-10T18:53:20.910Z weekly 0.7 https://pharmacountry.com/insights/news/osstem-implant-and-nexen-tire-launch-workplace-childcare-exchange-program 2026-09-10T18:53:20.745Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090609-for-atomoxetine-capsules-by-dr-reddys-laboratories 2026-09-10T17:50:30.602Z weekly 0.7 https://pharmacountry.com/insights/regulatory/beckman-coulter-dxc-500i500-au-analyzer-software-issue-may-reset-units 2026-09-10T17:50:30.488Z weekly 0.7 https://pharmacountry.com/insights/regulatory/beckman-coulter-dxc-500i-and-dxc-500-au-analyzers-software-issue-may-reset-units-on-plasma-tests 2026-09-10T17:50:30.352Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-oral-prednisolone-tablet-anda083675 2026-09-10T16:51:31.871Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-watson-labs-cobavite-injection-anda083064-as-discontinued 2026-09-10T16:51:31.739Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080718-for-thiamine-hydrochloride-injection-discontinued 2026-09-10T15:51:35.528Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-transderm-scop-nda017874-transdermal-scopolamine-patch 2026-09-10T15:51:35.391Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-pharmaceutical-safety-agency-announces-2026-secondhalf-narcotics-handling-education 2026-09-10T13:50:59.211Z weekly 0.7 https://pharmacountry.com/insights/reports/roche-korea-samsung-seoul-hospital-show-patientbased-realtime-qc 2026-09-10T13:50:59.114Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-t2-alpha-imn-advanced-locking-screw-lot-mislabelled-75-mm-instead-of-575-mm 2026-09-10T13:50:58.961Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078384-for-carvedilol-tablets-by-unichem-pharmaceuticals 2026-09-10T12:51:04.452Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-issues-labeling-alert-for-t2-alpha-imn-advanced-locking-screw-lot 2026-09-10T12:51:04.272Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-acthar-injectable-nda007504 2026-09-10T11:52:32.379Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nda017780-for-pharm-spec-heparin-sodium-injection 2026-09-10T11:52:32.224Z weekly 0.7 https://pharmacountry.com/insights/regulatory/national-university-hospital-establishment-act-proposed-to-boost-regional-healthcare 2026-09-10T10:51:34.541Z weekly 0.7 https://pharmacountry.com/insights/news/대한약학대학학생협회-2026-약대협-취업-로드맵-세미나-개최-제약-직무와-커리어-설계-소개 2026-09-10T10:51:34.384Z weekly 0.7 https://pharmacountry.com/insights/news/goyang-city-pharmacists-association-joins-2026-goyang-future-career-fair 2026-09-10T09:51:55.416Z weekly 0.7 https://pharmacountry.com/insights/regulatory/us-5th-circuit-court-dismisses-phrma-appeal-over-medicare-drug-pricing-rule 2026-09-10T09:51:55.232Z weekly 0.7 https://pharmacountry.com/insights/regulatory/revolution-medicines-daraxonrasib-rasonque-receives-fda-approval-for-metastatic-pancreatic-cancer 2026-09-10T09:51:55.055Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-approval-for-metoprolol-tartrate-injectable-anda078085-by-hospira 2026-09-10T08:51:33.420Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-chartwell-molecular-lamotrigine-tablet-anda077783 2026-09-10T08:51:33.189Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-amici-pharmas-generic-pravastatin-sodium-tablets-anda-077491 2026-09-10T07:51:33.808Z weekly 0.7 https://pharmacountry.com/insights/regulatory/meprobamate-anda-085721-discontinued-oral-tablet-fda 2026-09-10T07:51:33.605Z weekly 0.7 https://pharmacountry.com/insights/reports/glp1-obesity-drug-tirzepatide-linked-to-decreased-libido-and-vaginal-dryness-in-case-report 2026-09-10T06:52:47.009Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-discontinued-hydrocortisone-acetate-injection-anda085214 2026-09-10T06:52:46.815Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda084751-approval-for-dilor-400-400-mg-theophylline 2026-09-10T06:52:46.588Z weekly 0.7 https://pharmacountry.com/insights/reports/amgen-and-astrazenecas-tezspire-achieves-primary-and-key-secondary-endpoints-in-phase-3-eoe-trial 2026-09-10T05:51:28.031Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-advises-symptom-based-selection-of-hangover-remedies 2026-09-10T05:51:27.901Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacy-groups-focus-on-cabinet-reshuffle-as-sme-ministry-nominee-named 2026-09-10T05:51:27.764Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-advises-personalized-selection-of-hangover-remedies 2026-09-10T04:52:13.541Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacy-prescription-compounding-and-otc-sales-drop-in-week-34-2026 2026-09-10T04:52:13.306Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-updates-safety-labeling-for-triptolide-and-azathioprine-drugs 2026-09-10T04:52:13.072Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076335-for-tri-previfem-oral-tablet 2026-09-10T03:51:30.237Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077182-for-desogestrelethinyl-estradiol-oral-tablets 2026-09-10T03:51:30.035Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-084286-for-triamcinolone-2mg-oral-tablet-discontinued 2026-09-10T02:51:31.199Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ani-pharms-fosinoprilhctz-tablets-anda-076608 2026-09-10T02:51:31.027Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-nda-007883-antabuse-disulfiram-supplemental-manufacturing-and-labeling-submissions 2026-09-10T02:51:30.756Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-health-insurance-drug-list-shrinks-otc-items-decline-faster-than-prescription 2026-09-10T01:51:33.644Z weekly 0.7 https://pharmacountry.com/insights/news/lee-so-young-nominated-for-sme-ministry-amid-health-committee-tenure 2026-09-10T01:51:33.424Z weekly 0.7 https://pharmacountry.com/insights/news/senior-pharma-professionals-advise-pharmacy-students-at-2026-pharma-basics-seminar 2026-09-10T00:51:56.218Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-association-accelerates-emergency-committee-formation-amid-telemedicine-delivery-expansion 2026-09-10T00:51:56.031Z weekly 0.7 https://pharmacountry.com/insights/regulatory/government-to-expand-telemedicine-drug-delivery-calls-for-safety-and-liability-framework 2026-09-10T00:51:55.845Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-two-discontinued-fluconazole-injection-products-under-anda-076889 2026-09-09T23:52:39.450Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cam-metrazine-anda085320-discontinued-oral-tablet-by-chartwell-rx 2026-09-09T23:52:39.238Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-issues-anda-approval-for-watson-labs-procaineamide-hydrochloride-oral-capsule-anda083795 2026-09-09T23:52:39.041Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-to-refund-376-trillion-won-for-out-of-pocket-caps 2026-09-09T22:51:24.514Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-submissions-for-lidocaine-hydrochloride-injection-discontinued-product 2026-09-09T22:51:24.317Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080800-for-diphenhydramine-hydrochloride-oral-capsule 2026-09-09T22:51:24.169Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-mylan-nisoldipine-extendedrelease-tablets-anda-079051-discontinued-products 2026-09-09T22:51:23.899Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-oral-prednisone-5mg-tablet-anda080300 2026-09-09T21:51:21.856Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-association-holds-344th-relay-rally-to-address-herbal-pharmacist-license-scope 2026-09-09T21:51:21.665Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-oxford-pharm-generic-simvastatin-tablets-anda078735 2026-09-09T21:51:21.475Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-impax-labs-acarbose-oral-tablets-anda-078441 2026-09-09T21:51:21.295Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-announces-discontinuation-of-watson-labs-potassium-chloride-injection-anda-086210 2026-09-09T21:51:21.103Z weekly 0.7 https://pharmacountry.com/insights/reports/hira-hosts-international-ai-symposium-to-shape-future-healthcare-innovation 2026-09-09T20:51:42.423Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda085790-for-isoniazid-100-mg-tablet-by-watson-labs 2026-09-09T20:51:42.230Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-086892-for-chlordiazepoxide-hydrochloride-capsules 2026-09-09T20:51:42.057Z weekly 0.7 https://pharmacountry.com/insights/reports/postpartum-pelvic-floor-symptoms-linked-to-depression-study-finds 2026-09-09T20:51:41.907Z weekly 0.7 https://pharmacountry.com/insights/reports/web-based-care-app-lowers-stress-for-dementia-caregivers 2026-09-09T20:51:41.705Z weekly 0.7 https://pharmacountry.com/insights/news/restless-legs-syndrome-may-underlie-nighttime-sleep-disturbances 2026-09-09T20:51:41.512Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077247-for-carboplatin-injectable-products-discontinued 2026-09-09T19:51:28.189Z weekly 0.7 https://pharmacountry.com/insights/reports/oxford-study-links-shingles-vaccine-to-reduced-heart-disease-risk 2026-09-09T19:51:27.992Z weekly 0.7 https://pharmacountry.com/insights/reports/donggwang-pharma-reduces-indenol-10-mg-tablet-size-while-keeping-dosage 2026-09-09T19:51:27.805Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-345-day-protest-calls-for-han-yak-sa-reform 2026-09-09T19:51:27.612Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-anda087397-for-watson-labs-bethanechol-chloride-tablet-discontinued 2026-09-09T18:50:34.385Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076672-for-oral-gabapentin-solution-250-mg5-ml-by-taro 2026-09-09T18:50:34.244Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-tentative-approval-for-tolterodine-oral-tablets-anda-076953 2026-09-09T18:50:34.039Z weekly 0.7 https://pharmacountry.com/insights/regulatory/philips-unity-bv-pulsera-mobile-c-arm-systems-may-experience-x-ray-failure-due-to-air-bubbles 2026-09-09T18:50:33.860Z weekly 0.7 https://pharmacountry.com/insights/regulatory/philips-unity-bv-pulsera-carm-systems-may-experience-xray-failure-due-to-air-bubbles-in-monoblock-oil 2026-09-09T18:50:33.641Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-apotexs-albuterol-sulfate-inhalation-solution-anda-076391 2026-09-09T17:52:11.137Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078152-for-oral-ondansetron-tablets-4-mg-8-mg 2026-09-09T17:52:10.929Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-fluoxetine-oral-solution-anda077849-by-lannett-company 2026-09-09T17:52:10.690Z weekly 0.7 https://pharmacountry.com/insights/news/dog-muzzles-benefits-risks-and-care-guidelines 2026-09-09T16:51:49.283Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-novitium-pharma-escitalopram-oxalate-anda077550 2026-09-09T16:51:49.051Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-mfds-expands-gift-review-to-include-patient-experience-data 2026-09-09T16:51:48.842Z weekly 0.7 https://pharmacountry.com/insights/reports/virtual-maumjaro-experience-mimics-obesity-drug-injection-online 2026-09-09T16:51:48.637Z weekly 0.7 https://pharmacountry.com/insights/analysis/boryeong-launches-malkuncho-kids-syrup-to-enter-10-billion-krw-childrens-digestive-otc-market 2026-09-09T16:51:48.411Z weekly 0.7 https://pharmacountry.com/insights/analysis/il-yang-pharmaceutical-launches-gigaen-a-bronchial-health-supplement 2026-09-09T15:50:27.091Z weekly 0.7 https://pharmacountry.com/insights/regulatory/philips-issues-software-alert-for-mr-imaging-systems-r5-r11 2026-09-09T15:50:26.899Z weekly 0.7 https://pharmacountry.com/insights/regulatory/philips-mr-imaging-systems-software-issue-may-halt-exams 2026-09-09T15:50:26.654Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-multiple-field-safety-notices-31-aug-4-sep-2026 2026-09-09T14:50:38.196Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-to-hold-3rd-management-pharmacist-training-in-daejeon-on-oct-17 2026-09-09T13:52:14.276Z weekly 0.7 https://pharmacountry.com/insights/news/gyeongnam-branch-launches-experiential-drug-prevention-program-for-youth 2026-09-09T13:52:14.051Z weekly 0.7 https://pharmacountry.com/insights/regulatory/jw중외제약-보팡글루타이드-2형-당뇨병-3상-임상-ind-신청 2026-09-09T12:51:28.455Z weekly 0.7 https://pharmacountry.com/insights/news/daewoong-pharmaceutical-receives-ministerial-award-as-world-class-outstanding-company 2026-09-09T12:51:28.222Z weekly 0.7 https://pharmacountry.com/insights/reports/senigen-pursues-aidesigned-2ndgen-chimera-endolysin-for-sepsis-treatment 2026-09-09T12:51:28.024Z weekly 0.7 https://pharmacountry.com/insights/regulatory/양천구약사회-비대면진료-약배송-확대-정책-강하게-규탄 2026-09-09T11:52:01.386Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-pharmacists-association-schedules-emergency-meeting-on-telemedicine-delivery-and-pharmacy-regulations 2026-09-09T11:52:01.172Z weekly 0.7 https://pharmacountry.com/insights/regulatory/parliamentarians-host-policy-forum-on-biodata-platform-activation 2026-09-09T10:51:35.973Z weekly 0.7 https://pharmacountry.com/insights/reports/birp-connect-showcases-pharma-data-productization-at-tableau-datafam-seoul-2026 2026-09-09T09:51:38.399Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-pharmaceutical-to-produce-documentary-on-development-of-glp1-obesity-drug-efe 2026-09-09T09:51:38.156Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mylans-chlordiazepoxide-hydrochloride-oral-capsule-anda-084887-discontinued 2026-09-09T08:51:03.128Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sodium-chloride-injection-nda018090 2026-09-09T08:51:02.913Z weekly 0.7 https://pharmacountry.com/insights/regulatory/joa-pharmaceutical-reintroduces-gareo-aq-digestive-medicine-after-3-year-clinical-reassessment 2026-09-09T07:51:04.244Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-science-supplies-15000-plantbased-protein-drinks-to-floodhit-gyeongnam 2026-09-09T07:51:04.018Z weekly 0.7 https://pharmacountry.com/insights/reports/gc-green-cross-teams-with-osivax-on-nextgen-combined-influenza-vaccine 2026-09-09T06:50:59.195Z weekly 0.7 https://pharmacountry.com/insights/reports/kddf-concludes-2026-science-conference-on-translating-discoveries-to-clinical-impact 2026-09-09T06:50:58.935Z weekly 0.7 https://pharmacountry.com/insights/news/오송첨단의료산업진흥재단-제6대-이사장-후보자-공개모집 2026-09-09T06:50:58.715Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-revises-gift-review-guidelines-to-include-patient-experience-for-rare-disease-drugs 2026-09-09T05:51:02.646Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090018-for-zoledronic-acid-injectable-discontinued 2026-09-09T05:51:02.476Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda089116-for-brompheril-extended-release-tablet 2026-09-09T05:51:02.350Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-submissions-for-sublingual-buprenorphine-hydrochloride-tablets-products-001-002 2026-09-09T05:51:02.154Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda089479-for-acetaminophencodeine-phosphate-tablet-discontinued 2026-09-09T04:53:27.348Z weekly 0.7 https://pharmacountry.com/insights/analysis/daewon-pharmaceutical-continues-production-and-supply-of-cough-expectorant-kodaewonjeong 2026-09-09T04:53:27.126Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-079054-for-alfuzosin-hydrochloride-extendedrelease-tablet 2026-09-09T04:53:26.923Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fosphenytoin-sodium-anda078736-fda-approval 2026-09-09T04:53:26.717Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078442-for-alprazolam-extended-release-tablets-discontinued 2026-09-09T04:53:26.460Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lupin-generic-levetiracetam-tablets-anda-078154 2026-09-09T03:51:33.071Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077850-for-nicotine-polacrilex-buccal-gum 2026-09-09T03:51:32.808Z weekly 0.7 https://pharmacountry.com/insights/news/gwangjingu-pharmacists-association-womens-committee-reviews-community-outreach-plans 2026-09-09T02:52:25.248Z weekly 0.7 https://pharmacountry.com/insights/analysis/nestlé-health-science-launches-glp1-nutrition-platform 2026-09-09T02:52:25.038Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-cracks-down-on-illegal-sale-of-imported-medicines-in-traditional-market-stalls 2026-09-09T02:52:24.791Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-revolution-medicines-daraxonrasib-rasonque-for-metastatic-pancreatic-cancer 2026-09-09T01:51:46.655Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-adds-15-facilities-to-police-probe-over-illegal-fee-refunds 2026-09-09T01:51:46.448Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-adds-domperidone-contraindication-for-chromaffincell-tumor-patients-across-38-products 2026-09-09T01:51:46.257Z weekly 0.7 https://pharmacountry.com/insights/reports/rhodiola-extract-may-enhance-exercise-endurance-study-shows 2026-09-09T00:52:11.791Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sandoz-ondansetron-hydrochloride-preservativefree-injection-anda-077551 2026-09-09T00:52:11.569Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-hokuriku-branch-marks-10year-anniversary-with-regulatory-cooperation-symposium 2026-09-09T00:52:11.372Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077248-for-pilocarpine-hydrochloride-oral-tablets 2026-09-08T23:51:31.196Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-flumazenil-anda076955-for-intravenous-use 2026-09-08T23:51:30.994Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-watson-labs-ciprofloxacin-ophthalmic-solution-anda-076673 2026-09-08T22:51:30.181Z weekly 0.7 https://pharmacountry.com/insights/regulatory/essential-medicine-supply-disruption-highlighted-in-koreas-2026-national-audit 2026-09-08T22:51:29.965Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-government-delays-generic-drug-price-cuts-to-april-2025-sets-sep-1-2024-baseline 2026-09-08T22:51:29.766Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-26-new-drugs-in-h1-2026-highlighting-oral-therapies-and-protacs 2026-09-08T21:51:27.670Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-tightens-penalties-for-drug-induced-drowsy-driving-emphasizes-pharmacy-warnings 2026-09-08T21:51:27.443Z weekly 0.7 https://pharmacountry.com/insights/reports/robot-assisted-knee-replacement-shows-no-long-term-benefit-over-conventional-surgery-study-finds 2026-09-08T21:51:27.220Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076392-for-mefloquine-hydrochloride 2026-09-08T20:51:33.080Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080807-for-diphenhydramine-capsules-impax-labs 2026-09-08T20:51:32.812Z weekly 0.7 https://pharmacountry.com/insights/regulatory/marshall-pharma-prednisone-tablet-5-mg-anda080301-discontinued 2026-09-08T19:52:32.693Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-gyne-lotrimin-vaginal-cream-clotrimazole-1 2026-09-08T19:52:32.486Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-oral-solution-pamelor-nortriptyline-hydrochloride-nda-018012 2026-09-08T19:52:32.264Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-city-pharmacists-association-announces-2026-temporary-delegate-general-meeting 2026-09-08T18:51:56.940Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sorbitol-mannitol-nda018316-for-urethral-irrigation 2026-09-08T18:51:56.698Z weekly 0.7 https://pharmacountry.com/insights/news/korean-medical-association-to-host-2026-cmaao-seoul-general-assembly-sep-24 2026-09-08T17:51:03.592Z weekly 0.7 https://pharmacountry.com/insights/analysis/dongkook-pharmaceutical-launches-teca-plus-formula-facial-repair-cream-light 2026-09-08T17:51:03.371Z weekly 0.7 https://pharmacountry.com/insights/news/korean-medical-associations-urge-nomination-of-cha-jiho-for-who-secretarygeneral 2026-09-08T16:52:09.318Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gurogu-pharmaceutical-association-opposes-full-expansion-of-prescription-drug-delivery-for-telemedicine 2026-09-08T16:52:09.098Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda086088-for-hydralazine-hydrochloride-oral-tablet-discontinued 2026-09-08T15:51:02.730Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-proval-3-oral-capsule-anda085685 2026-09-08T15:51:02.537Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-watson-labs-meclizine-hydrochloride-125-mg-tablet-anda-085195-as-discontinued 2026-09-08T14:52:12.548Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084731-for-theophylline-oral-capsules-discontinued 2026-09-08T14:52:12.349Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda084259-for-methocarbamol-500-mg-oral-tablet-mylan-discontinued 2026-09-08T14:52:12.157Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090265-for-hydrocodoneacetaminophen-tablets 2026-09-08T13:51:48.025Z weekly 0.7 https://pharmacountry.com/insights/reports/medical-radiation-exams-reach-4316-million-in-2025-ct-scans-drive-majority-of-dose 2026-09-08T13:51:47.813Z weekly 0.7 https://pharmacountry.com/insights/news/toxin-research-association-metacentrics-explore-new-counseling-strategies-for-community-pharmacies 2026-09-08T12:51:17.519Z weekly 0.7 https://pharmacountry.com/insights/regulatory/public-petition-calls-for-withdrawal-of-koreas-remote-drug-delivery-expansion 2026-09-08T12:51:17.310Z weekly 0.7 https://pharmacountry.com/insights/news/gangdong-district-pharmacy-association-hosts-cinema-day-for-members 2026-09-08T11:51:35.022Z weekly 0.7 https://pharmacountry.com/insights/regulatory/quad-pharms-isoniazid-injection-100-mgml-listed-as-discontinued-in-fda-anda089816 2026-09-08T11:51:34.820Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hydroxyzine-hydrochloride-50-mg-tablet-discontinued-fda-submission-history 2026-09-08T11:51:34.590Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cenci-announces-discontinuation-of-promethazine-oral-syrup-anda089013 2026-09-08T10:51:02.770Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-kvk-tech-betaxolol-hydrochloride-oral-tablets-anda078962 2026-09-08T10:51:02.502Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sun-pharm-inds-inc-anda078654-for-clonazepam-odts 2026-09-08T09:51:04.053Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-updates-for-chartwell-rxs-discontinued-desloratadine-tablet-anda078364 2026-09-08T09:51:03.838Z weekly 0.7 https://pharmacountry.com/insights/news/gwanak-district-pharmaceutical-society-chair-appointed-to-youth-guidance-committee 2026-09-08T08:51:03.945Z weekly 0.7 https://pharmacountry.com/insights/analysis/healthcare-platform-geoyoung-conducts-joint-fire-safety-inspection-and-training-in-incheon 2026-09-08T08:51:03.725Z weekly 0.7 https://pharmacountry.com/insights/news/yaksa-gongron-launches-14th-young-reporter-cohort-with-two-day-program 2026-09-08T07:51:03.568Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-student-wins-top-award-in-kpa-youth-journalist-program 2026-09-08T07:51:03.332Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-calcitriol-injection-anda078066 2026-09-08T06:51:39.522Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077766-for-simvastatin-generic-tablets 2026-09-08T06:51:39.273Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-for-tevas-discontinued-ramipril-capsules-anda-077470 2026-09-08T05:52:02.824Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076589-for-flumazenil-injectable-products 2026-09-08T05:52:02.546Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077165-for-granisetron-hydrochloride-preservativefree-injection-dr-reddys 2026-09-08T04:51:40.173Z weekly 0.7 https://pharmacountry.com/insights/regulatory/samjin-and-jongkundang-voluntarily-cut-prices-of-epilepsy-and-ezetimibe-drugs 2026-09-08T04:51:39.980Z weekly 0.7 https://pharmacountry.com/insights/news/dongwha-pharmaceutical-holds-13th-14th-youth-reporter-corps-ceremony 2026-09-08T04:51:39.785Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-forms-emergency-committee-to-counter-expanded-telemedicine-prescription-delivery-policy 2026-09-08T03:51:12.560Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-requests-public-comments-on-draft-regulatory-science-standards 2026-09-08T03:51:12.369Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-invites-public-comments-on-draft-regulatory-science-standards 2026-09-08T03:51:12.157Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sandoz-anda076873-for-metformin-hydrochloride-extendedrelease-tablet 2026-09-08T02:51:05.650Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda083022-for-dodex-injectable-cyanocobalamin 2026-09-08T02:51:05.417Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-isoniazid-oral-tablet-anda083632 2026-09-08T01:50:59.211Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080693-for-hydrocortisone-1-topical-cream 2026-09-08T01:50:59.032Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-anda-080086-for-triple-sulfa-oral-tablet-by-purepac-pharm 2026-09-08T01:50:58.845Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-health-committee-awaits-schedule-for-pharmacy-law-amendments 2026-09-08T00:51:25.982Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076316-for-sodium-chloride-09-injection 2026-09-08T00:51:25.800Z weekly 0.7 https://pharmacountry.com/insights/analysis/kpa-and-paju-city-sign-mou-to-build-joint-pharma-logistics-hub-in-peace-economic-zone 2026-09-07T23:51:11.877Z weekly 0.7 https://pharmacountry.com/insights/news/korea-merck-highlights-bavencio-avelumab-for-urothelial-cancer 2026-09-07T23:51:11.678Z weekly 0.7 https://pharmacountry.com/insights/regulatory/human-tissue-distributor-a-receives-one-month-suspension-for-sop-breach 2026-09-07T23:51:11.428Z weekly 0.7 https://pharmacountry.com/insights/regulatory/서울시약사회-비대면진료-의약품-배송-확대안전상비제도창고형-약국-확대에-대한-임시대의원총회-소집-촉구 2026-09-07T22:50:57.500Z weekly 0.7 https://pharmacountry.com/insights/news/veteran-rd-scientist-dr-shin-heejong-publishes-new-practical-pharmacology-book 2026-09-07T22:50:57.290Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-expands-controlled-substance-monitoring-to-include-propofol 2026-09-07T22:50:57.075Z weekly 0.7 https://pharmacountry.com/insights/regulatory/four-experts-appointed-as-direct-advisors-to-korean-national-assembly-speaker-including-former-mfds-chief 2026-09-07T21:51:39.286Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-strengthens-onsite-monitoring-of-medical-narcotics-with-new-training-program 2026-09-07T21:51:39.053Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-lawmaker-proposes-mandatory-psychiatric-care-for-inmates-with-mental-health-risks 2026-09-07T21:51:38.852Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-association-holds-343rd-day-relay-rally-at-blue-house-over-herbal-pharmacist-issues 2026-09-07T20:51:01.110Z weekly 0.7 https://pharmacountry.com/insights/news/wonju-pharma-society-trains-instructors-on-narcotic-misuse-prevention 2026-09-07T20:51:00.915Z weekly 0.7 https://pharmacountry.com/insights/news/koreas-medical-innovation-committee-proposes-integrated-regional-health-system-for-superaged-society 2026-09-07T20:51:00.747Z weekly 0.7 https://pharmacountry.com/insights/regulatory/광주지방법원-처방전-외-약-조제-약사에-300만원-벌금-선고 2026-09-07T20:51:00.559Z weekly 0.7 https://pharmacountry.com/insights/analysis/sk-biopharm-secures-global-rights-to-biohavens-opakalim-bhv7000-for-epilepsy 2026-09-07T19:51:43.956Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-reveals-illegal-distribution-of-unapproved-foreign-medicines-in-korean-import-markets 2026-09-07T19:51:43.742Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-national-audit-flags-weak-telemedicine-narcotics-prescription-oversight 2026-09-07T19:51:43.503Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-forms-emergency-committee-to-address-expanded-telemedicine-drug-delivery 2026-09-07T18:51:03.357Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-association-welcomes-pharmacy-naming-law-amendment 2026-09-07T18:51:03.117Z weekly 0.7 https://pharmacountry.com/insights/news/donghwa-pharmaceutical-chairman-yoon-do-jun-highlights-129year-pharma-legacy-and-role-of-future-pharmacists 2026-09-07T17:51:49.062Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrions-ramcima-sc-and-us-zimpenra-post-456-trillion-krw-h1-sales 2026-09-07T17:51:48.846Z weekly 0.7 https://pharmacountry.com/insights/reports/daewoong-pharma-secures-uspto-patent-for-eturna-ionizable-lipid-technology 2026-09-07T17:51:48.573Z weekly 0.7 https://pharmacountry.com/insights/analysis/hecto-healthcare-to-showcase-probiotic-and-babykids-brands-at-vitafoods-asia-2026-in-bangkok 2026-09-07T16:51:03.596Z weekly 0.7 https://pharmacountry.com/insights/regulatory/amgen-koreas-blincyto-gains-healthinsurance-coverage-for-phnegative-bcell-all-in-sep-2024 2026-09-07T16:51:03.337Z weekly 0.7 https://pharmacountry.com/insights/regulatory/us-regulators-say-ai-generated-influencers-promoting-supplements-must-meet-same-truth-standards 2026-09-07T16:51:03.073Z weekly 0.7 https://pharmacountry.com/insights/reports/lundbeck-expands-use-of-eversana-ai-agency-platform-across-us-commercial-ops 2026-09-07T15:51:02.121Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-writers-association-launches-literary-corner 2026-09-07T15:51:01.881Z weekly 0.7 https://pharmacountry.com/insights/news/systemic-lupus-erythematosus-in-women-2040-fatigue-joint-pain-rash 2026-09-07T14:51:08.079Z weekly 0.7 https://pharmacountry.com/insights/news/1등약국-프로젝트-시즌-2-시작-현장-약사-참여로-실무-경영-노하우-제공 2026-09-07T13:51:07.550Z weekly 0.7 https://pharmacountry.com/insights/news/sk-biopharm-invests-in-opakalim-bhv7000-epilepsy-candidate 2026-09-07T12:51:30.716Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-advances-pharmacy-name-restriction-law-to-curb-consumer-misuse 2026-09-07T12:51:30.546Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-health-authorities-guide-duplicateprescription-claims-for-disasterarea-patients 2026-09-07T11:51:21.648Z weekly 0.7 https://pharmacountry.com/insights/regulatory/six-rsacovered-oncology-drugs-see-contract-changes-and-renewals-in-korea 2026-09-07T11:51:21.455Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharma-bio-leaders-call-for-nextgen-modalities-ai-integration-and-regulatory-reform 2026-09-07T11:51:21.224Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacy-goodwill-prices-in-seoul-area-exceed-typical-salesmultiple-calculations 2026-09-07T10:51:04.034Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacy-students-urge-caution-on-expanding-drug-delivery-services 2026-09-07T10:51:03.742Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-insurance-review-assessment-service-appoints-prof-oh-joo-hwan-as-new-director-of-policy-research-institute 2026-09-07T09:51:02.586Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-passes-pharmacist-law-amendment-restricting-pharmacy-names-that-may-promote-drug-overconsumption 2026-09-07T09:51:02.380Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-pharmacists-association-provides-hygiene-products-and-supplements-to-vulnerable-children-and-youth 2026-09-07T08:51:03.203Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-pharmacists-association-calls-for-prompt-review-of-pending-pharmacy-legislation 2026-09-07T08:51:02.988Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-demand-emergency-kpa-meeting-over-expanded-remote-prescription-delivery 2026-09-07T07:52:17.483Z weekly 0.7 https://pharmacountry.com/insights/reports/gyeonggi-do-pharmaceutical-association-and-pulsenell-sign-mou-to-use-ai-health-platform-mindfulness 2026-09-07T07:52:17.237Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-pharmacists-association-and-student-group-sign-future-pharmacist-partnership-agreement 2026-09-07T06:52:16.190Z weekly 0.7 https://pharmacountry.com/insights/news/sk-biopharm-secures-global-rights-to-opakalim-expands-epilepsy-portfolio 2026-09-07T05:51:33.532Z weekly 0.7 https://pharmacountry.com/insights/reports/vaxdigm-joins-korean-govt-project-to-develop-nextgen-antivirals-for-rna-viruses 2026-09-07T05:51:33.320Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-parliament-passes-pharmacy-naming-restriction-law 2026-09-07T04:52:36.729Z weekly 0.7 https://pharmacountry.com/insights/news/novartis-korea-holds-semblix-step-symposium-on-cml-therapy 2026-09-07T04:52:36.498Z weekly 0.7 https://pharmacountry.com/insights/regulatory/alpbio-executive-receives-mfds-director-award-for-functional-food-contributions 2026-09-07T03:51:28.782Z weekly 0.7 https://pharmacountry.com/insights/regulatory/government-to-discuss-expanding-telemedicine-medication-delivery-issue-expected-in-national-audit 2026-09-07T03:51:28.544Z weekly 0.7 https://pharmacountry.com/insights/regulatory/national-bio-innovation-committee-urges-integrated-regulatory-and-investment-reform-at-cphi-korea-2026 2026-09-07T03:51:28.367Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-marks-342day-relay-protest-over-herbal-pharmacist-licensing 2026-09-07T02:51:52.230Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-ngos-oppose-government-plan-to-expand-remote-prescription-drug-delivery-to-all-patients 2026-09-07T02:51:52.028Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-lawmaker-proposes-amendment-to-align-national-health-insurance-act-terminology-with-tax-collection-law 2026-09-07T02:51:51.728Z weekly 0.7 https://pharmacountry.com/insights/regulatory/national-health-insurance-ilsan-hospital-to-host-2026-insurer-hospital-policy-forum 2026-09-07T01:51:31.070Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hira-appoints-prof-oh-joo-hwan-as-director-of-policy-research-institute 2026-09-07T01:51:30.884Z weekly 0.7 https://pharmacountry.com/insights/regulatory/over-60-of-korean-regions-lack-pediatric-palliative-care-support-institutions 2026-09-07T01:51:30.686Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-ngos-oppose-expansion-of-telemedicine-prescription-delivery-to-all-patients 2026-09-07T01:51:30.444Z weekly 0.7 https://pharmacountry.com/insights/news/solbit-pf-chairperson-son-won-roks-mother-lee-young-ji-passes-away-at-90 2026-09-07T00:52:21.856Z weekly 0.7 https://pharmacountry.com/insights/news/daewoong-pharmaceutical-joins-seouls-bloodglucose-catch-9988-prediabetes-program 2026-09-07T00:52:21.659Z weekly 0.7 https://pharmacountry.com/insights/analysis/eu-establishes-new-supply-chain-for-visudyne-to-address-shortage 2026-09-06T23:51:03.272Z weekly 0.7 https://pharmacountry.com/insights/analysis/daewon-pharmaceutical-continues-production-and-sale-of-cough-expectorant-kodaewon 2026-09-06T23:51:03.020Z weekly 0.7 https://pharmacountry.com/insights/reports/kcdc-releases-2025-injury-statistics-highlighting-agespecific-risks-in-er-patients 2026-09-06T23:51:02.786Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-cdc-launches-nationwide-hairy-tick-surveillance-for-autumn-season 2026-09-06T22:51:03.280Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chungbuk-pharmacists-and-students-protest-for-clear-hanyaksa-licensing 2026-09-06T22:51:03.030Z weekly 0.7 https://pharmacountry.com/insights/reports/high-intensity-unpaid-caregiving-linked-to-depression-and-lower-life-satisfaction-canadian-study-finds 2026-09-06T21:51:04.311Z weekly 0.7 https://pharmacountry.com/insights/analysis/wells-fargo-analysis-glp-1-obesity-drugs-disrupt-us-healthcare-revenue-model 2026-09-06T21:51:04.099Z weekly 0.7 https://pharmacountry.com/insights/regulatory/roche-and-eli-lillys-elecsys-ptau217-blood-test-receives-fda-approval 2026-09-06T21:51:03.855Z weekly 0.7 https://pharmacountry.com/insights/regulatory/eu-approves-gileads-trodelvy-with-mercks-keytruda-for-pdl1positive-triplenegative-breast-cancer 2026-09-06T20:51:02.727Z weekly 0.7 https://pharmacountry.com/insights/reports/intermittent-fasting-reduces-chronic-pain-and-improves-cognition-in-rat-study 2026-09-06T20:51:02.503Z weekly 0.7 https://pharmacountry.com/insights/reports/leisure-exercise-lowers-dementia-risk-occupational-labor-may-raise-it-study-shows 2026-09-06T19:51:59.816Z weekly 0.7 https://pharmacountry.com/insights/news/heatrelated-exercise-risks-rhabdomyolysis-and-kidney-injury 2026-09-06T19:51:59.640Z weekly 0.7 https://pharmacountry.com/insights/news/drug-addiction-counseling-demand-rises-1342-hotline-cases-up-30-in-july 2026-09-06T19:51:59.386Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-advises-against-repeated-strong-backthumping-for-muscle-relief-during-hiking 2026-09-06T18:51:52.195Z weekly 0.7 https://pharmacountry.com/insights/news/daewoong-pharma-resolves-distribution-conflict-renames-regional-wholesale-to-distribution-partner 2026-09-06T18:51:51.938Z weekly 0.7 https://pharmacountry.com/insights/regulatory/three-new-drugs-enter-final-health-insurance-pricing-negotiations-in-korea 2026-09-06T18:51:51.643Z weekly 0.7 https://pharmacountry.com/insights/regulatory/85-korean-drugs-set-for-price-reductions-following-pva-negotiations 2026-09-06T18:51:51.363Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-accused-of-compounding-rx-drugs-without-pharmacist 2026-09-06T17:51:03.199Z weekly 0.7 https://pharmacountry.com/insights/reports/pharmacies-offer-more-than-medication-arrows-theory-on-uncertainty-info-asymmetry 2026-09-06T17:51:02.917Z weekly 0.7 https://pharmacountry.com/insights/analysis/metropolitan-pharmacy-franchise-fees-diverge-from-traditional-salesmultiple-formula 2026-09-06T16:51:02.048Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-pharmacists-association-calls-for-emergency-assembly-over-expanded-telemedicine-drug-delivery 2026-09-06T16:51:01.808Z weekly 0.7 https://pharmacountry.com/insights/regulatory/democratic-party-policy-chief-cautions-against-premature-expansion-of-telemedicine-drug-delivery-in-korea 2026-09-06T15:51:28.488Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-vows-strong-opposition-to-govt-full-prescription-drug-delivery-expansion 2026-09-06T15:51:28.286Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-fair-trade-commission-refunds-over-100-bn-krw-in-fines-despite-90-winrate-claim 2026-09-06T15:51:28.065Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lawmaker-proposes-national-suicide-prevention-fund-pm-signals-support 2026-09-06T14:51:03.086Z weekly 0.7 https://pharmacountry.com/insights/news/proposal-to-institutionalize-multidisciplinary-inpatient-care-with-ward-pharmacists-in-korea 2026-09-06T14:51:02.854Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-urges-multidisciplinary-inpatient-care-with-dedicated-pharmacists 2026-09-06T13:51:44.623Z weekly 0.7 https://pharmacountry.com/insights/news/ulsangyeongnam-health-review-office-partners-with-seniors-for-safe-medicine-disposal 2026-09-06T13:51:44.412Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-insurance-premium-relief-and-extra-benefits-for-disasterhit-residents-in-gyeongbuk-and-gyeongnam 2026-09-06T13:51:44.145Z weekly 0.7 https://pharmacountry.com/insights/regulatory/uk-enacts-tobacco-and-vapes-act-2026-to-protect-future-nonsmoking-generation 2026-09-06T12:51:42.955Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-health-ngos-criticize-governments-telemedicine-drug-delivery-expansion 2026-09-06T12:51:42.750Z weekly 0.7 https://pharmacountry.com/insights/news/sanofi-wins-top-privatesector-award-for-elderly-respiratory-health-campaign-in-korea 2026-09-06T12:51:42.578Z weekly 0.7 https://pharmacountry.com/insights/analysis/metagenics-launches-korean-market-with-free-phyto-multi-multivitamin-promotion 2026-09-06T11:51:57.917Z weekly 0.7 https://pharmacountry.com/insights/news/amgen-korea-hosts-2026-japac-vision-symposium-on-thyroid-eye-disease 2026-09-06T11:51:57.651Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrion-expands-omliclo-omalizumab-biosimilar-line-with-300-mg-launch-in-europe 2026-09-06T11:51:57.400Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hubase-hosts-2026-pharmacy-opening-symposium-on-risk-management-in-seoul 2026-09-06T10:51:54.509Z weekly 0.7 https://pharmacountry.com/insights/reports/lotte-biologics-secures-gseed-excellent-grade-for-songdo-bio-campus-phase-1 2026-09-06T10:51:54.273Z weekly 0.7 https://pharmacountry.com/insights/reports/biosolution-and-merck-life-science-unveil-animalfree-testing-solution-at-cphi-korea-2026 2026-09-06T10:51:54.020Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-prac-launches-review-of-injectable-iron-medicines-over-hypophosphatemia-risk 2026-09-06T09:50:56.547Z weekly 0.7 https://pharmacountry.com/insights/news/kpa-president-kwon-young-hee-visits-incheon-and-gyeongbuk-healthvulnerable-areas-to-assess-drug-access 2026-09-06T09:50:56.299Z weekly 0.7 https://pharmacountry.com/insights/news/iksoo-pharmaceutical-launches-community-herbal-scentpouch-program-to-gauge-consumer-perceptions 2026-09-06T09:50:56.099Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-to-expand-telemedicine-prescription-delivery-faces-hurdles 2026-09-06T08:51:03.944Z weekly 0.7 https://pharmacountry.com/insights/regulatory/tds-farm-fined-1935-million-krw-for-recordkeeping-violations-in-kataplasmaze-contract-manufacturing 2026-09-06T08:51:03.714Z weekly 0.7 https://pharmacountry.com/insights/reports/kpis-portal-and-related-drug-information-systems-to-undergo-maintenance-on-29th-possible-interruptions 2026-09-06T07:51:20.249Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacies-gain-regulatory-boost-for-custom-health-foods 2026-09-06T07:51:20.004Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-relay-protest-marks-341st-day-demanding-resolution-of-hanyaksa-issues 2026-09-06T07:51:19.774Z weekly 0.7 https://pharmacountry.com/insights/analysis/seltrion-tops-k-brand-index-pharmabio-sector-in-korea 2026-09-06T06:50:58.830Z weekly 0.7 https://pharmacountry.com/insights/news/koreas-new-drug-foundation-and-tech-guarantee-fund-name-standup-therapeutics-ticaros-as-ip-value-smes 2026-09-06T06:50:58.572Z weekly 0.7 https://pharmacountry.com/insights/reports/br-p-connect-and-pharmaceutical-policy-research-institute-sign-mou-for-datadriven-policy-research 2026-09-06T06:50:58.373Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gc-green-cross-secures-hunterraze-approvals-in-india-and-taiwan-expands-asian-raredisease-market 2026-09-06T05:51:05.082Z weekly 0.7 https://pharmacountry.com/insights/reports/short-high-intensity-exercise-triggers-broad-blood-protein-changes-study-finds 2026-09-06T05:51:04.803Z weekly 0.7 https://pharmacountry.com/insights/reports/study-suggests-combining-potassium-increase-with-sodium-reduction-improves-hypertension-control 2026-09-06T04:50:56.945Z weekly 0.7 https://pharmacountry.com/insights/analysis/eli-lilly-and-novo-nordisk-vie-for-obesity-drug-market-amid-pricing-and-prescriber-preferences 2026-09-06T04:50:56.716Z weekly 0.7 https://pharmacountry.com/insights/reports/pharmacists-urged-to-guide-patients-on-ai-driven-digital-health-tools 2026-09-06T04:50:56.469Z weekly 0.7 https://pharmacountry.com/insights/news/restaurant-review-man-su-mu-kang-course-featured-in-recent-kpa-news-article 2026-09-06T03:52:15.482Z weekly 0.7 https://pharmacountry.com/insights/regulatory/koreas-central-pharmaceutical-review-committee-conditions-approval-of-handoks-myelofibrosis-drug-for-low-platelet-patients 2026-09-06T03:52:15.317Z weekly 0.7 https://pharmacountry.com/insights/reports/boehringer-ingelheim-halts-phase-1-trial-of-oral-small-molecule-bi-3031185-over-safety-event 2026-09-06T02:51:56.009Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-drugs-pinteplaac-breztri-aerosphere-polaiviju-and-beova-jeong-set-for-reimbursement 2026-09-06T02:51:55.786Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacies-with-365-in-name-rise-indicating-growing-365day-service-model 2026-09-06T02:51:55.575Z weekly 0.7 https://pharmacountry.com/insights/analysis/hanmi-pharmaceutical-signs-23b-exclusive-license-with-genentech-for-obesity-drug-candidate-hm17321 2026-09-06T01:51:02.285Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-debates-expanding-drug-delivery-for-telemedicine-patients-amid-pharmacist-opposition 2026-09-06T01:51:02.039Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-act-amendment-to-restrict-pharmacy-names-moves-toward-plenary-vote 2026-09-06T00:52:01.974Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-oppose-government-plan-to-expand-prescription-delivery-for-all-telemedicine-patients 2026-09-06T00:52:01.788Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacy-franchise-fees-in-seoul-deviate-from-traditional-salesmultiple-formula 2026-09-06T00:52:01.566Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmaker-introduces-bill-to-improve-emergency-medical-staff-compensation 2026-09-05T23:51:08.552Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lawmaker-urges-national-medical-school-and-central-hospital-to-bridge-regional-healthcare-gaps 2026-09-05T23:51:08.336Z weekly 0.7 https://pharmacountry.com/insights/news/jw중외제약-프렌즈-아이케어-브랜드를-화장품의료기기식품까지-확대 2026-09-05T23:51:08.168Z weekly 0.7 https://pharmacountry.com/insights/news/ai-시대-약사-역할과-진로-확대-논의-대구-명사특강-개최 2026-09-05T22:51:55.977Z weekly 0.7 https://pharmacountry.com/insights/news/dong-a-socio-group-holds-phoenix-super-camp-for-employees-children 2026-09-05T22:51:55.802Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-to-expand-pharmacy-data-shared-with-telemedicine-platforms-raising-privacy-concerns 2026-09-05T22:51:55.589Z weekly 0.7 https://pharmacountry.com/insights/regulatory/dongjakgu-pharmacy-association-urges-immediate-halt-to-expanded-prescription-delivery-for-telemedicine 2026-09-05T22:51:55.349Z weekly 0.7 https://pharmacountry.com/insights/regulatory/보건복지부-2026년-혁신형-제약기업-평가기준-전면-확정 2026-09-05T21:52:21.052Z weekly 0.7 https://pharmacountry.com/insights/regulatory/democratic-party-official-urges-patientfirst-focus-in-government-drugdelivery-expansion 2026-09-05T21:52:20.852Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ministry-of-health-and-welfare-appoints-kim-minjung-as-section-chief-of-medical-information-policy 2026-09-05T21:52:20.640Z weekly 0.7 https://pharmacountry.com/insights/regulatory/japanese-home-medication-models-highlighted-at-korean-integrated-care-conference 2026-09-05T20:51:58.370Z weekly 0.7 https://pharmacountry.com/insights/news/south-korea-to-chair-apec-health-working-group-20262027-driving-regional-health-cooperation 2026-09-05T20:51:58.165Z weekly 0.7 https://pharmacountry.com/insights/reports/rhodiola-rosea-홍경천-adaptogen-with-rosavin-and-salidroside 2026-09-05T20:51:57.915Z weekly 0.7 https://pharmacountry.com/insights/news/nhis-expands-polypharmacy-management-program-amid-community-integrated-care-expansion 2026-09-05T19:52:14.084Z weekly 0.7 https://pharmacountry.com/insights/regulatory/isotretinoin-linked-to-joint-pain-in-50yearold-woman-with-seborrheic-dermatitis 2026-09-05T19:52:13.836Z weekly 0.7 https://pharmacountry.com/insights/reports/chronic-rhinitis-prevalence-classification-and-standard-therapies 2026-09-05T19:52:13.597Z weekly 0.7 https://pharmacountry.com/insights/news/parkinsons-disease-management-requires-more-than-medication 2026-09-05T18:51:55.445Z weekly 0.7 https://pharmacountry.com/insights/reports/parkinsons-disease-pathology-symptoms-and-current-treatment-options 2026-09-05T18:51:55.242Z weekly 0.7 https://pharmacountry.com/insights/reports/parkinsons-disease-dopamine-therapy-limits-and-emerging-nonmotor-symptom-concerns 2026-09-05T18:51:55.042Z weekly 0.7 https://pharmacountry.com/insights/news/avodart-05-mg-dutasteride-inhibits-both-5αreductase-types-for-hair-loss-and-bph 2026-09-05T18:51:54.821Z weekly 0.7 https://pharmacountry.com/insights/news/korea-menarini-shifts-to-specialty-care-launches-prostate-cancer-drug-enzalex 2026-09-05T17:51:02.282Z weekly 0.7 https://pharmacountry.com/insights/reports/study-finds-38-of-korean-parkinsons-patients-receive-potentially-inappropriate-medications 2026-09-05T17:51:02.085Z weekly 0.7 https://pharmacountry.com/insights/news/avodart-05-mg-soft-capsules-inhibit-dht-by-blocking-both-type-i-and-ii-5αreductase 2026-09-05T16:51:51.881Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-koreas-parliament-accelerates-pharmacy-legislation-eyes-pharmacy-name-restriction-act 2026-09-05T16:51:51.670Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmacy-society-holds-2026-polypharmacy-collaboration-conference 2026-09-05T16:51:51.458Z weekly 0.7 https://pharmacountry.com/insights/reports/pharmacies-use-claude-design-to-create-aipowered-patient-brochures 2026-09-05T15:51:57.912Z weekly 0.7 https://pharmacountry.com/insights/analysis/jeil-pharm-focuses-zaqubo-production-as-quzetas-and-oncap-halted-raising-supply-concerns 2026-09-05T15:51:57.684Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-oppose-government-plan-to-expand-telemedicine-prescription-delivery 2026-09-05T15:51:57.399Z weekly 0.7 https://pharmacountry.com/insights/regulatory/telemedicine-institutionalization-shifts-focus-to-prescription-dispensing-and-drug-delivery-in-korea 2026-09-05T14:51:03.511Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-association-urges-pause-on-expanding-remote-prescription-delivery 2026-09-05T14:51:03.268Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ewha-pharmacy-alumni-association-adopts-resolution-on-safe-medication-use 2026-09-05T13:51:06.177Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-junggu-pharmacists-association-opposes-govt-expansion-of-emergency-drug-sales 2026-09-05T13:51:05.824Z weekly 0.7 https://pharmacountry.com/insights/news/lee-kyung-dong-promotion-director-of-gyeongbuk-advancement-andong-sobeksan-pharmacy-announces-fathers-passing 2026-09-05T12:51:04.252Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-to-conduct-targeted-inspections-of-customized-health-functional-food-sellers-aug-24-28 2026-09-05T12:51:03.944Z weekly 0.7 https://pharmacountry.com/insights/regulatory/jeju-pharmacists-association-opposes-government-drug-delivery-expansion 2026-09-05T11:51:48.348Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-selects-10-functional-ingredients-including-bilberry-extract-for-2027-reevaluation 2026-09-05T11:51:48.196Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sandoz-dralserp-tablet-hydralazine-hclreserpine-anda084617 2026-09-05T11:51:47.955Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chlorpromazine-hydrochloride-anda084113-fda-approval 2026-09-05T10:50:58.038Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-manufacturing-and-labeling-for-propoxyphe-ne-hydrochloride-65-mg-oral-capsules 2026-09-05T10:50:57.830Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-aminophylline-injection-anda081142-by-teva-parenteral 2026-09-05T10:50:57.634Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nda007392-for-secobarbital-sodium-injection-seconal 2026-09-05T09:51:01.480Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078292-for-dronabinol-oral-capsules-discontinued 2026-09-05T09:51:01.184Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080517-for-prednisolone-sodium-phosphate-injection 2026-09-05T08:50:52.343Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sorbitol-3-irrigation-solution-nda017863 2026-09-05T08:50:52.139Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharma-firms-recall-batches-of-diabetes-drugs-and-antiemetics-over-quality-issues 2026-09-05T08:50:51.902Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gyeonggi-pharmacy-leaders-oppose-governments-home-delivery-expansion-for-telemedicine 2026-09-05T08:50:51.697Z weekly 0.7 https://pharmacountry.com/insights/news/yuhan-yanghang-delivers-antiinflammatory-patch-boxes-to-elderly-national-merit-recipients 2026-09-05T08:50:51.421Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078889-for-metoprolol-succinate-extendedrelease-tablets 2026-09-05T07:50:55.475Z weekly 0.7 https://pharmacountry.com/insights/news/joa-pharmaceutical-launches-three-jalkton-powder-health-supplements-for-growth-stage 2026-09-05T07:50:55.264Z weekly 0.7 https://pharmacountry.com/insights/regulatory/samjin-pharmaceutical-conducts-dementia-awareness-training-and-pursues-leading-company-certification 2026-09-05T07:50:55.023Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmaresearchs-rejuran-cosmetic-to-enter-singapore-sephora-via-olive-young-kbeauty-edit 2026-09-05T07:50:54.815Z weekly 0.7 https://pharmacountry.com/insights/analysis/easymedicom-partners-with-ism-korea-to-launch-chsca-and-chscm-certifications-in-korea 2026-09-05T06:50:58.702Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-hydroxyzine-hydrochloride-injection-anda087592 2026-09-05T06:50:58.459Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-fluonid-topical-ointment-anda-087157 2026-09-05T06:50:58.247Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-dextroamphetamine-sulfate-tablet-5-mg-as-discontinued-anda-086521 2026-09-05T05:51:09.462Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda085964-for-acetaminophen-and-codeine-phosphate-tablet 2026-09-05T05:51:09.177Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-077395-for-paroxetine-hydrochloride-oral-suspension-discontinued 2026-09-05T05:51:08.932Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-pharma-licenses-metabolic-drug-hm17321-to-genentech-for-global-development 2026-09-05T04:51:03.826Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-updates-labels-for-inhaled-triple-therapy-and-caspofungin-amid-postmarketing-findings 2026-09-05T04:51:03.627Z weekly 0.7 https://pharmacountry.com/insights/reports/study-finds-depression-impairs-hippocampal-neurogenesis-process 2026-09-05T03:50:57.668Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacies-risk-prescription-errors-by-misreading-patient-names-highlights-recent-commentary 2026-09-05T03:50:57.508Z weekly 0.7 https://pharmacountry.com/insights/reports/medication-errors-in-korean-pharmacies-focus-on-patients-65 2026-09-05T03:50:57.292Z weekly 0.7 https://pharmacountry.com/insights/regulatory/quinapril-hydrochloride-and-hydrochlorothiazide-tablets-fda-labeling-approvals-anda-077093 2026-09-05T02:51:01.606Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076802-for-glimepiride-tablets-discontinued 2026-09-05T02:51:01.336Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-government-considers-expanding-telemedicine-drug-delivery-legislative-review-ongoing 2026-09-05T01:52:18.957Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-updates-for-discontinued-fenofibrate-tablet-products-anda-076520 2026-09-05T01:52:18.772Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076251-for-fluoxetine-hydrochloride-capsules-discontinued 2026-09-05T01:52:18.508Z weekly 0.7 https://pharmacountry.com/insights/regulatory/68-korean-medicines-face-insurance-price-cuts-starting-sept-1-pharmacies-warned-on-returns 2026-09-05T00:52:19.306Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077991-for-otc-cetirizinepseudoephedrine-extendedrelease-tablet 2026-09-05T00:52:19.097Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-apotex-latanoprost-ophthalmic-solution-anda077697 2026-09-05T00:52:18.833Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-to-expand-medication-delivery-for-all-telemedicine-patients 2026-09-04T23:51:03.884Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-do-pharmaceutical-society-holds-online-training-to-boost-homevisit-pharmacists-prescription-review-skills 2026-09-04T23:51:03.626Z weekly 0.7 https://pharmacountry.com/insights/regulatory/medibiolab-launches-gumgoods-health-supplement-using-mfdsapproved-pmec-ingredient 2026-09-04T22:51:52.414Z weekly 0.7 https://pharmacountry.com/insights/news/sports-pharmacy-society-and-jeju-pharmaceutical-association-hold-2026-sports-pharmacy-jeju-forum 2026-09-04T22:51:52.187Z weekly 0.7 https://pharmacountry.com/insights/reports/m2cloud-to-provide-coldcare-iot-service-for-modernas-mrna-vaccine-storage 2026-09-04T22:51:51.953Z weekly 0.7 https://pharmacountry.com/insights/regulatory/anguk-pharmaceutical-holds-company-wide-compliance-training-on-fair-trade-and-legal-risks 2026-09-04T21:51:03.152Z weekly 0.7 https://pharmacountry.com/insights/regulatory/opposition-parties-urge-ruling-party-to-end-boycott-of-health-committee-and-normalize-parliament 2026-09-04T21:51:02.937Z weekly 0.7 https://pharmacountry.com/insights/reports/jw중외제약-혈액종양내과-의사-대상-itpciacrs-최신-치료-전략-fantasy-심포지엄-개최 2026-09-04T20:51:03.212Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hazardous-ingredients-surge-in-overseas-directpurchase-health-foods-20232025 2026-09-04T20:51:02.937Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-gwangjingu-pharmaceutical-association-provides-otc-medicines-to-local-childrens-center 2026-09-04T19:51:59.304Z weekly 0.7 https://pharmacountry.com/insights/reports/da-information-renames-to-dai-targets-aibased-business-transformation 2026-09-04T19:51:59.053Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-celcuitys-revtorpyk-for-hrher2-breast-cancer-nonpik3ca 2026-09-04T19:51:58.784Z weekly 0.7 https://pharmacountry.com/insights/regulatory/novo-nordisk-secures-eu-approval-for-oral-wegovy-obesity-treatment 2026-09-04T18:50:24.305Z weekly 0.7 https://pharmacountry.com/insights/news/sanofi-sues-pfizer-and-moderna-over-lnp-patent-infringement 2026-09-04T18:50:24.102Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-alert-stryker-lifepak-r35-connector-seating-issue 2026-09-04T18:50:23.886Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-lifepak-r-35-monitor-defibrillator-may-have-improperly-seated-connectors 2026-09-04T18:50:23.654Z weekly 0.7 https://pharmacountry.com/insights/regulatory/new-minimum-wage-bills-target-small-businesses-may-affect-pharmacies 2026-09-04T17:51:02.780Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gsks-depemokimab-fails-korean-orphandrug-review-over-efficacy-concerns 2026-09-04T17:51:02.548Z weekly 0.7 https://pharmacountry.com/insights/reports/nicotinamide-supplement-linked-to-lower-glaucoma-risk-in-ocular-hypertension-patients 2026-09-04T16:50:25.666Z weekly 0.7 https://pharmacountry.com/insights/analysis/jongkundang-q2-outlook-steady-on-obesity-drug-wegobi-profit-forecast-slightly-below-consensus 2026-09-04T16:50:25.390Z weekly 0.7 https://pharmacountry.com/insights/regulatory/boston-scientific-initiates-recall-of-imager-ii-angiographic-catheters-over-tip-issue 2026-09-04T16:50:25.096Z weekly 0.7 https://pharmacountry.com/insights/regulatory/boston-scientific-initiates-recall-of-imager-ii-angiographic-catheters 2026-09-04T16:50:24.813Z weekly 0.7 https://pharmacountry.com/insights/reports/us-pilot-tests-fully-autonomous-robot-pharmacy-system 2026-09-04T15:51:04.233Z weekly 0.7 https://pharmacountry.com/insights/analysis/dongguk-pharmaceutical-projects-q2-sales-rise-on-overseas-cosmetics-growth 2026-09-04T15:51:03.986Z weekly 0.7 https://pharmacountry.com/insights/reports/daewoong-pharma-snu-bundang-hospital-and-365mc-launch-new-indication-study-for-volet-dca-injection 2026-09-04T14:50:32.666Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gore-reports-quality-issue-with-viabahn-devices-potentially-affecting-tip-bonding 2026-09-04T14:50:32.450Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gore-viabahn-device-quality-issue-identified 2026-09-04T14:50:32.247Z weekly 0.7 https://pharmacountry.com/insights/news/mapogu-pharmaceutical-society-holds-advisory-committee-meeting-highlights-2026-achievements 2026-09-04T13:52:01.616Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kada-receives-first-excellent-a-rating-in-2025-public-institution-management-evaluation 2026-09-04T13:52:01.398Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-and-students-hold-301day-relay-protest-at-cheong-wa-dae-over-han-yaksa-issues 2026-09-04T12:51:03.097Z weekly 0.7 https://pharmacountry.com/insights/reports/first-bundibugyo-ebola-virus-vaccine-enters-phase-1-trial-in-uk 2026-09-04T12:51:02.839Z weekly 0.7 https://pharmacountry.com/insights/reports/inefficient-patient-recruitment-reduces-eligible-enrollment-at-over-half-of-us-trial-sites-survey-shows 2026-09-04T11:51:00.699Z weekly 0.7 https://pharmacountry.com/insights/reports/mild-cardiac-dysfunction-linked-to-future-brain-changes-study-finds 2026-09-04T11:51:00.430Z weekly 0.7 https://pharmacountry.com/insights/reports/whoiarc-predicts-up-to-667-rise-in-global-cancer-cases-by-2050 2026-09-04T10:50:59.169Z weekly 0.7 https://pharmacountry.com/insights/reports/pharmacists-advise-caution-on-sinetrol-weightloss-ingredient 2026-09-04T10:50:58.955Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-marks-300-days-of-protest-over-herbal-pharmacist-licensing 2026-09-04T10:50:58.702Z weekly 0.7 https://pharmacountry.com/insights/reports/study-links-long-term-soccer-play-to-brain-atrophy-and-mood-issues 2026-09-04T09:51:01.380Z weekly 0.7 https://pharmacountry.com/insights/regulatory/dongguk-pharmaceuticals-rosutanmet-tablets-lose-health-insurance-coverage-after-approval-cancellation 2026-09-04T09:51:01.194Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharma-companies-reshape-distribution-networks-amid-pricecut-policies 2026-09-04T09:51:00.974Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-pushes-pharmacy-law-amendment-to-block-external-capital-in-pharmacies 2026-09-04T09:51:00.695Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daewoong-bio-receives-1month-manufacturing-suspension-over-claim-handling-lapse 2026-09-04T08:51:37.607Z weekly 0.7 https://pharmacountry.com/insights/reports/wegovy-semaglutide-shows-weight-loss-and-cardiovascular-benefits 2026-09-04T08:51:37.453Z weekly 0.7 https://pharmacountry.com/insights/regulatory/online-sale-of-pharmacyonly-otc-drugs-triggers-calls-for-stricter-regulation 2026-09-04T07:51:34.034Z weekly 0.7 https://pharmacountry.com/insights/analysis/kwangdong-pharmas-vline-corn-silk-tea-hits-16-billion-cumulative-sales-on-20th-anniversary 2026-09-04T07:51:33.810Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-health-ministry-announces-directorlevel-and-managerlevel-personnel-transfers 2026-09-04T06:52:13.649Z weekly 0.7 https://pharmacountry.com/insights/reports/progen-and-rani-therapeutics-report-early-phase-1a-results-for-oral-glp1glp2-obesity-drug-rpg102 2026-09-04T06:52:13.366Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kang-cheong-hee-appointed-chairman-of-south-koreas-national-health-insurance-service 2026-09-04T06:52:13.115Z weekly 0.7 https://pharmacountry.com/insights/analysis/bookwang-pharmas-regadex-ranks-second-in-south-koreas-liver-disease-combo-market-within-a-year 2026-09-04T05:52:03.205Z weekly 0.7 https://pharmacountry.com/insights/reports/dong-a-st-presents-nonclinical-data-on-gpx4-activator-da-7505-and-tau-inhibitor-da-7503-at-aaic 2026-09-04T05:52:02.927Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-lawmaker-introduces-three-bills-on-future-security-and-public-welfare 2026-09-04T05:52:02.690Z weekly 0.7 https://pharmacountry.com/insights/reports/daewoong-pharmaceutical-secures-liver-organoid-technology-via-kribb-partnership 2026-09-04T04:52:25.376Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-pharmaceutical-safety-agency-highlights-updated-narcotics-regulations-at-kma-2026-conference 2026-09-04T04:52:25.104Z weekly 0.7 https://pharmacountry.com/insights/regulatory/king-pharm-discontinues-quinidine-sulfate-oral-tablet-anda-085175 2026-09-04T03:51:27.591Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-labeling-updates-for-levetiracetam-oral-solution 2026-09-04T03:51:27.360Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090572-for-childrens-cetirizine-oral-solutions 2026-09-04T03:51:27.149Z weekly 0.7 https://pharmacountry.com/insights/news/hk-innon-expands-gen-z-reach-for-hangover-relief-brand-condition-via-student-supporters 2026-09-04T02:52:19.887Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda090249-for-chloroquine-phosphate-tablet-ipca-labs-now-discontinued 2026-09-04T02:52:19.601Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078948-for-ibandronate-sodium-tablet 2026-09-04T02:52:19.308Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda080667-submission-for-thiamine-hydrochloride-injection-discontinued 2026-09-04T01:51:27.712Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-subcutaneous-initiation-of-leqembi-for-alzheimers-by-biogen-eisai 2026-09-04T01:51:27.466Z weekly 0.7 https://pharmacountry.com/insights/analysis/astrazeneca-grants-dizal-pharmaceutical-global-rights-to-oral-egfr-lung-cancer-drug-zegfrovy 2026-09-04T01:51:27.194Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-issues-anda-approval-for-stilbestrol-oral-tablet-discontinued 2026-09-04T00:52:43.413Z weekly 0.7 https://pharmacountry.com/insights/analysis/biogens-alzheimer-antitau-candidate-diranersen-shows-mixed-phase-2-results-shares-drop 2026-09-04T00:52:43.232Z weekly 0.7 https://pharmacountry.com/insights/regulatory/germany-passes-health-insurance-premium-stabilization-law-seen-as-benchmark-for-korea 2026-09-04T00:52:43.039Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-mk-labs-sosol-500-mg-sulfisoxazole-oral-tablet-anda-080036-discontinued 2026-09-03T23:52:41.442Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078641-for-injectable-famotidine-mylan 2026-09-03T23:52:41.247Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078052-for-fosphenytoin-injection 2026-09-03T23:52:41.087Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ciplas-abacavir-sulfate-oral-solution-receives-tentative-fda-approval-anda-078348 2026-09-03T22:53:31.512Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-simvastatin-tablet-labeling-submissions-anda-077752 2026-09-03T22:53:31.301Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-fresenius-kabis-octreotide-acetate-injectable-anda-077457 2026-09-03T22:53:31.031Z weekly 0.7 https://pharmacountry.com/insights/news/korean-medical-association-reports-growing-share-of-korean-medicine-in-autoinsurance-claims 2026-09-03T21:51:29.946Z weekly 0.7 https://pharmacountry.com/insights/regulatory/woodwards-milrinone-lactate-injection-products-discontinued-anda077151 2026-09-03T21:51:29.716Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084712-for-bethanechol-chloride-tablet-10-mg-lannett 2026-09-03T21:51:29.498Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrion-accelerates-biosimilar-growth-in-europe-and-us-launches-ct-p68-trial 2026-09-03T20:51:28.717Z weekly 0.7 https://pharmacountry.com/insights/news/patient-admitted-to-bundang-cha-hospital-emergency-department-condition-critical 2026-09-03T20:51:28.473Z weekly 0.7 https://pharmacountry.com/insights/regulatory/green-cross-fined-for-delayed-postmarketing-study-of-hantabax-hemorrhagic-fever-vaccine 2026-09-03T20:51:28.215Z weekly 0.7 https://pharmacountry.com/insights/regulatory/temporary-reimbursement-granted-for-pediatric-smectite-after-indication-removal 2026-09-03T19:52:17.625Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacist-group-calls-for-further-revisions-to-otc-standard-manufacturing-criteria 2026-09-03T19:52:17.413Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084231-for-methocarbamol-500-mg-oral-tablet 2026-09-03T18:51:49.954Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-actavis-labs-metoprolol-succinate-extendedrelease-tablets-anda-076862 2026-09-03T18:51:49.729Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076576-for-sotalol-hydrochloride-tablets-by-sun-pharm-industries 2026-09-03T18:51:49.492Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda083606-for-butabarital-sodium-oral-tablet 2026-09-03T17:52:26.248Z weekly 0.7 https://pharmacountry.com/insights/regulatory/dicopac-kit 2026-09-03T17:52:26.032Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-cipla-cetirizine-allergy-tablets-anda077318 2026-09-03T17:52:25.802Z weekly 0.7 https://pharmacountry.com/insights/news/mapo-gu-pharmaceutical-association-completes-2026-first-half-audit-highlights-education-and-member-welfare-initiatives 2026-09-03T16:51:33.295Z weekly 0.7 https://pharmacountry.com/insights/regulatory/2027-minimum-wage-set-at-17000-krw-per-hour 2026-09-03T16:51:33.067Z weekly 0.7 https://pharmacountry.com/insights/reports/gyeongbuk-pharma-association-medinfols-sign-automation-deal-for-diabetes-prescriptions 2026-09-03T15:51:55.610Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-medical-devices-2428-aug-2026 2026-09-03T15:51:55.351Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-apotex-cilostazol-anda077030 2026-09-03T14:51:32.591Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-econopred-ophthalmic-suspension-nda-017468-discontinued 2026-09-03T14:51:32.277Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-anda076458-for-fluoxetine-hydrochloride-oral-solution-discontinued 2026-09-03T13:51:37.108Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-records-show-discontinued-aminophyllin-tablet-products-and-historical-submissions 2026-09-03T13:51:36.867Z weekly 0.7 https://pharmacountry.com/insights/regulatory/balt-extrusion-recalls-anryv-connectors-over-endotoxin-test-issue 2026-09-03T12:51:31.910Z weekly 0.7 https://pharmacountry.com/insights/regulatory/balt-extrusion-voluntarily-recalls-anryv-connectors-over-bacterial-endotoxin-test-failure 2026-09-03T12:51:31.663Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-pharmacists-association-launches-third-summer-healthsupport-activity-for-vulnerable-women 2026-09-03T11:52:33.726Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-to-hold-public-private-forum-on-digital-convergence-medicines-regulation 2026-09-03T11:52:33.538Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-government-boosts-drug-prevention-education-youth-awareness-scores-rise 2026-09-03T11:52:33.311Z weekly 0.7 https://pharmacountry.com/insights/regulatory/president-lee-calls-for-rapid-approval-and-prescription-system-for-abortion-medication 2026-09-03T10:51:39.865Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-adds-12-hospitals-to-police-investigation-over-alleged-cancer-patient-fee-refunds 2026-09-03T10:51:39.618Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078511-for-midazolam-hydrochloride-injection 2026-09-03T09:51:33.846Z weekly 0.7 https://pharmacountry.com/insights/regulatory/caraco-receives-tentative-fda-approval-for-escitalopram-anda078219 2026-09-03T09:51:33.586Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cipla-efavirenz-600mg-tablet-gets-fda-tentative-approval-anda-077916 2026-09-03T08:51:32.953Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda209610-for-clindamycin-phosphate-and-benzoyl-peroxide-gel 2026-09-03T08:51:32.730Z weekly 0.7 https://pharmacountry.com/insights/regulatory/german-parliament-passes-healthinsurance-reform-raising-original-drug-discount-to-155 2026-09-03T07:51:33.991Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chinas-fastfollower-model-pressures-biotech-ip-strategies 2026-09-03T07:51:33.761Z weekly 0.7 https://pharmacountry.com/insights/reports/diabetes-increases-risk-of-hearing-loss-especially-in-under60s 2026-09-03T06:51:34.022Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-holds-300day-relay-protest-to-demand-reform-of-herbal-pharmacist-licensing 2026-09-03T06:51:33.767Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lupin-anda209272-for-metoprolol-succinate-er-tablets 2026-09-03T05:51:32.507Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-tolsura-itraconazole-oral-capsule-nda208901 2026-09-03T05:51:32.253Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-forum-holds-2nd-reader-committee-meeting-to-refine-content-strategy 2026-09-03T04:52:00.366Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sanofi-aventis-uss-ornidyl-injection-eflornithine-hydrochloride-nda019879 2026-09-03T04:52:00.121Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda208181-for-tiagabine-tablets-amneal 2026-09-03T04:51:59.923Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-prilosec-omeprazole-nda-019810-submissions 2026-09-03T03:51:16.448Z weekly 0.7 https://pharmacountry.com/insights/reports/early-onset-dementia-linked-to-decline-in-work-productivity-up-to-15-years-prediagnosis 2026-09-03T02:52:14.186Z weekly 0.7 https://pharmacountry.com/insights/analysis/emerging-bio-clusters-expand-as-global-rd-space-tops-35m-sq-ft 2026-09-03T02:52:13.922Z weekly 0.7 https://pharmacountry.com/insights/reports/international-study-links-latenight-eating-to-higher-body-fat-and-metabolic-risk 2026-09-03T02:52:13.658Z weekly 0.7 https://pharmacountry.com/insights/regulatory/calls-intensify-for-normalization-of-korean-parliament-standing-committees 2026-09-03T01:52:31.047Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-reports-283-otc-adverse-events-highlighting-risks-with-common-cold-medicines 2026-09-03T01:52:30.686Z weekly 0.7 https://pharmacountry.com/insights/news/creative-rice-paper-wrapped-pork-cutlet-featured-at-jeckwa-donkatsu-in-damyang 2026-09-03T01:52:30.214Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda210272-for-buprenorphine-transdermal-patch 2026-09-03T00:50:58.141Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda209953-for-ranolazine-extendedrelease-tablets 2026-09-03T00:50:57.865Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lupins-cyanocobalamin-nasal-spray 2026-09-02T23:52:02.201Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-adjusts-drug-distribution-reporting-deadline-due-to-constitution-day-holiday 2026-09-02T23:52:01.935Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-methylphenidate-hydrochloride-oral-solution-anda-207417 2026-09-02T23:52:01.714Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda207047-for-clindamycin-palmitate-hydrochloride 2026-09-02T23:52:01.458Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda206666-approval-for-pentamidine-isethionate-injection 2026-09-02T23:52:01.189Z weekly 0.7 https://pharmacountry.com/insights/news/1등약국-프로젝트-시즌-2-시작-현장-약사-직접-필진-참여 2026-09-02T22:51:28.450Z weekly 0.7 https://pharmacountry.com/insights/analysis/namyang-dairy-collapse-triggers-longrunning-boycott-and-pharmacy-role-concerns-in-korea 2026-09-02T22:51:28.165Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacy-association-faces-criticism-over-large-pharmacy-bias-in-otc-oral-contraceptive-discount-promotion 2026-09-02T22:51:27.892Z weekly 0.7 https://pharmacountry.com/insights/analysis/large-martstyle-pharmacy-opens-in-seouls-olympic-park-foreon-expanding-into-dense-urban-market 2026-09-02T22:51:27.723Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-presidents-call-revives-domestic-mifepristone-approval-talks 2026-09-02T21:51:58.602Z weekly 0.7 https://pharmacountry.com/insights/news/daewoong-pharmaceutical-reports-96-parental-leave-return-rate-amid-expanded-govt-policy 2026-09-02T21:51:58.317Z weekly 0.7 https://pharmacountry.com/insights/news/korean-public-supports-local-routine-care-regional-hospitals-for-complex-treatments 2026-09-02T21:51:58.100Z weekly 0.7 https://pharmacountry.com/insights/regulatory/백종헌-의원-첨단재생의료법-일부개정안-14일-대표발의 2026-09-02T21:51:57.867Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-pharmaceutical-launches-hanmi-pentosan-capsule-for-interstitial-cystitis 2026-09-02T21:51:57.603Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lawmaker-cho-bo-yoon-holds-forum-on-monitoring-disability-convenience-facilities 2026-09-02T20:51:27.186Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-koreas-health-ministry-announces-major-organizational-overhaul 2026-09-02T20:51:26.950Z weekly 0.7 https://pharmacountry.com/insights/news/hubase-and-green-umbrella-launch-child-safety-mou-for-pharmacies 2026-09-02T20:51:26.687Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-concludes-12th-pharm-young-leader-academy-2026 2026-09-02T20:51:26.440Z weekly 0.7 https://pharmacountry.com/insights/regulatory/celltrion-maintains-aaa-aeo-certification-for-export-and-import 2026-09-02T20:51:26.228Z weekly 0.7 https://pharmacountry.com/insights/news/sanofi-highlights-comprehensive-long-term-management-for-fabry-disease-at-f1-symposium 2026-09-02T19:51:23.070Z weekly 0.7 https://pharmacountry.com/insights/news/goyang-city-pharmacists-association-completes-2026-h1-internal-audit-highlights-new-systems 2026-09-02T19:51:22.811Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-health-ministry-discuss-followup-on-traditional-pharmacist-and-warehouse-pharmacy-issues 2026-09-02T19:51:22.599Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gyeonggido-pharmacists-association-condemns-ftcs-pharmacy-advertising-restrictions 2026-09-02T19:51:22.362Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daewoong-pharma-dispute-over-blocktype-hub-wholesale-escalates 2026-09-02T19:51:22.066Z weekly 0.7 https://pharmacountry.com/insights/reports/stp0404-hiv1-candidate-shows-significant-antiviral-activity-in-us-phase-2a-trial 2026-09-02T18:50:58.845Z weekly 0.7 https://pharmacountry.com/insights/news/dongdaemun-pharmacists-association-sponsors-free-tango-cultural-performance 2026-09-02T18:50:58.585Z weekly 0.7 https://pharmacountry.com/insights/regulatory/2027-78th-pharmacist-national-exam-registration-opens-in-korea 2026-09-02T18:50:58.345Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-lp35-defibrillator-display-issue-identified 2026-09-02T18:50:58.092Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-association-supports-fast-abortion-drug-introduction 2026-09-02T17:51:05.113Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-lp35-defibrillator-fails-to-show-check-rhythm-prompt 2026-09-02T17:51:04.837Z weekly 0.7 https://pharmacountry.com/insights/regulatory/olympus-issues-recall-of-bicoag-hemostasis-probe-over-adhesive-defect 2026-09-02T16:50:36.007Z weekly 0.7 https://pharmacountry.com/insights/regulatory/olympus-recalls-bicoag-hemostasis-probe-over-adhesive-defect 2026-09-02T16:50:35.708Z weekly 0.7 https://pharmacountry.com/insights/regulatory/progen-begins-highdose-phase-1-trial-of-pg102-for-obesity 2026-09-02T15:51:35.833Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fair-trade-commission-closes-daewoong-pharma-wholesale-complaint 2026-09-02T15:51:35.534Z weekly 0.7 https://pharmacountry.com/insights/analysis/baropharm-launches-pharmacy-beauty-zones-targets-1000-pharmacies-nationwide 2026-09-02T14:51:36.709Z weekly 0.7 https://pharmacountry.com/insights/regulatory/biosolution-begins-domestic-clinical-development-of-speroqure-injectable-oa-cell-therapy 2026-09-02T14:51:36.401Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-song-jeong-suk-publishes-new-book-on-tumor-microenvironment-and-chronic-inflammation 2026-09-02T13:51:39.262Z weekly 0.7 https://pharmacountry.com/insights/news/mapo-district-pharmacists-association-updates-hall-reconstruction-progress 2026-09-02T13:51:39.019Z weekly 0.7 https://pharmacountry.com/insights/regulatory/blood-contamination-risk-in-quantum-pureflow-heat-exchanger 2026-09-02T12:50:32.794Z weekly 0.7 https://pharmacountry.com/insights/regulatory/potential-blood-contamination-risk-identified-in-quantum-pureflow-heat-exchanger 2026-09-02T12:50:32.527Z weekly 0.7 https://pharmacountry.com/insights/analysis/yuhan-corp-drug-business-exceeds-14-trillion-krw-in-2025-sales 2026-09-02T11:51:04.573Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-of-fatal-embolism-risk-when-parenteral-nutrition-administered-without-filter 2026-09-02T11:51:04.282Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-use-filters-for-parenteral-nutrition-to-prevent-fatal-embolism 2026-09-02T10:51:38.082Z weekly 0.7 https://pharmacountry.com/insights/reports/insilico-medicine-and-china-medical-system-holdings-sign-177b-cns-codevelopment-deal 2026-09-02T09:51:35.781Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacists-hold-299th-day-relay-protest-demanding-reform-of-korean-herbal-pharmacist-system 2026-09-02T09:51:35.553Z weekly 0.7 https://pharmacountry.com/insights/reports/q32-bios-bempikibart-demonstrates-clinical-improvement-in-phase-2-alopecia-areata-trial 2026-09-02T08:51:33.944Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-bill-aims-to-support-small-businesses-at-risk-of-closure-including-pharmacies 2026-09-02T08:51:33.765Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-approves-zinc-citrate-and-iron-chelate-as-new-nutrientfortification-ingredients 2026-09-02T08:51:33.514Z weekly 0.7 https://pharmacountry.com/insights/analysis/lc-bio-eyes-china-production-and-us-launch-for-skin-booster-re20-expects-strong-h2-growth 2026-09-02T07:52:37.061Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-tightens-penalties-for-drugimpaired-driving-after-apgujeong-rollsroyce-incident 2026-09-02T07:52:36.770Z weekly 0.7 https://pharmacountry.com/insights/regulatory/samchundang-pharma-receives-manufacturing-suspension-over-test-record-violations-and-recall-plan-failure 2026-09-02T06:51:27.895Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kim-taeyong-pharmacist-wins-2026-otc-adverseevent-reporting-event 2026-09-02T06:51:27.673Z weekly 0.7 https://pharmacountry.com/insights/reports/short-term-sleep-reduction-linked-to-weight-gain-and-lower-activity-in-6week-study 2026-09-02T06:51:27.366Z weekly 0.7 https://pharmacountry.com/insights/analysis/nextgeneration-drug-conjugates-project-doubledigit-growth-market-to-reach-425b-by-2035 2026-09-02T04:52:07.199Z weekly 0.7 https://pharmacountry.com/insights/analysis/20s-in-korea-prefer-olive-young-for-vitamins-pharmacies-for-cold-medicine 2026-09-02T03:51:55.055Z weekly 0.7 https://pharmacountry.com/insights/reports/light-physical-activity-boosts-survival-in-elderly-copd-patients-mayo-clinic-study-finds 2026-09-02T03:51:54.760Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-pfizerastellas-padcev-and-merck-keytruda-combo-for-all-mibc-patients 2026-09-02T03:51:54.545Z weekly 0.7 https://pharmacountry.com/insights/reports/eli-lilly-and-novo-nordisk-lead-ai-platform-citations-among-pharma-companies 2026-09-02T02:51:36.689Z weekly 0.7 https://pharmacountry.com/insights/news/kangwon-national-university-pharmacy-college-boosts-practical-training-with-osce 2026-09-02T01:51:36.695Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-five-new-products-in-june-spanning-cell-therapy-to-biosimilars 2026-09-02T01:51:36.492Z weekly 0.7 https://pharmacountry.com/insights/regulatory/special-police-authority-bill-revived-amid-new-pharmacy-act-amendments-targeting-warehouse-pharmacies 2026-09-02T01:51:36.283Z weekly 0.7 https://pharmacountry.com/insights/news/dry-eye-disease-causes-symptoms-and-vision-risk 2026-09-02T00:51:31.769Z weekly 0.7 https://pharmacountry.com/insights/reports/kpa-calls-pharmacies-to-join-braille-prescription-software-pilot 2026-09-02T00:51:31.592Z weekly 0.7 https://pharmacountry.com/insights/news/kangwon-national-university-pharmacy-college-expands-osce-practical-training 2026-09-01T23:51:16.952Z weekly 0.7 https://pharmacountry.com/insights/reports/korean-pharmaceutical-association-launches-aidriven-public-outreach-and-pharmacy-support-platforms 2026-09-01T23:51:16.659Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-student-club-dyk-launches-medication-counseling-for-seniors-in-seoul 2026-09-01T23:51:16.457Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-court-upholds-pharmacists-fronthospital-pharmacy-rights-rejects-rightfee-refund 2026-09-01T23:51:16.266Z weekly 0.7 https://pharmacountry.com/insights/news/cgrp-targeted-therapies-accelerate-shift-to-preventive-migraine-care 2026-09-01T23:51:15.978Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-issues-alternative-drug-list-after-dioctahedral-mesylate-pediatric-indication-removed 2026-09-01T23:51:15.688Z weekly 0.7 https://pharmacountry.com/insights/news/arkgen-bioscions-secures-10-billion-krw-series-a-funding-for-multiantibody-cancer-immunotherapy 2026-09-01T23:51:15.498Z weekly 0.7 https://pharmacountry.com/insights/news/pohang-pharmaceutical-society-delivers-medicines-and-music-to-local-senior-home 2026-09-01T20:52:32.554Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-national-university-hospital-rare-disease-center-signs-mou-with-korea-rare-essential-medicines-center 2026-09-01T20:52:32.286Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-secures-484m-doses-of-xfg-covid-19-vaccine-for-2026-2027-season 2026-09-01T20:52:32.149Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-association-calls-for-full-review-of-drug-pricing-urges-competitive-pricing-system 2026-09-01T20:52:31.931Z weekly 0.7 https://pharmacountry.com/insights/news/korean-institute-announces-2026-long-term-care-policy-leader-ceo-course 2026-09-01T19:50:38.735Z weekly 0.7 https://pharmacountry.com/insights/reports/pcmo-and-baielt-sign-mou-to-advance-mrna-therapeutics-development 2026-09-01T19:50:38.502Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-novo-nordisk-pharmas-alhemo-prefilled-pen-gains-mfds-approval-for-hemophilia-a-b-prophylaxis 2026-09-01T19:50:38.309Z weekly 0.7 https://pharmacountry.com/insights/news/albozen-korea-wins-social-contribution-company-award-for-environmental-and-community-initiatives 2026-09-01T19:50:38.050Z weekly 0.7 https://pharmacountry.com/insights/news/korean-society-of-sports-pharmacy-holds-first-2026-academic-conference-on-multidisciplinary-clinical-and-data-integration 2026-09-01T19:50:37.821Z weekly 0.7 https://pharmacountry.com/insights/news/korean-society-of-clinical-pharmacy-to-host-2026-drug-therapy-training-course-online-on-aug-21 2026-09-01T19:50:37.611Z weekly 0.7 https://pharmacountry.com/insights/analysis/daewoongs-botulinum-toxin-nabota-hits-1-trillion-krw-cumulative-sales-eyes-global-expansion 2026-09-01T19:50:37.382Z weekly 0.7 https://pharmacountry.com/insights/news/dongdaemun-gu-pharmacists-association-holds-2026-training-for-240-members 2026-09-01T19:50:37.150Z weekly 0.7 https://pharmacountry.com/insights/analysis/il-yang-pharmas-dodamdodam-triple-vitaac-sales-rise-over-70-in-h1 2026-09-01T19:50:36.906Z weekly 0.7 https://pharmacountry.com/insights/reports/men-detect-cancer-later-than-women-study-shows 2026-09-01T19:50:36.619Z weekly 0.7 https://pharmacountry.com/insights/reports/ai-chatbots-mirror-social-bias-toward-mental-illness-and-hiv-patients-study-finds 2026-09-01T19:50:36.386Z weekly 0.7 https://pharmacountry.com/insights/regulatory/oral-obesity-drugs-gain-ground-as-novo-nordisk-and-eli-lilly-secure-approvals-in-europe-and-us 2026-09-01T19:50:36.179Z weekly 0.7 https://pharmacountry.com/insights/reports/roche-halts-development-of-two-huntingtons-disease-drug-candidates 2026-09-01T19:50:35.934Z weekly 0.7 https://pharmacountry.com/insights/news/gsk-terminates-22-bn-alector-partnership-after-clinical-failures 2026-09-01T19:50:35.637Z weekly 0.7 https://pharmacountry.com/insights/reports/ipsens-dysport-meets-primary-endpoints-in-phase-3-trials-for-episodic-and-chronic-migraine-prevention 2026-09-01T15:51:32.021Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sanofis-subcutaneous-sarclisa-escena-for-multiple-myeloma 2026-09-01T15:51:31.744Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-proposes-multiple-bills-to-tighten-narcotics-control-and-support-medical-cannabis-production 2026-09-01T15:51:31.406Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-koreas-mfds-orders-recall-of-daewoong-and-ys-life-science-medicines-over-packaging-label-mismatch 2026-09-01T14:51:36.669Z weekly 0.7 https://pharmacountry.com/insights/analysis/st-pharm-projected-q2-earnings-beat-expectations-on-oligonucleotide-sales 2026-09-01T14:51:36.326Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-resumes-health-insurance-survey-to-crack-down-on-pharmacy-false-claims 2026-09-01T13:51:36.854Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-anti-corruption-commission-rules-claim-period-starts-from-reimbursement-decision-date 2026-09-01T12:51:16.273Z weekly 0.7 https://pharmacountry.com/insights/analysis/hk-innoens-kcap-tegoprazan-targets-us-launch-boosts-growth-prospects 2026-09-01T12:51:16.055Z weekly 0.7 https://pharmacountry.com/insights/regulatory/3rd-pharmacy-agreement-council-meeting-to-address-korean-medicine-pharmacist-licensure-and-warehouse-pharmacies 2026-09-01T12:51:15.813Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-do-pharmacists-association-holds-8th-regular-board-meeting-sets-2026-h2-plans 2026-09-01T12:51:15.647Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-launches-voluntary-data-submission-pilot-for-new-approach-methodologies 2026-09-01T12:51:15.460Z weekly 0.7 https://pharmacountry.com/insights/news/gangseo-gu-women-pharmacists-committee-holds-wine-class-to-foster-camaraderie 2026-09-01T12:51:15.272Z weekly 0.7 https://pharmacountry.com/insights/reports/sinetrol-complex-extract-citrus-polyphenols-for-fat-reduction 2026-09-01T12:51:14.965Z weekly 0.7 https://pharmacountry.com/insights/news/who-marks-world-patient-safety-day-on-september-17 2026-09-01T12:51:14.648Z weekly 0.7 https://pharmacountry.com/insights/news/common-cold-symptoms-selflimiting-course-risks-for-vulnerable 2026-09-01T09:51:26.619Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-visits-highlight-common-misconceptions-about-headache-treatment 2026-09-01T09:51:26.431Z weekly 0.7 https://pharmacountry.com/insights/regulatory/astrogens-asd-syrup-ast-001-faces-regulatory-hurdles-in-korea 2026-09-01T09:51:26.190Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-to-incorporate-3r-principles-in-biological-product-testing-adding-cho-cell-method-for-pertussis-vaccine 2026-09-01T09:51:25.990Z weekly 0.7 https://pharmacountry.com/insights/news/40-former-korean-health-officials-publish-book-on-covid19-frontline-lessons 2026-09-01T09:51:25.759Z weekly 0.7 https://pharmacountry.com/insights/reports/lung-cancer-5year-survival-in-korea-jumps-to-425-amid-egfrtki-advances 2026-09-01T08:50:45.043Z weekly 0.7 https://pharmacountry.com/insights/analysis/samjin-pharma-to-normalize-hydrasec-supply-after-mfds-pediatric-indication-withdrawal 2026-09-01T08:50:44.809Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-raise-alarm-over-rapid-rise-of-warehouse-pharmacies-and-herbal-pharmacist-issues 2026-09-01T08:50:44.661Z weekly 0.7 https://pharmacountry.com/insights/regulatory/warehouse-pharmacy-regulation-bills-stalled-as-health-committee-remains-inactive 2026-09-01T08:50:44.523Z weekly 0.7 https://pharmacountry.com/insights/news/daegu-pharmacists-association-holds-2026-dpsl-yutnori-tournament 2026-09-01T08:50:44.303Z weekly 0.7 https://pharmacountry.com/insights/news/kcdc-issues-first-heatwave-severe-warning-urges-health-guidelines 2026-09-01T08:50:44.131Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-pharmaceutical-safety-agency-holds-advanced-training-for-postmarketing-safety-managers-july-910-2026 2026-09-01T08:50:43.982Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-holds-second-seoul-station-campaign-to-distinguish-pharmacies-from-herbal-shops 2026-09-01T08:50:43.803Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-launches-second-campaign-to-differentiate-pharmacies-and-herbal-shops 2026-09-01T08:50:43.597Z weekly 0.7 https://pharmacountry.com/insights/regulatory/relay-protest-calls-for-reform-of-korean-herbal-pharmacist-system-continues-296-days 2026-09-01T08:50:43.404Z weekly 0.7 https://pharmacountry.com/insights/reports/fatty-liver-may-accelerate-liver-metastasis-in-colorectal-cancer-study-finds 2026-09-01T08:50:43.155Z weekly 0.7 https://pharmacountry.com/insights/reports/bariatric-surgery-increases-alcohol-absorption-raising-dependence-risk-study-finds 2026-09-01T08:50:42.868Z weekly 0.7 https://pharmacountry.com/insights/reports/satellos-bioscience-reports-activity-signal-for-dmd-candidate-sat-3247-in-adult-study 2026-09-01T08:50:42.671Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-temporarily-suspends-crl-publication-policy 2026-09-01T08:50:42.492Z weekly 0.7 https://pharmacountry.com/insights/regulatory/china-nhsa-uncovers-signature-fraud-by-foreign-innovator-in-vbp-bid 2026-09-01T03:50:36.377Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacists-highlight-esgs-growing-role-in-healthcare-sustainability 2026-09-01T03:50:36.202Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacists-launch-literary-corner-featuring-poetry-and-essays 2026-09-01T03:50:36.024Z weekly 0.7 https://pharmacountry.com/insights/regulatory/warehouse-and-corporate-network-pharmacies-face-new-legislative-restrictions 2026-09-01T03:50:35.862Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharmacy-compounding-and-otc-sales-stabilize-in-korea-week-27-minor-declines-in-key-categories 2026-09-01T03:50:35.718Z weekly 0.7 https://pharmacountry.com/insights/regulatory/bonofrazan-fumarate-enters-korean-health-insurance-price-negotiations-alongside-original-product 2026-09-01T03:50:35.530Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-do-pharmaceutical-association-holds-online-medication-management-training-for-2026-h2 2026-09-01T03:50:35.257Z weekly 0.7 https://pharmacountry.com/insights/news/korean-japan-mangawebtoon-delegation-explores-ip-collaboration-in-tokyo 2026-09-01T03:50:34.978Z weekly 0.7 https://pharmacountry.com/insights/reports/ai-pharmacy-automation-ax-zone-to-debut-at-2026-gwangju-pharmacist-conference 2026-09-01T03:50:34.685Z weekly 0.7 https://pharmacountry.com/insights/news/gangnam-district-pharmacists-association-donates-5m-krw-to-support-lowincome-female-patients 2026-09-01T03:50:34.455Z weekly 0.7 https://pharmacountry.com/insights/reports/biobridge-2026-forum-unveils-relational-innovation-ecosystem-for-biotech-commercialization 2026-08-31T23:52:21.385Z weekly 0.7 https://pharmacountry.com/insights/news/kcdc-announces-senior-personnel-changes-in-chronic-disease-management-bureau 2026-08-31T23:52:21.220Z weekly 0.7 https://pharmacountry.com/insights/analysis/astrazeneca-pays-200m-upfront-to-sino-biopharma-for-pde34-inhibitor-rights 2026-08-31T23:52:21.024Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-restoril-temazepam-capsules-nda018163 2026-08-31T23:52:20.802Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-084030-for-amosene-400-mg-meprobamate-tablet 2026-08-31T23:52:20.571Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda083389-for-lidocaine-hydrochloride-with-epinephrine-injection-discontinued 2026-08-31T23:52:20.309Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-submissions-for-cyclocort-topical-cream-nda018116 2026-08-31T22:50:41.115Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda089606-watson-labs-prochlorperazine-edisylate-injection-discontinued 2026-08-31T22:50:40.918Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-anda089249-for-nandrolone-decanoate-injection 2026-08-31T22:50:40.737Z weekly 0.7 https://pharmacountry.com/insights/reports/keenova-therapeutics-xiaflex-meets-primary-endpoint-in-phase-3-plantar-fibromatosis-trial 2026-08-31T22:50:40.571Z weekly 0.7 https://pharmacountry.com/insights/news/mapogu-pharmaceutical-association-donates-refrigerator-to-womens-rehab 2026-08-31T22:50:40.409Z weekly 0.7 https://pharmacountry.com/insights/news/gangseo-district-pharmacists-association-offers-pharmacy-career-experience-to-students 2026-08-31T22:50:40.255Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-088872-for-thioridazine-hydrochloride-tablet-discontinued 2026-08-31T22:50:40.029Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ranbaxy-ramipril-capsules-anda078849 2026-08-31T22:50:39.867Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-issues-anda078545-approval-for-discontinued-lamivudine-tablet-products 2026-08-31T22:50:39.685Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-medicine-committee-urges-international-decoction-oversight 2026-08-31T22:50:39.502Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daewoong-pharmaceutical-starts-phase-3-trial-of-pecusclu-for-maintenance-therapy-in-erosive-esophagitis 2026-08-31T22:50:39.339Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seongdong-gu-pharmaceutical-association-holds-7th-board-meeting-tackles-pharmacy-solicitation-and-integrated-care-plans 2026-08-31T22:50:39.162Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078249-for-torsemide-tablets-by-aurobindo-pharma 2026-08-31T22:50:38.951Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-for-lupins-meloxicam-tablets-anda-077944 2026-08-31T22:50:38.741Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077655-for-valacyclovir-hydrochloride-tablets 2026-08-31T22:50:38.537Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-077351-for-multiple-oral-acidreducer-brands 2026-08-31T18:50:19.640Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-sun-pharm-pantoprazole-sodium-anda077058 2026-08-31T18:50:19.483Z weekly 0.7 https://pharmacountry.com/insights/analysis/duolac-launches-travelfocused-probiotic-campaign-with-creator-bunny-bottle 2026-08-31T18:50:19.271Z weekly 0.7 https://pharmacountry.com/insights/regulatory/il-dong-pharmaceutical-group-conducts-fair-trade-law-training-for-all-employees 2026-08-31T18:50:19.060Z weekly 0.7 https://pharmacountry.com/insights/news/dong-a-pharmaceutical-launches-spraytype-athletes-foot-treatment-terbinu-double-action-aerosol 2026-08-31T18:50:18.859Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-supplements-for-discontinued-escitalopram-oxalate-tablets-anda-076765 2026-08-31T18:50:18.641Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-076484-for-ciprofloxacin-injectable-products-by-fresenius-kabi-usa 2026-08-31T18:50:18.385Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-apotex-sotalol-hydrochloride-tablets-anda-076214 2026-08-31T18:50:18.140Z weekly 0.7 https://pharmacountry.com/insights/analysis/gc-green-cross-and-korea-vaccine-sign-mou-for-vaccine-cmo-collaboration 2026-08-31T18:50:17.982Z weekly 0.7 https://pharmacountry.com/insights/news/trione-co-selected-for-rd-funding-to-develop-dualtarget-parkinsons-drug-ph-30 2026-08-31T18:50:17.774Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrion-biosimilars-gain-momentum-in-europe-omliclo-reaches-16-share-q1 2026-08-31T18:50:17.537Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda081029-for-quinidine-sulfate-tablets-by-sun-pharm-industries 2026-08-31T18:50:17.293Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080445-for-meperidine-hydrochloride-injectable-products 2026-08-31T18:50:17.096Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda079162-for-topiramate-generic-tablets 2026-08-31T18:50:16.902Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-recall-jamp-temozolomide-140-mg-capsules-out-of-specification 2026-08-31T18:50:16.645Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hlb-liver-cancer-drug-approval-delayed-again-over-cgmp-manufacturing-issue 2026-08-31T12:52:08.969Z weekly 0.7 https://pharmacountry.com/insights/reports/hanmi-pharm-pushes-belvarafenib-into-phase-2-for-nrasmutant-melanoma 2026-08-31T12:52:08.794Z weekly 0.7 https://pharmacountry.com/insights/reports/yeast-βglucan-enhances-anticancer-immunity-and-reverses-obesityrelated-immune-decline-study-finds 2026-08-31T12:52:08.645Z weekly 0.7 https://pharmacountry.com/insights/news/btg-expands-cmo-contract-with-alteogen-to-884-billion-krw 2026-08-31T11:50:49.515Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-considers-expanding-cgm-insurance-coverage-to-type-2-diabetes-patients 2026-08-31T11:50:49.244Z weekly 0.7 https://pharmacountry.com/insights/news/kpa-initiates-public-trial-of-customized-health-supplement-portioning-at-member-pharmacies 2026-08-31T11:50:49.020Z weekly 0.7 https://pharmacountry.com/insights/analysis/hanmi-pharm-q2-earnings-buoyed-by-oneoff-lilly-tech-transfer-payment-core-sales-lag 2026-08-31T11:50:48.852Z weekly 0.7 https://pharmacountry.com/insights/regulatory/koreas-first-cart-therapy-rimkato-secures-healthinsurance-reimbursement-approval 2026-08-31T11:50:48.646Z weekly 0.7 https://pharmacountry.com/insights/reports/ncia-highlights-autophagybased-brain-health-strategy-and-launches-neuroap-supplement 2026-08-31T11:50:48.430Z weekly 0.7 https://pharmacountry.com/insights/reports/dioni-healthcare-showcases-regenerative-cell-products-at-2026-daegu-pharmacy-fair 2026-08-31T11:50:48.197Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-introduces-bill-to-ban-warehousetype-pharmacies 2026-08-31T11:50:47.988Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-highlights-samgyetangs-role-in-summer-nutrient-replenishment 2026-08-31T11:50:47.809Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-highlights-samgyetang-benefits-for-summer-nutrient-balance 2026-08-31T11:50:47.647Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-relay-protest-marks-295th-day-calls-for-han-yaksa-licensing-reform 2026-08-31T11:50:47.377Z weekly 0.7 https://pharmacountry.com/insights/news/experts-emphasize-lifestyle-changes-for-effective-hemorrhoid-management 2026-08-31T11:50:47.119Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daewoong-bio-revamps-prescription-drug-packaging-following-mfds-safety-initiative 2026-08-31T11:50:46.831Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-court-dismisses-claim-in-pharmacy-lease-dispute-involving-special-contractual-clauses 2026-08-31T07:50:35.021Z weekly 0.7 https://pharmacountry.com/insights/regulatory/myeongin-pharma-advances-parkinsons-drug-p2b001-toward-korean-approval 2026-08-31T07:50:34.782Z weekly 0.7 https://pharmacountry.com/insights/regulatory/창고형-약국-방지법-조만간-발의-예정 2026-08-31T07:50:34.631Z weekly 0.7 https://pharmacountry.com/insights/regulatory/keytruda-gains-two-korean-approvals-adds-bladder-ovarian-uses 2026-08-31T07:50:34.497Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-to-establish-health-personnel-task-adjustment-committee-for-pharmacist-scope 2026-08-31T07:50:34.272Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-pushes-community-approach-to-drug-addiction 2026-08-31T07:50:34.004Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cresoti-reports-data-breach-of-e-prescription-scanner-service 2026-08-31T07:50:33.787Z weekly 0.7 https://pharmacountry.com/insights/analysis/il-yang-pharmas-noltec-plus-sees-137-q2-prescription-sales-rise 2026-08-31T07:50:33.602Z weekly 0.7 https://pharmacountry.com/insights/regulatory/proposal-to-expand-health-insurance-coverage-of-cgm-to-insulintreated-type-2-diabetes-patients 2026-08-31T07:50:33.385Z weekly 0.7 https://pharmacountry.com/insights/news/seochogu-pharmaceutical-society-and-women-pharmacists-committee-donate-to-yangjae-welfare-center 2026-08-31T07:50:33.215Z weekly 0.7 https://pharmacountry.com/insights/news/gwangju-pharmacists-association-grants-hopedream-scholarships-and-medicines 2026-08-31T07:50:33.046Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-dobong-gangbuk-pharmacy-associations-review-2026-drug-safety-education 2026-08-31T07:50:32.781Z weekly 0.7 https://pharmacountry.com/insights/regulatory/suwon-pharmacists-association-holds-mid-year-audit-addresses-warehouse-pharmacies-and-drug-shortages 2026-08-31T07:50:32.632Z weekly 0.7 https://pharmacountry.com/insights/analysis/kmi-korean-medical-institute-donates-300-m-krw-to-support-shipping-costs-for-rare-disease-and-type-1-diabetes-patients 2026-08-31T07:50:32.479Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-provides-guidance-and-consultation-services-for-samd-approval 2026-08-31T07:50:32.073Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-health-ministry-appoints-kim-hyun-sook-as-population-and-child-policy-director 2026-08-31T02:50:29.104Z weekly 0.7 https://pharmacountry.com/insights/news/south-korea-health-ministry-appoints-kim-jina-as-head-of-basic-income-care-medical-promotion-team 2026-08-31T02:50:28.902Z weekly 0.7 https://pharmacountry.com/insights/reports/korea-copd-patients-with-cardiovascular-disease-face-higher-exacerbation-risk-and-costs 2026-08-31T02:50:28.658Z weekly 0.7 https://pharmacountry.com/insights/reports/samsung-bioepis-proteina-expand-ai-antibody-development 2026-08-31T02:50:28.412Z weekly 0.7 https://pharmacountry.com/insights/reports/novartis-korea-shares-long-term-pnh-drug-data-at-eha-2026 2026-08-31T02:50:28.234Z weekly 0.7 https://pharmacountry.com/insights/news/korea-gsk-marks-40-years-with-employee-celebration-and-patientcentric-vision 2026-08-31T02:50:27.984Z weekly 0.7 https://pharmacountry.com/insights/regulatory/curocells-limkato-cart-therapy-passes-first-healthinsurance-review-in-korea 2026-08-31T02:50:27.763Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmaker-reports-decrease-in-medical-narcotics-misuse-cases-after-legislative-reform 2026-08-31T02:50:27.541Z weekly 0.7 https://pharmacountry.com/insights/regulatory/g-cell-immune-cell-therapy-listed-in-who-atc-l01xl-category 2026-08-31T02:50:27.395Z weekly 0.7 https://pharmacountry.com/insights/reports/jongkundang-launches-nurateon-rd-subsidiary-to-expand-pharma-platform 2026-08-31T02:50:27.254Z weekly 0.7 https://pharmacountry.com/insights/regulatory/regulatory-inspections-reveal-rising-pdrn-use-in-korean-cosmetics 2026-08-31T02:50:27.064Z weekly 0.7 https://pharmacountry.com/insights/news/rigachem-bio-receives-milestone-royalty-as-lcb97-adc-enters-firstpatient-dosing 2026-08-31T02:50:26.852Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmdaatc-us-fda-pediatric-review-seminar-2026-concludes-with-broad-international-participation 2026-08-31T02:50:26.611Z weekly 0.7 https://pharmacountry.com/insights/regulatory/report-calls-for-strengthening-national-university-hospitals-and-regional-care 2026-08-30T22:51:20.369Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-biotech-firms-rank-second-globally-in-fda-biosimilar-approvals 2026-08-30T22:51:20.213Z weekly 0.7 https://pharmacountry.com/insights/analysis/pharma-distributors-adjust-schedules-for-july-17-constitution-day 2026-08-30T22:51:20.042Z weekly 0.7 https://pharmacountry.com/insights/news/sk-chemical-publishes-2025-sustainable-management-report-with-expanded-esg-analysis 2026-08-30T22:51:19.836Z weekly 0.7 https://pharmacountry.com/insights/analysis/high-won-exchange-rate-affects-pharma-bio-companies-differently 2026-08-30T22:51:19.650Z weekly 0.7 https://pharmacountry.com/insights/analysis/hanmi-pharmaceuticals-rosuzet-gains-market-share-in-koreas-dyslipidemia-treatment 2026-08-30T21:50:44.844Z weekly 0.7 https://pharmacountry.com/insights/news/huons-en-expands-chuncheon-plant-boosting-healthfunctional-ingredient-capacity-to-16500-tyr 2026-08-30T21:50:44.592Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-director-publishes-new-book-on-policy-pr-strategies 2026-08-30T21:50:44.418Z weekly 0.7 https://pharmacountry.com/insights/news/sports-pharmacy-society-to-host-2026-sports-pharmacy-jeju-forum-on-aug-23 2026-08-30T21:50:44.205Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-court-overturns-rejection-of-jointstem-stem-cell-therapy-for-osteoarthritis 2026-08-30T21:50:44.003Z weekly 0.7 https://pharmacountry.com/insights/regulatory/policy-report-calls-for-reassessment-of-convenience-store-otc-medicine-expansion-in-korea 2026-08-30T21:50:43.821Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lawmakers-propose-nursing-act-amendment-to-address-workplace-bullying-in-korea 2026-08-30T21:50:43.618Z weekly 0.7 https://pharmacountry.com/insights/regulatory/huons-ens-hagocho-extract-powder-approved-as-functional-ingredient-for-prostate-health 2026-08-30T21:50:43.401Z weekly 0.7 https://pharmacountry.com/insights/reports/gwangdong-pharmaceutical-selected-for-koreas-2026-smart-ecofactory-project-to-upgrade-green-production-facilities 2026-08-30T21:50:43.170Z weekly 0.7 https://pharmacountry.com/insights/regulatory/qurocells-cart-therapy-rimcato-clears-hira-severe-disease-review-for-insurance-coverage 2026-08-30T21:50:42.971Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-expands-rehab-linkage-for-drug-addicts-adds-1342-hotline-in-54-prisons 2026-08-30T21:50:42.739Z weekly 0.7 https://pharmacountry.com/insights/reports/daewoongs-enblo-inabogliflozin-shows-fattyliver-improvement-in-t2dm-study-in-diabetes-obesity-metabolism 2026-08-30T21:50:42.536Z weekly 0.7 https://pharmacountry.com/insights/analysis/vc-funding-in-h1-2026-focuses-on-cancer-and-immunology-biotech-startups 2026-08-30T21:50:42.332Z weekly 0.7 https://pharmacountry.com/insights/news/ai-firms-and-philanthropists-fund-500m-intercept-project-to-combat-cold-and-flu 2026-08-30T21:50:42.139Z weekly 0.7 https://pharmacountry.com/insights/reports/artificial-sweeteners-may-increase-hba1c-and-insulin-levels-study-finds 2026-08-30T21:50:41.917Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kennedy-jrs-maha-policy-drives-retail-pharmacy-shift 2026-08-30T17:50:49.605Z weekly 0.7 https://pharmacountry.com/insights/reports/large-study-links-hormonal-contraceptives-to-higher-meningioma-risk 2026-08-30T17:50:49.436Z weekly 0.7 https://pharmacountry.com/insights/regulatory/parliamentary-stalemate-hinders-health-committee-activities-in-south-korea 2026-08-30T17:50:49.169Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-continues-294-day-relay-protest-demanding-herbal-pharmacist-licensure-clarification 2026-08-30T17:50:48.932Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacists-gather-at-fusion-restaurant-in-namyangju-for-culinary-experience 2026-08-30T17:50:48.770Z weekly 0.7 https://pharmacountry.com/insights/reports/ligacem-bioscience-unveils-lcb-20-rd-strategy-targeting-adc-innovation-and-nextgen-modalities 2026-08-30T17:50:48.479Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daewoong-pharmaceutical-initiates-phase-1-trials-of-olmesartanindapamide-triple-antihypertensive 2026-08-30T17:50:48.253Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-govt-confirms-1-trillion-won-healthinsurance-fund-not-from-generic-drug-savings 2026-08-30T17:50:48.071Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-announces-health-insurance-reimbursement-halt-for-dioctahexdylsmechtaite-in-children-from-july-2026 2026-08-30T17:50:47.851Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-court-upholds-1year-suspension-of-exception-pharmacy-for-refusing-health-ministry-inspection 2026-08-30T17:50:47.663Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-health-ministry-opens-recruitment-for-community-primary-care-innovation-pilot 2026-08-30T17:50:47.479Z weekly 0.7 https://pharmacountry.com/insights/news/yuhan-yanghang-launches-wonderslim-probiotic-for-bodyfat-reduction 2026-08-30T17:50:47.258Z weekly 0.7 https://pharmacountry.com/insights/news/우정바이오-사명-변경해-콜마바이오텍으로-전환바이오-전문기업-새-출발 2026-08-30T17:50:47.090Z weekly 0.7 https://pharmacountry.com/insights/regulatory/albozen-korea-to-distribute-eurobaxom-for-chronic-utis-ma-transfer-expected-q4-2026 2026-08-30T17:50:46.858Z weekly 0.7 https://pharmacountry.com/insights/analysis/baim-launches-juvelook-flagship-cafe-in-seouls-samseongdong 2026-08-30T17:50:46.631Z weekly 0.7 https://pharmacountry.com/insights/reports/korean-pharmbios-orafang-shows-safety-comparable-to-2l-peg-in-large-real-world-study 2026-08-30T10:50:50.262Z weekly 0.7 https://pharmacountry.com/insights/regulatory/yuhan-yanghang-upholds-global-ethical-standards-in-clinical-trials 2026-08-30T10:50:50.131Z weekly 0.7 https://pharmacountry.com/insights/news/an-guk-pharmaceutical-launches-koreas-first-indapamidebased-triplecombo-hypertension-drug 2026-08-30T10:50:49.974Z weekly 0.7 https://pharmacountry.com/insights/analysis/baropharm-announces-baroland-promotion-for-pharmacies-5th-anniversary 2026-08-30T10:50:49.716Z weekly 0.7 https://pharmacountry.com/insights/news/international-pharmaceutical-launches-rosuvastatinamlodipine-combo-tablet-rosudipin-in-three-strengths 2026-08-30T10:50:49.586Z weekly 0.7 https://pharmacountry.com/insights/news/jeonbuk-advancement-society-holds-16th-golf-tournament-to-fund-drug-abuse-prevention-and-care-projects 2026-08-30T10:50:49.322Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-koreas-first-domestic-cart-therapy-rimkatoju-clears-initial-healthinsurance-hurdle 2026-08-30T10:50:49.106Z weekly 0.7 https://pharmacountry.com/insights/news/korea-health-welfare-institute-launches-hiv-counseling-nurse-training-program 2026-08-30T10:50:48.930Z weekly 0.7 https://pharmacountry.com/insights/regulatory/neca-announces-revised-notice-for-two-prp-based-medical-technologies-approved-in-2026 2026-08-30T10:50:48.753Z weekly 0.7 https://pharmacountry.com/insights/reports/ligachem-bio-unveils-long-term-rd-roadmap-focused-on-adc-advancement-and-new-therapeutic-modalities 2026-08-30T10:50:48.619Z weekly 0.7 https://pharmacountry.com/insights/news/jeju-warehouse-pharmacy-halts-operations-police-dispatched-amid-unsettled-payments 2026-08-30T10:50:48.432Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-reviews-healthinsurance-coverage-for-domestic-cart-therapy-rimkatoju 2026-08-30T10:50:48.254Z weekly 0.7 https://pharmacountry.com/insights/analysis/pamgen-science-launches-first-8hour-sustained-vitamin-b-complex 2026-08-30T10:50:48.081Z weekly 0.7 https://pharmacountry.com/insights/news/kyungdong-pharmaceutical-launches-coin-shaped-anicoin-hot-cool-plaster 2026-08-30T10:50:47.920Z weekly 0.7 https://pharmacountry.com/insights/news/dong-a-exec-wins-iron-tower-medal-for-safety-leadership 2026-08-30T10:50:47.644Z weekly 0.7 https://pharmacountry.com/insights/analysis/optima-launches-premium-dermocosmetic-line-lidorcel-celebrity-with-liwon-dermatology 2026-08-30T06:50:47.508Z weekly 0.7 https://pharmacountry.com/insights/news/optima-pharmacy-chain-launches-silk-peptide-supplement-리셀a-360-for-pharmacists 2026-08-30T06:50:47.313Z weekly 0.7 https://pharmacountry.com/insights/news/donghwa-pharmaceutical-and-labor-union-declare-partnership-for-sustainable-growth 2026-08-30T06:50:47.093Z weekly 0.7 https://pharmacountry.com/insights/news/gc-cell-forms-cgt-value-chain-alliance-with-domestic-biotech-partners 2026-08-30T06:50:46.927Z weekly 0.7 https://pharmacountry.com/insights/news/kolon-life-science-publishes-2025-sustainability-report-detailing-esg-progress 2026-08-30T06:50:46.763Z weekly 0.7 https://pharmacountry.com/insights/news/yuyu-taejin-sponsors-breatheasy-moment-contest-to-celebrate-launch-of-smart-oxygen-generator-품케어 2026-08-30T06:50:46.585Z weekly 0.7 https://pharmacountry.com/insights/news/lg-chem-partners-with-chinas-otr-therapeutics-to-expand-oncology-pipeline 2026-08-30T06:50:46.392Z weekly 0.7 https://pharmacountry.com/insights/reports/metacentra-therapeutics-partners-with-samsung-health-to-offer-age-management-content 2026-08-30T06:50:46.200Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-announces-draft-rules-for-cosmetics-safety-assessment-open-for-comment 2026-08-30T06:50:45.998Z weekly 0.7 https://pharmacountry.com/insights/analysis/kbiohealthbacked-chungbuk-firms-secure-406m-talks-at-bio-usa-2026 2026-08-30T06:50:45.806Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-urges-careful-use-of-glp-1-obesity-drugs-amid-misuse-concerns 2026-08-30T06:50:45.586Z weekly 0.7 https://pharmacountry.com/insights/regulatory/vera-therapeutics-atacicept-trutakna-gains-fda-accelerated-approval-for-iga-nephropathy 2026-08-30T06:50:45.384Z weekly 0.7 https://pharmacountry.com/insights/analysis/vertex-pharmaceuticals-to-acquire-crinetics-for-10b-securing-palsonify-and-cah-candidate 2026-08-30T06:50:45.183Z weekly 0.7 https://pharmacountry.com/insights/reports/novo-nordisk-partners-with-vivani-medical-to-develop-semaglutide-implant-for-weight-management 2026-08-30T06:50:44.981Z weekly 0.7 https://pharmacountry.com/insights/reports/boehringer-ingelheim-adopts-pvts-orf-virus-platform-for-nextgen-cancer-vaccine-rd 2026-08-30T06:50:44.761Z weekly 0.7 https://pharmacountry.com/insights/analysis/samjin-pharmaceutical-to-raise-trestan-prices-by-15-in-july-2026 2026-08-30T02:18:19.108Z weekly 0.7 https://pharmacountry.com/insights/analysis/taejeon-group-secures-exclusive-korean-distribution-rights-for-metagenics-health-supplements 2026-08-30T02:18:18.931Z weekly 0.7 https://pharmacountry.com/insights/analysis/polident-launches-5minute-quick-power-clean-for-orthodontic-appliance-users 2026-08-30T02:18:18.772Z weekly 0.7 https://pharmacountry.com/insights/analysis/rf-bio-showcases-core-portfolio-at-amwc-korea-2026-boosting-global-aesthetic-presence 2026-08-30T02:18:18.609Z weekly 0.7 https://pharmacountry.com/insights/analysis/wisebuzz-forms-us-dtc-advertising-team-to-support-korean-pharma-expansion 2026-08-30T02:18:18.436Z weekly 0.7 https://pharmacountry.com/insights/analysis/south-koreas-regalon-epilepsy-capsule-faces-limited-release-amid-rising-demand 2026-08-30T02:18:18.270Z weekly 0.7 https://pharmacountry.com/insights/analysis/albozen-korea-launches-new-2026-campaign-for-top-oral-contraceptive-머시론 2026-08-30T02:18:18.096Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrions-bevacizumab-biosimilar-베그젤마-added-to-major-us-pbm-formularies 2026-08-30T02:18:17.922Z weekly 0.7 https://pharmacountry.com/insights/analysis/june-outofstock-notification-requests-shift-to-epilepsy-and-hypertension-drugs-in-korea 2026-08-30T02:18:17.683Z weekly 0.7 https://pharmacountry.com/insights/analysis/cellmed-nutrition-counseling-brand-reaches-3000-member-pharmacies-in-south-korea 2026-08-30T02:18:17.509Z weekly 0.7 https://pharmacountry.com/insights/analysis/quantumcell-to-acquire-alzecures-alzheimers-platform-and-acd856-in-22b-deal 2026-08-30T02:18:17.368Z weekly 0.7 https://pharmacountry.com/insights/analysis/domestic-noac-leader-rixiana-faces-supply-strain-ahead-of-november-patent-expiry 2026-08-30T02:18:17.242Z weekly 0.7 https://pharmacountry.com/insights/analysis/supply-prices-of-hydrasexan-antidiarrheal-raised-effective-july-1 2026-08-30T02:18:17.131Z weekly 0.7 https://pharmacountry.com/insights/analysis/celltrion-beats-q2-market-expectations-analysts-raise-target-prices 2026-08-30T02:18:16.790Z weekly 0.7 https://pharmacountry.com/insights/analysis/sky-labs-announces-kosdaq-ipo-plans-to-offer-2-million-shares 2026-08-30T02:18:16.584Z weekly 0.7 https://pharmacountry.com/insights/analysis/im-securities-pharmabio-fundamentals-steady-h2-focus-on-obesity-drugs-and-adcs 2026-08-30T02:18:16.407Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lotte-biologics-obtains-use-approval-for-phase1-plant-at-songdo-bio-campus 2026-08-30T02:17:33.964Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hyundai-bios-antiviral-candidate-xafty-shows-negative-genotoxicity-in-glp-micronucleus-test 2026-08-30T02:17:33.796Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-to-hold-public-hearing-on-digital-healthcare-and-health-data-law 2026-08-30T02:17:33.622Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacies-must-report-human-use-prescription-drug-sales-to-animal-hospitals 2026-08-30T02:17:33.487Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-introduces-real-time-hazardous-drug-distribution-alert-service 2026-08-30T02:17:33.338Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-to-amend-approval-conditions-for-mycophenolate-and-albendazole-products-based-on-fda-and-ema-safety-reviews 2026-08-30T02:17:33.192Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-hospital-pharmacists-association-prioritizes-warddedicated-pharmacist-system-for-patient-safety 2026-08-30T02:17:33.028Z weekly 0.7 https://pharmacountry.com/insights/regulatory/krpia-welcomes-koreas-first-international-joint-drug-review-via-emas-open-program 2026-08-30T02:17:32.887Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharma-association-to-host-online-forum-on-hairloss-drug-insurance-coverage 2026-08-30T02:17:32.734Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-reviews-removal-of-pediatric-indication-for-dioctahedralsmektate-antidiarrheal 2026-08-30T02:17:32.572Z weekly 0.7 https://pharmacountry.com/insights/regulatory/calls-to-extend-mandatory-serialnumber-reporting-to-otc-medicines 2026-08-30T02:17:32.434Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacyonly-platform-yakolryeo-sparks-debate-over-pricing-and-regulatory-fairness 2026-08-30T02:17:32.305Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-issues-draft-amendment-order-for-opicapone-oral-formulations-to-update-adverse-reaction-precautions 2026-08-30T02:17:32.164Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-hikma-dronabinol-oral-capsules-anda-079217 2026-08-30T02:17:32.020Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-zydus-generic-galantamine-hydrobromide-tablets-anda078898 2026-08-30T02:17:31.866Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-approval-for-prednisolone-5-mg-tablet-anda-080531-by-chartwell-rx 2026-08-30T02:17:31.709Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-president-kwon-highlights-legislative-push-on-network-pharmacies-and-professional-standards 2026-08-30T02:17:31.535Z weekly 0.7 https://pharmacountry.com/insights/regulatory/daegu-pharmacists-host-2026-farm-fair-mandatory-training 2026-08-30T02:17:31.387Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-mylan-fentanyl-transdermal-patches-anda076258 2026-08-30T02:17:31.266Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ofloxacin-otic-anda-076527-generic-ear-drops 2026-08-30T02:17:31.146Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anagrelide-anda076811 2026-08-30T02:17:30.997Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-orsythia-anda077099-oral-tablet 2026-08-30T02:17:30.867Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ranitidine-oral-syrup-anda077405 2026-08-30T02:17:30.729Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078594-for-topical-ciclopirox-shampoo 2026-08-30T02:17:30.586Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pamidronate-disodium-injection-products-discontinued-anda077703 2026-08-30T02:17:30.445Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077997-for-caffeine-citrate-intravenous-solution 2026-08-30T02:17:30.276Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-scientists-caution-against-easing-peptide-drug-regulations-for-compounding-pharmacies 2026-08-30T02:17:30.115Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078299-for-ketorolac-tromethamine-injectable-products 2026-08-30T02:17:29.950Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-methotrexate-sodium-injection-anda089309 2026-08-30T02:17:29.820Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-088622-for-amitriptyline-hydrochloride-50-mg-tablet-watson-labs 2026-08-30T02:17:29.664Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-revises-enforcement-regulations-to-strengthen-rd-oversight 2026-08-30T02:17:29.500Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-teva-hydrochlorothiazide-50-mg-tablet-anda-088923 2026-08-30T02:17:29.339Z weekly 0.7 https://pharmacountry.com/insights/regulatory/unexpected-shutdown-of-carestation-850-anesthesia-systems-when-ac-power-is-lost 2026-08-30T02:17:29.201Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gentherm-medical-reports-overheated-circuit-boards-in-some-devices 2026-08-30T02:17:29.073Z weekly 0.7 https://pharmacountry.com/insights/regulatory/unexpected-shutdown-risk-for-carestation-850850c-anesthesia-systems 2026-08-30T02:17:28.959Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gentherm-medical-reports-overheated-circuit-boards-in-blanketrol-devices 2026-08-30T02:17:28.828Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-imipramine-hydrochloride-anda088292 2026-08-30T02:17:28.663Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda081189-for-hydrochlorothiazide-25-mg-tablet-by-watson-labs 2026-08-30T02:17:28.523Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mylan-discontinues-propoxyphene-hydrochloride-32-mg-oral-capsule-anda083528 2026-08-30T02:17:28.376Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kv-pharms-phendimetrazine-tartrate-tablet-anda-084138-discontinued 2026-08-30T02:17:28.217Z weekly 0.7 https://pharmacountry.com/insights/regulatory/tablicaps-submits-anda084632-for-discontinued-oral-aminophylline-100-mg-delayedrelease-tablet 2026-08-30T02:17:28.035Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077533-for-terbinafine-oral-tablet 2026-08-30T02:17:27.844Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-to-ban-dioctahedral-smectite-antidiarrheal-from-july-13 2026-08-30T02:17:27.660Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-cilostazol-tablets-anda077831 2026-08-30T02:17:27.474Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078132-for-discontinued-ibuprofen-tablet-products 2026-08-30T02:17:27.287Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-teva-generic-carvedilol-tablets-anda-076373 2026-08-30T02:17:27.104Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-proglycem-diazoxide-oral-suspension-nda-017453 2026-08-30T02:17:26.925Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-and-manufacturing-updates-for-isopaque-280-nda-017506 2026-08-30T02:17:26.730Z weekly 0.7 https://pharmacountry.com/insights/regulatory/sun-pharma-canada-receives-fda-approval-for-halobetasol-propionate-005-cream-anda077227 2026-08-30T02:17:26.579Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nabumetone-anda078420-for-prescription-oral-tablets 2026-08-30T02:17:26.402Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-hikma-international-pharmaceutics-lithium-carbonate-tablet-anda-078715 2026-08-30T02:17:26.237Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda079029-for-amiodarone-hydrochloride-tablets-by-zydus 2026-08-30T02:17:26.066Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-supplemental-anda-086178-for-glycopyrrolate-tablet 2026-08-30T02:17:25.881Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-086865-for-chlorpropamide-tablet-discontinued 2026-08-30T02:17:25.710Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-flutex-topical-ointment-anda087377 2026-08-30T02:17:25.585Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-calls-for-clear-definition-of-herbal-pharmacist-scope 2026-08-30T02:17:25.411Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda083061-diphenhydramine-hydrochloride-capsules-discontinued 2026-08-30T02:17:25.226Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-levetiracetam-oral-solution-anda078976 2026-08-30T02:17:25.022Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-085208-for-hydrochlorothiazide-50-mg-oral-tablet-discontinued 2026-08-30T02:17:24.831Z weekly 0.7 https://pharmacountry.com/insights/regulatory/purepac-pharm-discontinues-methocarbamol-tablet-products-anda085718 2026-08-30T02:17:24.649Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-technescan-gluceptate-injection-nda018272 2026-08-30T02:17:24.452Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-technescan-hdp-nda018321-for-intravenous-use 2026-08-30T02:17:24.269Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-advances-legal-framework-for-medical-cannabis-to-aid-rare-disease-patients 2026-08-30T02:17:24.078Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-bans-pediatric-use-of-daewoongs-starvic-and-daewons-potagel-suspensions 2026-08-30T02:17:23.899Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-orders-recall-of-il-dong-pharmas-consenvita-premium-800-tablets-due-to-labeling-omissions 2026-08-30T02:17:23.711Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pharmacist-consults-on-harsh-tax-audit-result-and-appeal-process 2026-08-30T02:17:23.571Z weekly 0.7 https://pharmacountry.com/insights/regulatory/amgen-initiates-voluntary-recall-of-1m-bottles-of-corlanor-in-us 2026-08-30T02:17:23.377Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-insurance-copayment-cap-beneficiaries-rise-65-annually-costs-climb 2026-08-30T02:17:23.196Z weekly 0.7 https://pharmacountry.com/insights/regulatory/2025-korean-local-governments-miss-disability-employment-quotas 2026-08-30T02:17:23.041Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmaker-proposes-inclusive-content-industry-amendment 2026-08-30T02:17:22.869Z weekly 0.7 https://pharmacountry.com/insights/regulatory/32-new-drugs-added-to-korea-health-insurance-reimbursement-list-in-h1-2024 2026-08-30T02:17:22.724Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmaceutical-association-calls-for-mandatory-reporting-of-human-drugs-used-in-veterinary-clinics 2026-08-30T02:17:22.552Z weekly 0.7 https://pharmacountry.com/insights/regulatory/경방신약-기준서-미준수로-의약품-제조-1개월-정지 2026-08-30T02:17:22.380Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-parliament-proposes-stricter-otc-drug-sales-controls-and-medication-guidance 2026-08-30T02:17:22.209Z weekly 0.7 https://pharmacountry.com/insights/regulatory/2027-minimum-wage-talks-resume-pharmacies-monitor-labor-cost-implications 2026-08-30T02:17:22.034Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-marks-292nd-day-of-one-person-protest-over-herbal-pharmacist-pharmacy-and-otc-sales 2026-08-30T02:17:21.890Z weekly 0.7 https://pharmacountry.com/insights/reports/ai-in-pharma-faces-datagathering-delays-not-scientific-limits 2026-08-30T02:15:18.734Z weekly 0.7 https://pharmacountry.com/insights/reports/lg-chem-teams-up-with-labgenius-therapeutics-to-speed-ai-driven-multiantibody-cancer-drug-discovery 2026-08-30T02:15:18.564Z weekly 0.7 https://pharmacountry.com/insights/reports/celltrion-to-showcase-aidriven-drug-development-at-bio-usa-2026 2026-08-30T02:15:18.386Z weekly 0.7 https://pharmacountry.com/insights/reports/acelra-presents-phase-1-results-of-acl-508-at-nla-conference 2026-08-30T02:15:18.196Z weekly 0.7 https://pharmacountry.com/insights/reports/korea-nhis-launches-public-electronic-prescription-delivery-system-for-telemedicine 2026-08-30T02:15:18.053Z weekly 0.7 https://pharmacountry.com/insights/reports/generative-ai-expands-into-pharmacy-education-and-practice-study-shows 2026-08-30T02:15:17.945Z weekly 0.7 https://pharmacountry.com/insights/reports/inofutics-parkinsons-gene-therapy-ips101a-selected-for-2026-national-new-drug-development-project 2026-08-30T02:15:17.780Z weekly 0.7 https://pharmacountry.com/insights/reports/korea-calls-for-national-infectious-disease-pipeline-intelligence-to-boost-pandemic-response 2026-08-30T02:15:17.622Z weekly 0.7 https://pharmacountry.com/insights/reports/boehringer-ingelheim-korea-signs-mou-with-kmi-for-rwe-liverhealth-study-in-obesity 2026-08-30T02:15:17.433Z weekly 0.7 https://pharmacountry.com/insights/reports/korea-oganon-hosts-fertility-power-symposium-during-2026-oganon-week 2026-08-30T02:15:17.257Z weekly 0.7 https://pharmacountry.com/insights/reports/sk-biopharm-partners-with-insilico-medicine-on-ai-driven-cns-drug-discovery 2026-08-30T02:15:17.119Z weekly 0.7 https://pharmacountry.com/insights/reports/free-ai-webinar-for-pharmacists-on-using-claude-to-accelerate-research 2026-08-30T02:15:16.997Z weekly 0.7 https://pharmacountry.com/insights/reports/ai-and-digital-literacy-become-essential-skills-for-pharmacists 2026-08-30T02:15:16.807Z weekly 0.7 https://pharmacountry.com/insights/reports/nordic-walking-significantly-improves-moderate-to-severe-depression-symptoms-study-finds 2026-08-30T02:15:16.641Z weekly 0.7 https://pharmacountry.com/insights/reports/parosai-bio-partners-with-capsbio-to-develop-nextgen-menin-inhibitors-using-ai-and-tpd 2026-08-30T02:15:16.478Z weekly 0.7 https://pharmacountry.com/insights/reports/korean-institute-develops-6stage-prognostic-system-for-alzheimers-progression 2026-08-30T02:15:16.299Z weekly 0.7 https://pharmacountry.com/insights/reports/who-2021-report-shows-40-global-population-affected-by-headache-10-by-migraine 2026-08-30T02:15:16.129Z weekly 0.7 https://pharmacountry.com/insights/reports/vitamin-a-and-d-linked-to-improved-lung-function-in-asthma-patients-study-finds 2026-08-30T02:15:15.966Z weekly 0.7 https://pharmacountry.com/insights/reports/melatonin-shows-potential-as-adjunct-therapy-for-chronic-pain-study-finds 2026-08-30T02:15:15.776Z weekly 0.7 https://pharmacountry.com/insights/reports/내가-누구약-card-news-series-offers-concise-patientfriendly-drug-information-for-pharmacies 2026-08-30T02:15:15.614Z weekly 0.7 https://pharmacountry.com/insights/reports/glycerol-glycerine-overview-properties-uses-and-safety 2026-08-30T02:15:15.445Z weekly 0.7 https://pharmacountry.com/insights/reports/seojinus-launches-tema-smart-patch-thermometer-for-infants 2026-08-30T02:15:15.302Z weekly 0.7 https://pharmacountry.com/insights/reports/roche-diagnostics-hosts-vip-symposium-on-emerging-biomarkers-for-ovarian-and-breast-cancer 2026-08-30T02:15:15.174Z weekly 0.7 https://pharmacountry.com/insights/reports/hlb-life-science-rd-joins-5th-national-project-to-develop-nextgen-medical-cannabinoids-from-industrial-hemp 2026-08-30T02:15:15.011Z weekly 0.7 https://pharmacountry.com/insights/reports/gijang-hospital-adopts-daewoong-pharmaceuticals-aibased-thync-smart-bed-monitoring-system 2026-08-30T02:15:14.862Z weekly 0.7 https://pharmacountry.com/insights/reports/hugel-hosts-symposium-to-boost-korean-aesthetic-medicine-research 2026-08-30T02:15:14.716Z weekly 0.7 https://pharmacountry.com/insights/reports/ligachembio-showcases-adc-platform-and-pipeline-at-global-rd-day-in-seoul 2026-08-30T02:15:14.572Z weekly 0.7 https://pharmacountry.com/insights/news/chosun-university-college-of-pharmacy-alumni-hold-2026-homecoming-and-general-meeting 2026-08-30T02:11:42.448Z weekly 0.7 https://pharmacountry.com/insights/news/busan-pharmacists-association-hosts-world-anti-drug-day-symposium 2026-08-30T02:11:42.264Z weekly 0.7 https://pharmacountry.com/insights/news/gyeongbuk-anti-drug-campaign-introduces-2026-school-drug-prevention-musical 2026-08-30T02:11:42.116Z weekly 0.7 https://pharmacountry.com/insights/news/daegu-anti-drug-unit-provides-youth-education-and-anonymous-screening 2026-08-30T02:11:41.978Z weekly 0.7 https://pharmacountry.com/insights/news/engichem-life-science-and-immunobiotech-partner-to-develop-oral-dissolving-film-immune-health-product 2026-08-30T02:11:41.833Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-netherlands-strengthen-global-health-partnership-in-strategic-dialogue 2026-08-30T02:11:41.685Z weekly 0.7 https://pharmacountry.com/insights/news/spains-health-secretary-discusses-joint-global-health-priorities-with-who 2026-08-30T02:11:41.532Z weekly 0.7 https://pharmacountry.com/insights/news/central-university-pharmacy-womens-alumni-holds-2026-healing-workshop 2026-08-30T02:11:41.391Z weekly 0.7 https://pharmacountry.com/insights/news/ewha-womans-university-college-of-pharmacy-alumni-association-holds-34th-national-executive-training-at-yuhan-headquarters 2026-08-30T02:11:41.178Z weekly 0.7 https://pharmacountry.com/insights/news/health-ministers-back-who-investment-round-at-g20-meeting-in-brazil 2026-08-30T02:11:41.006Z weekly 0.7 https://pharmacountry.com/insights/news/plus-therapeutics-rebrands-as-cerenome-to-signal-business-expansion 2026-08-30T02:11:40.836Z weekly 0.7 https://pharmacountry.com/insights/news/korea-bms-pharma-holds-20th-anniversary-hematology-symposium-in-seoul 2026-08-30T02:11:40.724Z weekly 0.7 https://pharmacountry.com/insights/news/astrazeneca-korea-and-khidi-launch-nova-global-connect-to-boost-korean-biotech-international-partnerships 2026-08-30T02:11:40.626Z weekly 0.7 https://pharmacountry.com/insights/news/daejeon-pharmacists-association-holds-supplemental-training-for-2025-noncompleters 2026-08-30T02:11:40.496Z weekly 0.7 https://pharmacountry.com/insights/news/busan-pharmacists-association-holds-2026-academic-conference-with-2000-attendees 2026-08-30T02:11:40.236Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-do-pharmacists-association-evaluates-21st-gyeonggi-pharmacy-conference 2026-08-30T02:11:40.063Z weekly 0.7 https://pharmacountry.com/insights/news/diabetes-overview-types-insulin-and-blood-glucose-in-korea 2026-08-30T02:11:39.908Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacies-emphasize-nasal-route-for-cold-prevention 2026-08-30T02:11:39.777Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-pharmacists-association-holds-2026-wholesale-management-pharmacist-training 2026-08-30T02:11:39.648Z weekly 0.7 https://pharmacountry.com/insights/news/yongsangu-womens-pharmacy-committee-holds-2026-2nd-meeting-on-community-care 2026-08-30T02:11:39.523Z weekly 0.7 https://pharmacountry.com/insights/news/hubase-to-host-second-integrated-academic-symposium-on-pain-and-joint-health-in-busan-on-july-12 2026-08-30T02:11:39.267Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-pharmaceutical-and-kiwoom-securities-to-host-hanmi-kiwoom-bio-innovation-day-on-june-15 2026-08-30T02:11:39.102Z weekly 0.7 https://pharmacountry.com/insights/news/natural-clinical-society-wraps-up-neuroap-focused-study-group-for-pharmacists 2026-08-30T02:11:38.928Z weekly 0.7 https://pharmacountry.com/insights/news/university-students-create-health-notebook-and-calendar-pill-pack-to-aid-elderly-polypharmacy 2026-08-30T02:11:38.755Z weekly 0.7 https://pharmacountry.com/insights/news/mapo-pharmacy-association-holds-july-meeting-celebrates-shelters-award-in-national-content-contest 2026-08-30T02:11:38.581Z weekly 0.7 https://pharmacountry.com/insights/news/novartis-to-acquire-myricx-bio-for-11b-to-expand-adc-pipeline 2026-08-30T02:11:38.397Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-society-opens-12th-pyla-program-for-pharmacy-students 2026-08-30T02:11:38.194Z weekly 0.7 https://pharmacountry.com/insights/news/korean-gsk-launches-brenlab-for-relapsedrefractory-multiple-myeloma-hosts-clinician-symposium 2026-08-30T02:11:38.006Z weekly 0.7 https://pharmacountry.com/insights/news/taegeuk-pharmaceutical-launches-summer-uv-pigment-disorder-awareness-campaign-with-dominacream 2026-08-30T02:11:37.817Z weekly 0.7 https://pharmacountry.com/insights/news/samjin-pharma-launches-serd-for-advanced-hrher2negative-breast-cancer 2026-08-30T02:11:37.655Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-shin-tae-su-former-chungbuk-branch-head-dies 2026-08-30T02:11:37.544Z weekly 0.7 https://pharmacountry.com/insights/news/korean-anti-drug-movement-daegu-branch-releases-book-on-community-healing-and-addiction-recovery 2026-08-30T02:11:37.264Z weekly 0.7 https://pharmacountry.com/insights/news/experts-clarify-normal-bowel-frequency-and-proper-constipation-treatment 2026-08-30T02:11:37.090Z weekly 0.7 https://pharmacountry.com/insights/news/incheon-michuholgu-pharmacists-association-launches-nationwide-online-drug-mechanism-lecture-series 2026-08-30T02:11:36.918Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-southern-district-court-orders-landlord-to-pay-41617-m-krw-for-withholding-pharmacy-lease-premium 2026-08-30T02:11:36.806Z weekly 0.7 https://pharmacountry.com/insights/news/kpa-holds-public-pharmacist-career-briefing-for-pharmacy-students-with-six-agencies 2026-08-30T02:11:36.649Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-safety-roundup-latest-advice-for-medicines-and-devices 2026-08-30T02:08:40.328Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-issued-due-to-lack-of-assurance-of-sterility 2026-08-30T02:08:40.155Z weekly 0.7 https://pharmacountry.com/insights/regulatory/claudin182targeted-cart-therapy-achieves-first-global-approval-for-solid-tumor 2026-08-30T02:08:40.016Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-announces-ninth-annual-medsafety-week-410-november-2024 2026-08-30T02:08:39.849Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-march-2024-letters-and-medicine-recalls-summary 2026-08-30T02:08:39.712Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-halts-sobis-gout-drug-challenger-to-amgens-krystexxa 2026-08-30T02:08:39.507Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084306-for-mydriacyl-tropicamide-1-ophthalmic-solution 2026-08-30T02:08:39.324Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-approval-for-tevas-chlordiazepoxide-hydrochloride-anda-084768 2026-08-30T02:08:39.140Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ge-healthcare-alerts-carescape-central-station-may-delay-monitoring-after-restart 2026-08-30T02:08:39.037Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ge-healthcare-carescape-central-station-v30x-may-delay-monitoring-after-restart 2026-08-30T02:08:38.816Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmakers-propose-renaming-high-level-hospitals-to-severe-hospitals 2026-08-30T02:08:38.633Z weekly 0.7 https://pharmacountry.com/insights/regulatory/who-nations-agree-to-continue-drafting-global-pandemic-agreement-ahead-of-wha 2026-08-30T02:08:38.447Z weekly 0.7 https://pharmacountry.com/insights/regulatory/lawmakers-propose-amendments-to-election-laws-amid-voting-paper-shortage 2026-08-30T02:08:38.290Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gyeonggido-pharmacy-association-council-calls-for-withdrawal-of-govt-plan-to-expand-conveniencestore-otc-list 2026-08-30T02:08:38.192Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-national-assembly-processes-32-agenda-items-including-election-ballot-shortage-investigation 2026-08-30T02:08:38.040Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacy-information-center-extends-pm20-conversion-deadline 2026-08-30T02:08:37.894Z weekly 0.7 https://pharmacountry.com/insights/regulatory/seoul-pharmacists-association-completes-advanced-mfds-drug-safety-instructor-training 2026-08-30T02:08:37.711Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-lawmaker-proposes-ai-use-in-local-tax-delinquency-management 2026-08-30T02:08:37.569Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda-approval-for-amcinonide-topical-lotion-anda076329 2026-08-30T02:08:37.399Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-revonto-dantrolene-sodium-injectable-anda078378 2026-08-30T02:08:37.236Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078670-for-pioglitazone-hydrochloride-tablets 2026-08-30T02:08:37.087Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korea-sets-0018-basic-burden-rate-for-2026-drug-adverse-reaction-compensation-fund 2026-08-30T02:08:36.937Z weekly 0.7 https://pharmacountry.com/insights/regulatory/epic-pharma-llc-submits-anda078975-for-topical-ciclopirox-8-solution-discontinued 2026-08-30T02:08:36.744Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fougéra-pharms-receives-fda-approval-for-alclometasone-dipropionate-topical-ointment-anda-076884 2026-08-30T02:08:36.571Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-nesher-pharms-metoprolol-succinate-er-tablet-anda077176 2026-08-30T02:08:36.405Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-launches-fasttrack-healthinsurance-listing-pilot-for-rare-disease-drugs 2026-08-30T02:08:36.292Z weekly 0.7 https://pharmacountry.com/insights/regulatory/kpa-stresses-patient-safety-over-private-use-in-medical-data-discussions 2026-08-30T02:08:36.202Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076603-for-betamethasone-dipropionate-topical-cream 2026-08-30T02:08:36.064Z weekly 0.7 https://pharmacountry.com/insights/regulatory/sun-pharm-inds-ltd-benazeprilhydrochlorothiazide-anda-anda077483-products-discontinued 2026-08-30T02:08:35.945Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-alert-on-pro-model-p7924a13-labeling-error 2026-08-30T02:08:35.773Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-labeling-alert-for-pro-model-p7924a13 2026-08-30T02:08:35.605Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-078079-for-ciclopirox-8-topical-solution 2026-08-30T02:08:35.435Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080123-for-lantrisul-oral-suspension 2026-08-30T02:08:35.270Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080711-for-procaine-hydrochloride-injection 2026-08-30T02:08:35.148Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-isoniazid-tablet-anda083060 2026-08-30T02:08:35.039Z weekly 0.7 https://pharmacountry.com/insights/regulatory/wharton-labs-anda083665-oral-vitamin-a-capsule-discontinued 2026-08-30T02:08:34.819Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-084279-for-probenecid-and-colchicine-oral-tablet 2026-08-30T02:08:34.634Z weekly 0.7 https://pharmacountry.com/insights/regulatory/calls-for-special-law-to-boost-medical-data-use-and-biosecurity-in-digital-healthcare-act 2026-08-30T02:08:34.477Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-issues-anda084743-for-inwood-labs-phendimetrazine-tartrate-tablet-discontinued 2026-08-30T02:08:34.295Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-issues-recall-of-strykeflow-ps-handpieces-over-leakage-issues 2026-08-30T02:08:34.144Z weekly 0.7 https://pharmacountry.com/insights/regulatory/abiomed-voluntary-recall-of-automated-impella-controller-in-canada-over-purge-flag-issues 2026-08-30T02:08:34.027Z weekly 0.7 https://pharmacountry.com/insights/regulatory/abiomed-voluntary-recall-of-automated-impella-controllers-in-canada-over-purge-flag-issues 2026-08-30T02:08:33.826Z weekly 0.7 https://pharmacountry.com/insights/regulatory/stryker-issues-recall-of-strykeflow-ps-handpiece-over-leak-complaints 2026-08-30T02:08:33.690Z weekly 0.7 https://pharmacountry.com/insights/regulatory/apotex-aposemaglutide-injection-recall-due-to-incorrect-dose-display 2026-08-30T02:08:33.531Z weekly 0.7 https://pharmacountry.com/insights/regulatory/tablicaps-submits-anda085207-for-oral-reserpine-025-mg-tablet-discontinued 2026-08-30T02:08:33.345Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-085702-for-phendimetrazine-tartrate-oral-capsule 2026-08-30T02:08:33.155Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-guanethidine-monosulfate-oral-tablet-anda-086114 2026-08-30T02:08:33.028Z weekly 0.7 https://pharmacountry.com/insights/regulatory/krpia-welcomes-first-joint-drug-review-via-emas-open-program 2026-08-30T02:08:32.826Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-manufacturing-submissions-for-xylocaine-ointment-nda-008048 2026-08-30T02:08:32.626Z weekly 0.7 https://pharmacountry.com/insights/news/korea-abbvie-concludes-13th-week-of-possibilities-volunteer-program 2026-08-30T02:06:22.570Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacistled-medication-reconciliation-advocated-to-reduce-care-transition-errors 2026-08-30T02:06:22.387Z weekly 0.7 https://pharmacountry.com/insights/news/park-geunmi-wins-award-at-2026-korean-hospital-pharmacy-conference 2026-08-30T02:06:22.247Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacies-to-become-painmanagement-counseling-hubs-hubase-symposium 2026-08-30T02:06:22.115Z weekly 0.7 https://pharmacountry.com/insights/news/saeromms-chosen-to-run-ministrys-nonfacetoface-island-doctor-project-targeting-200-units-by-yearend 2026-08-30T02:06:22.008Z weekly 0.7 https://pharmacountry.com/insights/news/alp-bio-ceo-kim-hyunseon-resigns-after-six-months-yoon-jaehoon-to-lead-alone 2026-08-30T02:06:21.899Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-explains-importance-of-correct-medication-timing 2026-08-30T02:06:21.733Z weekly 0.7 https://pharmacountry.com/insights/news/2nd-otc-pharmacy-counseling-contest-awards-15-top-pharmacists-in-korea 2026-08-30T02:06:21.582Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-park-jeongbins-secret-note-column-returns-for-season-2-in-may-2026 2026-08-30T02:06:21.418Z weekly 0.7 https://pharmacountry.com/insights/news/rimegepant-vs-fremanezumab-migraine-treatment-comparison 2026-08-30T02:06:21.264Z weekly 0.7 https://pharmacountry.com/insights/news/swedish-ent-doctor-warns-against-relying-on-internet-for-symptom-searches 2026-08-30T02:06:21.118Z weekly 0.7 https://pharmacountry.com/insights/news/seoul-launches-girl-care-pharmacy-program-to-support-atrisk-female-teens 2026-08-30T02:06:20.966Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-ahn-jiwon-highlights-correct-medication-timing 2026-08-30T02:06:20.802Z weekly 0.7 https://pharmacountry.com/insights/news/otc-options-for-early-depression-mind-trol-tablets-and-qup-amp-highlighted-in-korea 2026-08-30T02:06:20.638Z weekly 0.7 https://pharmacountry.com/insights/news/roche-ranks-top-in-cancertreatment-corporate-reputation-astrazeneca-second 2026-08-30T02:06:20.498Z weekly 0.7 https://pharmacountry.com/insights/news/hanmi-science-launches-procalm-egf-urea-keratin-cream 2026-08-30T02:06:20.320Z weekly 0.7 https://pharmacountry.com/insights/news/goyang-city-pharmacists-association-marks-60th-anniversary-with-ceremony-and-training 2026-08-30T02:06:20.136Z weekly 0.7 https://pharmacountry.com/insights/news/2026-daegu-pharmacist-farm-fair-and-training-successfully-held 2026-08-30T02:06:19.989Z weekly 0.7 https://pharmacountry.com/insights/news/weekly-pharma-issues-recap-highlights-warehouse-pharmacies-and-youth-otc-misuse 2026-08-30T02:06:19.821Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacists-explore-literature-with-new-pharmacy-public-forum-initiative 2026-08-30T02:06:19.657Z weekly 0.7 https://pharmacountry.com/insights/reports/asco-breakthrough-2026-showcases-early-detection-and-precision-oncology-advances-in-singapore 2026-08-30T02:05:06.544Z weekly 0.7 https://pharmacountry.com/insights/reports/huons-initiates-phase-2-trial-of-peptide-dryeye-drug-huc1394-with-first-patient-enrolled 2026-08-30T02:05:06.419Z weekly 0.7 https://pharmacountry.com/insights/reports/vaccination-with-varicella-covid19-hpv-and-shingles-reduces-idiopathic-uveitis-risk-study-finds 2026-08-30T02:05:06.252Z weekly 0.7 https://pharmacountry.com/insights/reports/migraine-imposes-significant-personal-and-socioeconomic-burden-in-south-korea 2026-08-30T02:05:06.071Z weekly 0.7 https://pharmacountry.com/insights/reports/korean-pharma-bio-sector-eyes-july-rd-releases-fda-reviews-and-q2-results 2026-08-30T02:05:05.896Z weekly 0.7 https://pharmacountry.com/insights/reports/digital-pharma-firm-welt-marks-10th-anniversary-announces-aidriven-digital-convergent-medicines 2026-08-30T02:05:05.770Z weekly 0.7 https://pharmacountry.com/insights/reports/targeted-therapies-transform-atopic-dermatitis-treatment 2026-08-30T02:05:05.581Z weekly 0.7 https://pharmacountry.com/insights/reports/glycerol-identified-as-potential-sports-hydration-aid-in-korean-study 2026-08-30T02:05:05.315Z weekly 0.7 https://pharmacountry.com/insights/reports/curtin-university-study-shows-lifestyle-changes-can-prevent-dementia 2026-08-30T02:05:05.166Z weekly 0.7 https://pharmacountry.com/insights/reports/high-coffee-consumption-linked-to-lower-liver-disease-risk-in-large-us-study 2026-08-30T02:05:05.019Z weekly 0.7 https://pharmacountry.com/insights/news/hubase-to-rehost-pharmacy-insight-conference-on-july-26-in-seoul 2026-08-30T02:03:41.701Z weekly 0.7 https://pharmacountry.com/insights/news/gyeonggi-do-pharmacists-association-holds-2025-supplemental-training-for-pharmacists 2026-08-30T02:03:41.522Z weekly 0.7 https://pharmacountry.com/insights/news/mapogu-pharmaceutical-association-women-pharmacists-committee-discuss-community-support-projects 2026-08-30T02:03:41.341Z weekly 0.7 https://pharmacountry.com/insights/news/over-90-of-pharmacists-demand-accurate-pharmacy-info-on-portals-survey-finds 2026-08-30T02:03:41.218Z weekly 0.7 https://pharmacountry.com/insights/news/seodaemungu-pharmaceutical-association-donates-funds-and-supplies-to-local-welfare-facilities 2026-08-30T02:03:41.033Z weekly 0.7 https://pharmacountry.com/insights/news/mega-pharmacy-names-surge-over-50-locations-seen-as-warehouse-stores 2026-08-30T02:02:56.747Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmacists-association-continues-289day-relay-protest-over-herbal-pharmacist-issue 2026-08-30T02:02:56.569Z weekly 0.7 https://pharmacountry.com/insights/news/mfds-launches-special-monitoring-team-for-medical-narcotics-and-opens-reporting-period 2026-08-30T02:02:56.414Z weekly 0.7 https://pharmacountry.com/insights/news/south-korea-deputy-speaker-discusses-patient-rights-with-danish-cancer-association-head 2026-08-30T02:02:56.272Z weekly 0.7 https://pharmacountry.com/insights/news/parliamentary-forum-on-patient-right-to-know-and-medical-advertising-regulation-held 2026-08-30T02:02:56.184Z weekly 0.7 https://pharmacountry.com/insights/news/lawmakers-propose-amendment-to-centralize-closed-clinic-records-in-korea 2026-08-30T02:02:55.982Z weekly 0.7 https://pharmacountry.com/insights/news/mfds-removes-pediatric-indication-for-diacetylsmectate-sparking-shortages-in-compounded-otc-drugs 2026-08-30T02:02:55.824Z weekly 0.7 https://pharmacountry.com/insights/news/kpa-urges-hospital-pharmacists-association-to-follow-pharmacist-training-standards 2026-08-30T02:02:55.689Z weekly 0.7 https://pharmacountry.com/insights/news/kpa-relay-protest-marks-293rd-day-calling-for-resolution-of-herbal-pharmacist-issues 2026-08-30T02:02:55.503Z weekly 0.7 https://pharmacountry.com/insights/news/korea-moves-to-allow-domestic-cbd-epilepsy-drug-production 2026-08-30T02:02:55.343Z weekly 0.7 https://pharmacountry.com/insights/news/ritpulo-capsule-for-severe-alopecia-requires-tb-hepatitis-screening 2026-08-30T02:02:55.180Z weekly 0.7 https://pharmacountry.com/insights/news/ritpulocapsule-ritlecitinib-requires-tb-and-hepatitis-screening-and-ongoing-infection-monitoring 2026-08-30T02:02:55.017Z weekly 0.7 https://pharmacountry.com/insights/news/broker-arrested-in-korean-credit-guarantee-fund-fraud-involving-doctors-and-pharmacists 2026-08-30T02:02:54.873Z weekly 0.7 https://pharmacountry.com/insights/news/jeju-warehouse-pharmacy-plans-to-resume-operations-amid-legal-review 2026-08-30T02:02:54.686Z weekly 0.7 https://pharmacountry.com/insights/news/korea-health-committee-delay-over-chair-allocation-impacts-pharma-law 2026-08-30T02:02:54.543Z weekly 0.7 https://pharmacountry.com/insights/news/13-korean-entities-cited-for-mishandling-medical-narcotics-15-individuals-referred-to-prosecutors 2026-08-30T02:02:54.375Z weekly 0.7 https://pharmacountry.com/insights/reports/ireland-and-who-partner-on-125-m-initiative-to-boost-global-assistive-technology-access 2026-08-30T01:50:44.903Z weekly 0.7 https://pharmacountry.com/insights/news/qatar-fund-for-development-contributes-4-million-to-whos-extended-13th-general-programme-of-work 2026-08-30T01:50:44.721Z weekly 0.7 https://pharmacountry.com/insights/reports/baropharm-launches-ai-powered-baroi-order-service-for-pharmacies 2026-08-30T01:39:43.303Z weekly 0.7 https://pharmacountry.com/insights/reports/immunomic-therapeutics-completes-first-patient-dosing-in-phase-1-trial-of-iti-9001-for-japanese-cedar-pollen-allergy 2026-08-30T01:39:43.164Z weekly 0.7 https://pharmacountry.com/insights/reports/daewoongs-gerd-drug-peksuklu-shows-9575-symptom-improvement-in-pms-interim-analysis 2026-08-30T01:39:43.030Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-alprazolam-extendedrelease-tablets-anda077777 2026-08-30T01:39:25.641Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-abbotts-calcium-gluceptate-injection-anda083159 2026-08-30T01:39:25.498Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lilly-methyltestosterone-tablet-anda080256-discontinued 2026-08-30T01:39:25.315Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-discontinues-piperazine-citrate-syrup-anda080774 2026-08-30T01:39:25.122Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-revamps-innovative-pharma-company-certification-to-quantitative-scoring 2026-08-30T01:39:24.916Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-abbvies-jak-inhibitor-rinbark-gains-ema-endorsement-for-alopecia-areata-and-vitiligo 2026-08-30T01:39:24.735Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-anda083760-for-watson-labs-pyridoxine-hydrochloride-injection-discontinued 2026-08-30T01:39:24.542Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda084351-for-brompheniramine-maleate-4-mg-tablet-now-discontinued 2026-08-30T01:39:24.379Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-acetazolamide-oral-tablet-anda084840 2026-08-30T01:39:24.252Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-kv-pharm-acetaminophencodeine-phosphate-tablet-anda085288 2026-08-30T01:39:24.165Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-labeling-and-rems-updates-for-hydrocodone-bitartrateibuprofen-oral-tablet-anda-076604 2026-08-30T01:39:23.959Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076330-for-octreotide-acetate-injection 2026-08-30T01:39:23.772Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076885-for-rabeprazole-sodium 2026-08-30T01:39:23.588Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-hikma-granisetron-hydrochloride-injection-anda077177 2026-08-30T01:39:23.417Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mylans-glimepiride-anda077486-receives-fda-approval 2026-08-30T01:39:23.234Z weekly 0.7 https://pharmacountry.com/insights/analysis/kolon-life-science-seeks-partners-for-tg-c-osteoarthritis-gene-therapy-at-bio-asiataiwan-2026 2026-08-30T01:38:39.505Z weekly 0.7 https://pharmacountry.com/insights/analysis/chd-pharma-launches-hydration-ors-and-electrolyte-glucose-candy-expands-electrolyte-line 2026-08-30T01:38:39.322Z weekly 0.7 https://pharmacountry.com/insights/news/athletes-show-signs-of-food-poisoning-after-south-africa-vs-mexico-match-in-monterrey 2026-08-30T01:37:44.030Z weekly 0.7 https://pharmacountry.com/insights/news/rising-interest-in-prescription-obesity-drugs-highlights-need-for-proper-use-and-lifestyle-changes 2026-08-30T01:37:43.865Z weekly 0.7 https://pharmacountry.com/insights/news/우신라보타치-2026-서울-약사학술제-팜엑스포에서-하이드로겔-패치-제품-선보여 2026-08-30T01:37:43.758Z weekly 0.7 https://pharmacountry.com/insights/news/samchundang-pharma-signs-term-sheet-with-dr-reddys-for-two-liposome-drugs 2026-08-30T01:37:43.585Z weekly 0.7 https://pharmacountry.com/insights/news/pharmaresearchmedicare-launches-c-pdrn-wound-dressing-rejuvi-md-cream 2026-08-30T01:37:43.404Z weekly 0.7 https://pharmacountry.com/insights/news/korean-new-drug-development-association-donates-10-m-krw-youth-fund-to-jeju-ymca-at-interbiz-forum 2026-08-30T01:37:43.244Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacy-student-club-launches-elderly-medication-safety-campaign-in-seoul 2026-08-30T01:37:43.106Z weekly 0.7 https://pharmacountry.com/insights/news/bukwang-pharmaceutical-achieves-aa-esg-rating-in-h1-2024-evaluation 2026-08-30T01:37:42.906Z weekly 0.7 https://pharmacountry.com/insights/news/six-year-pharmacy-curriculum-marks-11th-graduate-cohort-peet-exam-phased-out 2026-08-30T01:37:42.713Z weekly 0.7 https://pharmacountry.com/insights/regulatory/nesher-pharms-anda077779-for-metoprolol-succinate-er-tablet-approved-by-fda 2026-08-30T01:36:52.853Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda083666-for-hydrochlorothiazidereserpine-oral-tablet 2026-08-30T01:36:52.615Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-supplemental-submissions-for-procaineamide-hydrochloride-capsules-discontinued 2026-08-30T01:36:52.421Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda-084744-for-meprobamate-oral-tablets-200-mg-400-mg 2026-08-30T01:36:52.210Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-for-granisetron-hydrochloride-tablet-anda078080 2026-08-30T01:36:52.006Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-labeling-for-norethindroneethinyl-estradiol-tablet-anda078379 2026-08-30T01:36:51.868Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078671-for-nabumetone-oral-tablets 2026-08-30T01:36:51.703Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080126-for-stanozide-isoniazid-tablets-everylife 2026-08-30T01:36:51.526Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080712-for-thiamine-hydrochloride-injection-bel-mar 2026-08-30T01:36:51.351Z weekly 0.7 https://pharmacountry.com/insights/regulatory/worlds-first-oral-btk-inhibitor-approved-for-chronic-spontaneous-urticaria-in-korea 2026-08-30T01:36:51.200Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-human-skin-model-integrated-into-oecd-tg-498-boosts-global-regulatory-acceptance 2026-08-30T01:36:51.020Z weekly 0.7 https://pharmacountry.com/insights/news/who-launches-online-training-for-parliamentarians-on-health-security-preparedness 2026-08-29T21:50:37.124Z weekly 0.7 https://pharmacountry.com/insights/news/songpa-gu-pharmacists-association-launches-zolpidem-counseling-checklist-at-2026-training 2026-08-29T21:50:36.949Z weekly 0.7 https://pharmacountry.com/insights/reports/mokam-life-science-institute-partners-with-st-pharm-on-aidriven-rna-design-technology 2026-08-29T20:50:46.097Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-introduces-new-pancreas-disability-category-effective-july-1 2026-08-29T20:50:45.817Z weekly 0.7 https://pharmacountry.com/insights/regulatory/watson-labs-dexamethasone-sodium-phosphate-injection-discontinued-anda083702 2026-08-29T16:50:34.518Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda083089-for-propoxyphene-hydrochloride-capsules-roxane 2026-08-29T16:50:34.327Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-alerts-kpc-contamination-in-biofire-diagnostic-panels 2026-08-29T09:50:39.342Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-alert-on-kpc-contamination-in-biofire-filmarray-panels 2026-08-29T09:50:39.189Z weekly 0.7 https://pharmacountry.com/insights/news/india-pledges-85-million-to-who-global-centre-of-traditional-medicine 2026-08-29T05:50:37.410Z weekly 0.7 https://pharmacountry.com/insights/news/14-african-nations-and-partners-pledge-45m-to-who-investment-round 2026-08-29T05:50:37.129Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-viridians-lumvoa-challenging-amgens-tepezza-for-thyroid-eye-disease 2026-08-29T00:50:37.177Z weekly 0.7 https://pharmacountry.com/insights/analysis/fierce-pharma-launches-weekly-oral-glp1-tracker-to-monitor-wegovy-and-foundayo-market-share 2026-08-29T00:50:36.929Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fierce-pharma-regulatory-tracker-2026-highlights-inmarket-product-updates 2026-08-28T20:50:40.443Z weekly 0.7 https://pharmacountry.com/insights/analysis/gwangdong-pharmaceutical-appoints-gi-an84-as-brand-model-for-vita500-ion-kick 2026-08-28T20:50:40.228Z weekly 0.7 https://pharmacountry.com/insights/reports/dong-a-pharmaceutical-launches-mobile-barcode-safety-info-service-for-otc-products 2026-08-28T19:50:33.576Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-updates-loestrin-21-1530-nda-017875-submissions 2026-08-28T19:50:33.202Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-generic-levetiracetam-tablets-anda078993 2026-08-28T15:50:15.024Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-submissions-for-lortab-anda-087722 2026-08-28T15:50:14.823Z weekly 0.7 https://pharmacountry.com/insights/regulatory/icu-medical-canada-recalls-certain-iv-sets-due-to-possible-discoloration 2026-08-28T08:50:08.140Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cynosure-dermav-laser-system-reports-spark-noise-and-burn-risks-in-vascular-treatments 2026-08-28T08:50:07.864Z weekly 0.7 https://pharmacountry.com/insights/regulatory/icu-medical-canada-recalls-iv-sets-due-to-possible-drip-chamber-discoloration 2026-08-28T04:50:09.122Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cynosure-dermav-laser-system-linked-to-spark-related-burns-in-north-america 2026-08-28T04:50:08.881Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-republic-of-korea-hold-second-strategic-dialogue-in-seoul 2026-08-28T04:50:08.608Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-netherlands-renew-partnership-to-boost-climate-resilient-health-systems 2026-08-27T23:50:46.432Z weekly 0.7 https://pharmacountry.com/insights/news/france-signs-24-million-contribution-agreement-with-who 2026-08-27T23:50:46.278Z weekly 0.7 https://pharmacountry.com/insights/news/zymeworks-to-acquire-theravance-biopharma-for-929m 2026-08-27T23:50:46.039Z weekly 0.7 https://pharmacountry.com/insights/reports/beone-medicines-brukinsa-regimen-shows-major-pfs-benefit-in-first-line-mantle-cell-lymphoma 2026-08-27T23:50:45.773Z weekly 0.7 https://pharmacountry.com/insights/news/il-dong-pharmaceutical-group-to-showcase-new-drug-pipeline-at-bio-usa-2026 2026-08-27T19:50:43.817Z weekly 0.7 https://pharmacountry.com/insights/news/rf-bio-hosts-turkish-medical-professionals-for-factory-tour-showcasing-manufacturing-capabilities 2026-08-27T19:50:43.571Z weekly 0.7 https://pharmacountry.com/insights/news/incheon-center-and-hill-hospital-sign-agreement-to-boost-drug-abuse-prevention-and-treatment 2026-08-27T19:50:43.384Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-supplemental-submissions-for-lindane-1-topical-lotion-anda-087313 2026-08-27T19:50:43.123Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-submissions-for-scandonest-l-injection-discontinued 2026-08-27T19:50:42.912Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-announces-discontinued-ophthalmic-ointment-dexair-anda088071 2026-08-27T18:50:16.141Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-alert-on-maquet-percutaneous-insertion-kit-sterile-packaging 2026-08-27T18:50:15.990Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-fsca-for-maquet-pik-line-packaging-integrity 2026-08-27T18:50:15.863Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-flags-increased-wear-and-corrosion-risk-in-cobaltchrome-modular-neck-hip-stems 2026-08-27T18:50:15.642Z weekly 0.7 https://pharmacountry.com/insights/analysis/klick-health-acquires-oxford-pharmagenesis-in-third-takeover-within-18-months 2026-08-27T18:50:15.337Z weekly 0.7 https://pharmacountry.com/insights/regulatory/unicycive-optimistic-third-party-facility-can-meet-fda-standards-says-ceo 2026-08-27T14:50:10.481Z weekly 0.7 https://pharmacountry.com/insights/reports/cmi-media-group-launches-ad-astra-platform-to-unite-pharma-marketing-tech 2026-08-27T14:50:10.268Z weekly 0.7 https://pharmacountry.com/insights/news/luxembourg-and-who-sign-strategic-partnership-framework-and-health-agreement 2026-08-27T14:50:10.037Z weekly 0.7 https://pharmacountry.com/insights/regulatory/who-regrets-us-announcement-to-withdraw-from-organization 2026-08-27T14:50:09.760Z weekly 0.7 https://pharmacountry.com/insights/regulatory/gsk-and-spero-therapeutics-secure-fda-approval-for-oral-carbapenem-utebzi-for-cuti 2026-08-27T14:50:09.537Z weekly 0.7 https://pharmacountry.com/insights/reports/novo-nordisk-faces-25m-50m-ransomware-demands-after-it-breach 2026-08-27T07:50:45.340Z weekly 0.7 https://pharmacountry.com/insights/news/pharmacist-writers-initiative-partners-with-association-to-share-literary-works 2026-08-27T07:50:45.179Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077507-for-glipizide-and-metformin-hydrochloride-tablets 2026-08-27T07:50:44.994Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-announces-discontinued-alprazolam-extendedrelease-tablets-anda-077198 2026-08-27T07:50:44.861Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-atenolol-anda076900-oral-tablets 2026-08-27T07:50:44.751Z weekly 0.7 https://pharmacountry.com/insights/reports/abbvie-genmab-report-positive-phase-3-combo-trial-of-epkinly-after-monotherapy-setback 2026-08-27T07:50:44.520Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-selects-lilly-regeneron-fujifilm-and-four-others-for-precheck-pilot 2026-08-27T03:50:42.470Z weekly 0.7 https://pharmacountry.com/insights/regulatory/medical-journal-retracts-pivotal-study-data-for-amgens-raredisease-drug-tavneos 2026-08-27T03:50:42.288Z weekly 0.7 https://pharmacountry.com/insights/news/novo-nordisk-hires-tara-sparks-ahead-of-super-bowl 2026-08-27T03:50:42.096Z weekly 0.7 https://pharmacountry.com/insights/regulatory/astrazeneca-to-pay-34m-to-settle-texas-medicaid-kickback-lawsuit 2026-08-27T03:50:41.911Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-orca-bios-allogeneic-treg-cell-therapy-tregzi-for-blood-cancer-transplants 2026-08-27T03:50:41.735Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-saudi-arabia-sign-health-agreements-at-riyadh-forum 2026-08-27T03:50:41.568Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-switzerland-renew-cooperation-strategy-through-2028 2026-08-26T22:50:04.880Z weekly 0.7 https://pharmacountry.com/insights/news/belgium-and-who-strengthen-collaboration-on-uhc-vaccines-and-medicines 2026-08-26T22:50:04.719Z weekly 0.7 https://pharmacountry.com/insights/reports/nsaid-use-after-intense-exercise-may-hinder-natural-recovery-experts-warn 2026-08-26T22:50:04.590Z weekly 0.7 https://pharmacountry.com/insights/news/ucb-korea-highlights-diseasemodifying-potential-of-bimzelx-in-psoriasis-at-1year-launch-event 2026-08-26T22:50:04.494Z weekly 0.7 https://pharmacountry.com/insights/regulatory/parliamentary-committee-formation-may-impact-health-policy-amid-election-ballot-shortage 2026-08-26T22:50:04.388Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076620-for-fosinopril-sodium-tablets-submitted-by-actavis-labs 2026-08-26T22:50:04.172Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-teva-torsemide-generic-tablets-anda-076346 2026-08-26T18:50:31.561Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda077797-approval-for-cycbenzaprine-hydrochloride-tablets 2026-08-26T18:50:31.415Z weekly 0.7 https://pharmacountry.com/insights/reports/haleon-partners-with-microsoft-on-5-year-ai-initiative-to-modernize-consumer-health-operations 2026-08-26T18:50:31.306Z weekly 0.7 https://pharmacountry.com/insights/analysis/kimball-electronics-pursues-ma-to-expand-lifescience-cdmo-footprint-in-europe-and-india 2026-08-26T18:50:31.117Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-eib-global-commit-10-million-to-boost-lebanon-public-health 2026-08-26T18:50:30.942Z weekly 0.7 https://pharmacountry.com/insights/news/who-mobilizes-over-100-offices-for-world-health-day-2025-advocacy 2026-08-26T18:50:30.714Z weekly 0.7 https://pharmacountry.com/insights/news/gc-cell-expands-pipeline-to-autoimmune-diseases-advances-car-nk-and-car-t-therapies 2026-08-26T17:50:20.362Z weekly 0.7 https://pharmacountry.com/insights/analysis/korea-secures-enrylaze-supply-as-alternative-to-discontinued-erwinase-for-all-lymphoma 2026-08-26T17:50:20.192Z weekly 0.7 https://pharmacountry.com/insights/news/korean-pharmaceutical-association-launches-4th-sports-pharmacist-expert-course 2026-08-26T17:50:19.974Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-diprosone-topical-lotion-nda-017781 2026-08-26T17:50:19.744Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078395-for-dorzolamide-hydrochloride-ophthalmic-solution 2026-08-26T17:50:19.544Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078101-for-tevas-levetiracetam-oral-tablets 2026-08-26T17:50:19.372Z weekly 0.7 https://pharmacountry.com/insights/news/bridgebio-secures-up-to-1b-equity-funding-for-new-drug-launches-and-attrcm-program 2026-08-26T17:50:19.207Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fierce-pharma-introduces-h2-2026-regulatory-tracker-for-inmarket-products 2026-08-26T13:50:11.612Z weekly 0.7 https://pharmacountry.com/insights/regulatory/sanofis-genzyme-ireland-unit-receives-fda-form-483-faces-further-reprimand 2026-08-26T13:50:11.464Z weekly 0.7 https://pharmacountry.com/insights/regulatory/draeger-alerts-users-to-hose-cracks-in-ventstar-resus-neo-and-resuscitaire-devices 2026-08-26T13:50:11.313Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-recalls-twins-herbal-liquids-idakole-and-pelorie-for-undeclared-sildenafil 2026-08-26T13:50:11.121Z weekly 0.7 https://pharmacountry.com/insights/regulatory/draeger-alerts-potential-hose-cracks-in-ventstar-resus-neo-and-resuscitaire-devices 2026-08-26T13:50:10.982Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-revises-drug-reimbursement-criteria-opens-public-comment 2026-08-26T13:50:10.825Z weekly 0.7 https://pharmacountry.com/insights/news/lonza-expands-adc-manufacturing-capacity-and-deepens-us-drugmaker-partnership 2026-08-26T13:50:10.628Z weekly 0.7 https://pharmacountry.com/insights/analysis/tenpoints-yuvezzi-campaign-uses-handcrafted-puppets-to-highlight-presbyopia 2026-08-26T06:50:37.832Z weekly 0.7 https://pharmacountry.com/insights/analysis/roche-leads-patientview-oncology-reputation-ranking-astrazeneca-moves-to-second 2026-08-26T06:50:37.605Z weekly 0.7 https://pharmacountry.com/insights/news/who-highlights-philanthropic-support-at-philanthropy-asia-summit 2026-08-26T06:50:37.388Z weekly 0.7 https://pharmacountry.com/insights/news/who-and-african-union-renew-strategic-partnership-to-strengthen-health-systems-in-africa 2026-08-26T06:50:37.261Z weekly 0.7 https://pharmacountry.com/insights/news/timor-leste-certified-malaria-free-by-who 2026-08-26T06:50:36.974Z weekly 0.7 https://pharmacountry.com/insights/news/community-pharmacies-shift-toward-managementfocused-digitally-enabled-spaces 2026-08-26T06:50:36.751Z weekly 0.7 https://pharmacountry.com/insights/news/한국-의료-123차-체계와-약국-현장의-현실 2026-08-26T06:50:36.526Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korean-government-initiates-widescale-probe-into-illegal-medical-practices-targeting-cancer-patients 2026-08-26T02:50:37.274Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-anda085199-for-discontinued-phendimetrazine-tartrate-oral-tablet 2026-08-26T02:50:37.111Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-multiple-submissions-for-apresazide-anda-084735 2026-08-26T02:50:36.891Z weekly 0.7 https://pharmacountry.com/insights/news/fierce-pharma-seeks-nominations-for-rising-stars-marketing-qa-series 2026-08-26T02:50:36.754Z weekly 0.7 https://pharmacountry.com/insights/news/innoviva-forms-nortiva-bio-to-advance-longacting-oral-medicines 2026-08-26T02:50:36.629Z weekly 0.7 https://pharmacountry.com/insights/analysis/23-cell-therapy-automation-companies-secure-11b-in-funding-report-shows 2026-08-26T02:50:36.496Z weekly 0.7 https://pharmacountry.com/insights/news/who-pays-tribute-to-dr-david-nabarro 2026-08-26T02:50:36.273Z weekly 0.7 https://pharmacountry.com/insights/regulatory/who-regrets-us-decision-to-withdraw-from-the-organization 2026-08-25T21:50:02.166Z weekly 0.7 https://pharmacountry.com/insights/news/who-director-general-highlights-jordan-partnership-on-universal-health-coverage-mental-health-and-humanitarian-action 2026-08-25T21:50:01.989Z weekly 0.7 https://pharmacountry.com/insights/regulatory/eli-lilly-threatens-hospitals-with-loss-of-340b-discounts-over-data-submission-deadline 2026-08-25T21:50:01.772Z weekly 0.7 https://pharmacountry.com/insights/analysis/novo-nordisks-oral-wegovy-gains-rapid-uptake-over-lillys-oral-glp1-foundayo-says-spherix-analyst 2026-08-25T21:50:01.567Z weekly 0.7 https://pharmacountry.com/insights/news/pfizer-cfo-dave-denton-to-leave-in-august-cecile-guegan-interim 2026-08-25T21:50:01.276Z weekly 0.7 https://pharmacountry.com/insights/news/seongdong-gu-pharmaceutical-society-donates-funds-and-firstaid-medicines-to-disabled-rehab-facility 2026-08-25T21:50:01.065Z weekly 0.7 https://pharmacountry.com/insights/news/global-pharma-ceos-see-compensation-shifts-amid-strong-drug-demand-and-regulatory-changes 2026-08-25T21:50:00.853Z weekly 0.7 https://pharmacountry.com/insights/news/yuhan-corp-celebrates-100th-anniversary-highlights-social-contribution-model 2026-08-25T17:50:13.971Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-updates-labeling-for-discontinued-oral-syrup-depakene-valproic-acid 2026-08-25T17:50:13.742Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-lists-endep-amitriptyline-tablet-products-anda083639 2026-08-25T17:50:13.570Z weekly 0.7 https://pharmacountry.com/insights/regulatory/b-braun-dextrose-60-injectable-products-discontinued-nda-017995 2026-08-25T17:50:13.349Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-reminder-on-neuropsychiatric-risks-of-montelukast 2026-08-25T17:50:13.111Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-august-2026-safety-roundup-ventilator-pcba-fault-anaesthesia-workstation-defect-belzer-solution-update 2026-08-25T17:50:12.950Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-chmp-july-2026-meeting-recommends-12-new-medicines-and-multiple-extensions 2026-08-25T17:50:12.767Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-announces-new-leadership-team-appointments 2026-08-25T17:50:12.611Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacies-face-confusion-over-biokill-insecticide-recall-ahead-of-july-pesticide-approval-rollout 2026-08-25T16:50:15.704Z weekly 0.7 https://pharmacountry.com/insights/news/jw중외제약-비주력-제네릭-cso-영업대행-사업-1년-만에-철수 2026-08-25T16:50:15.524Z weekly 0.7 https://pharmacountry.com/insights/regulatory/suwon-court-orders-pharmacy-deposit-return-and-handover-in-saleslinked-lease-dispute 2026-08-25T16:50:15.262Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080699-for-meprobamate-oral-tablets 2026-08-25T16:50:15.057Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda080094-for-triple-sulfoid-oral-tablet-discontinued 2026-08-25T16:50:14.820Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078965-for-norethindroneethinyl-estradiolferrous-fumarate-tablet 2026-08-25T16:50:14.612Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-d-0296-2023-issued-over-lack-of-sterility-assurance 2026-08-25T16:50:14.375Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ftc-requires-aurobindo-to-divest-four-drugs-before-completing-250m-lannett-deal 2026-08-25T16:50:14.188Z weekly 0.7 https://pharmacountry.com/insights/analysis/pfizers-105b-oncology-deal-with-innovent-completed-in-under-five-months 2026-08-25T16:50:13.987Z weekly 0.7 https://pharmacountry.com/insights/analysis/big-pharma-reexamines-marketing-strategy-amid-growing-public-visibility 2026-08-25T12:50:15.235Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-introduces-patient-alert-card-for-finasteride-users 2026-08-25T12:50:15.089Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-april-2024-update-on-medicines-and-device-safety-communications 2026-08-25T12:50:14.964Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-of-risks-with-prolonged-use-of-high-potency-topical-steroids 2026-08-25T12:50:14.848Z weekly 0.7 https://pharmacountry.com/insights/analysis/abbvie-jj-lead-us-drug-ad-spend-eli-lilly-novo-nordisk-top-ai-citations 2026-08-25T12:50:14.697Z weekly 0.7 https://pharmacountry.com/insights/reports/chiles-food-labelling-law-linked-to-reduced-child-obesity-risk-study-finds 2026-08-25T12:50:14.533Z weekly 0.7 https://pharmacountry.com/insights/reports/glp1-agonists-linked-to-higher-hypotension-risk-in-patients-on-bloodpressure-meds 2026-08-25T12:50:14.359Z weekly 0.7 https://pharmacountry.com/insights/reports/ventoscity-launches-ventos-wearable-to-measure-gut-hydrogen-for-data-driven-gut-health 2026-08-25T12:50:14.222Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda087274-for-hydroxyzine-injectable-watson-labs 2026-08-25T12:50:14.032Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda086746-for-amitriptyline-tablet-lederle 2026-08-25T05:50:06.822Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-anda-086095-watson-labs-chlorpheniramine-injection-discontinued 2026-08-25T05:50:06.648Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-products-over-incorrect-or-missing-lot-and-expiration-dates 2026-08-25T05:50:06.519Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-drug-over-adulterated-api-and-content-uniformity-failure 2026-08-25T05:50:06.373Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-products-exposed-to-improper-temperatures-d-0179-2024 2026-08-25T05:50:06.252Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-summary-of-recent-medicine-and-device-safety-letters 2026-08-25T05:50:06.137Z weekly 0.7 https://pharmacountry.com/insights/regulatory/warfarin-and-tramadol-interaction-raises-bleeding-risk-mhra-alert 2026-08-25T05:50:06.002Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-new-safety-measures-topiramate-contraindicated-in-pregnancy 2026-08-25T05:50:05.807Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-postmarketing-drug-safety-information 2026-08-25T05:50:05.653Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-drug-safety-update-june-2024-letters-and-notifications 2026-08-25T04:51:30.740Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-epimax-ointments-may-cause-ocular-surface-toxicity-if-applied-to-face 2026-08-25T04:51:30.539Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-july-2024-drug-safety-update-letters-and-recalls-summary 2026-08-25T03:51:30.676Z weekly 0.7 https://pharmacountry.com/insights/reports/mhra-calls-for-contributions-to-study-genetic-links-to-doac-and-allopurinol-side-effects 2026-08-25T03:51:30.492Z weekly 0.7 https://pharmacountry.com/insights/reports/intermittent-fasting-cuts-stressinduced-depression-protects-myelin 2026-08-25T02:51:30.008Z weekly 0.7 https://pharmacountry.com/insights/reports/study-links-paternal-valproate-use-at-conception-to-neurodevelopmental-risks-in-children 2026-08-25T02:51:29.805Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-august-2024-drug-safety-update-summary-of-letters-and-recalls 2026-08-25T02:51:29.547Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-drug-safety-update-september-2024-letters-recalls 2026-08-25T01:51:31.619Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-advises-blood-pressure-monitoring-for-bromocriptine-patients 2026-08-25T01:51:31.397Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-guidance-for-reporting-adverse-incidents-with-diabetes-management-equipment 2026-08-25T00:52:11.754Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-reminds-hcps-to-discuss-glp1ra-side-effects-with-patients 2026-08-25T00:52:11.509Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-foreign-substances-and-heavy-metals-detected-in-product 2026-08-24T23:53:08.998Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-october-2024-drug-safety-update-to-healthcare-professionals 2026-08-24T23:53:08.764Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-summary-of-recent-medicine-and-device-safety-notices 2026-08-24T23:53:08.523Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda078070-for-valacyclovir-hydrochloride-tablets-by-pharmobedient 2026-08-24T23:53:08.302Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-padagis-israels-desoximetasone-025-topical-ointment-anda077770 2026-08-24T23:53:08.111Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-ondansetron-injectable-anda077473 2026-08-24T23:53:07.921Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-identifies-gmp-violations-affecting-sterility-assurance 2026-08-24T22:51:05.901Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-cgmp-deviations-due-to-intermittent-temperature-excursions 2026-08-24T22:51:05.758Z weekly 0.7 https://pharmacountry.com/insights/regulatory/label-mix-up-amantadine-capsules-contain-cyclobenzaprine-tablets 2026-08-24T22:51:05.601Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-summary-of-recent-medicine-and-device-safety-letters-dec-2024 2026-08-24T22:51:05.439Z weekly 0.7 https://pharmacountry.com/insights/regulatory/potential-pulmonary-aspiration-risk-with-glp-1-agonists-during-anaesthesia 2026-08-24T22:51:05.331Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chm-removes-specialist-review-for-men-already-on-valproate-retains-for-new-patients-under-55 2026-08-24T22:51:05.087Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmcpa-rebukes-alnylam-after-pfizer-complaint-uk-watchdog-overturns 2026-08-24T22:51:04.836Z weekly 0.7 https://pharmacountry.com/insights/regulatory/us-launches-probe-into-germanys-alleged-underpayment-for-new-medicines 2026-08-24T22:51:04.632Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-pharmacists-hold-273rd-relay-protest-for-herbal-pharmacist-licensing-reform 2026-08-24T22:51:04.430Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mfds-proposes-label-changes-for-134-dapagliflozinmetformin-combo-products 2026-08-24T22:51:04.257Z weekly 0.7 https://pharmacountry.com/insights/reports/migraine-affects-approximately-65-of-koreans-predominantly-women 2026-08-24T22:51:04.096Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda077168-for-fluticasone-propionate-topical-ointment-by-cosette-pharmaceuticals 2026-08-24T22:51:03.838Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-anda076877-for-gabapentin-tablets-discontinued 2026-08-24T20:50:42.852Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-grants-anda-approval-for-ciprofloxacin-hydrochloride-tablets-anda-076593 2026-08-24T20:50:42.626Z weekly 0.7 https://pharmacountry.com/insights/regulatory/recall-ifosfamide-iv-vials-not-refrigerated-at-amerisource-bergen-distribution-centers 2026-08-24T20:50:42.449Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-product-due-to-cgmp-deviations 2026-08-24T20:50:42.224Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-summary-of-recent-medicine-and-device-safety-letters 2026-08-24T20:50:42.037Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-removes-postoperative-pain-indication-for-all-prolongedrelease-opioids 2026-08-24T20:50:41.814Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-new-recommendations-for-fezolinetant-to-mitigate-liver-injury-risk 2026-08-24T20:50:41.657Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-incorrect-expiration-date-on-product-bottles 2026-08-24T20:50:41.450Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-sterile-injectable-drugs-due-to-glass-particulate-contamination 2026-08-24T20:50:41.323Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-products-due-to-contaminated-excipient-from-supplier 2026-08-24T20:50:41.178Z weekly 0.7 https://pharmacountry.com/insights/regulatory/spero-therapeutics-and-gsk-advance-utebzi-toward-fda-approval 2026-08-24T20:50:40.979Z weekly 0.7 https://pharmacountry.com/insights/analysis/gsk-launches-first-dtc-tv-ad-for-asthma-drug-exdensur-eyes-blockbuster-sales 2026-08-24T20:50:40.759Z weekly 0.7 https://pharmacountry.com/insights/reports/verastem-shifts-rd-focus-after-modest-data-on-pancreatic-cancer-combo 2026-08-24T20:50:40.515Z weekly 0.7 https://pharmacountry.com/insights/regulatory/korean-government-reaffirms-separate-payment-policy-for-specimen-tests 2026-08-24T16:50:42.569Z weekly 0.7 https://pharmacountry.com/insights/regulatory/south-korea-proposes-amendment-to-ban-promotional-sales-by-telemedicine-platforms 2026-08-24T16:50:42.416Z weekly 0.7 https://pharmacountry.com/insights/news/seong-yeong-joons-mother-gyeong-seon-deok-passes-away-at-91 2026-08-24T16:50:42.261Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-lidocaine-and-prilocaine-topical-cream-anda076320 2026-08-24T16:50:42.110Z weekly 0.7 https://pharmacountry.com/insights/regulatory/hikma-pharms-rosiglitazone-maleate-tablet-anda-receives-tentative-approval-anda078658 2026-08-24T16:50:41.959Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-approves-dr-reddys-desloratadine-oral-disintegrating-tablets-anda-078367 2026-08-24T16:50:41.867Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-of-severe-asthma-risk-from-overuse-of-shortacting-β2agonists 2026-08-24T16:50:41.781Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-to-infrequent-psychological-side-effects-of-kaftrio-in-cystic-fibrosis 2026-08-24T16:50:41.666Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-to-risk-of-intrahepatic-cholestasis-of-pregnancy-with-thiopurine-drugs 2026-08-24T16:50:41.534Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recall-notice-some-bottles-may-contain-mixed-strengths 2026-08-24T16:50:41.436Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-next-advanced-antibacterial-hand-sanitizer-over-methanol-contamination 2026-08-24T16:50:41.356Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-all-compounded-sterile-preparations-due-to-sterility-assurance-issues 2026-08-24T16:50:41.281Z weekly 0.7 https://pharmacountry.com/insights/reports/novo-targeted-by-hacking-groups-in-multimillion-ransomware-attempt 2026-08-24T16:50:41.200Z weekly 0.7 https://pharmacountry.com/insights/news/novo-nordisk-to-start-production-at-czech-plant-announces-29m-china-upgrade 2026-08-24T16:50:41.030Z weekly 0.7 https://pharmacountry.com/insights/regulatory/colorado-receives-fda-approval-for-state-drug-import-plan 2026-08-24T15:50:19.228Z weekly 0.7 https://pharmacountry.com/insights/regulatory/recall-of-edwards-foresight-oximeter-cable-for-inaccurate-sto2-readings 2026-08-24T15:50:19.045Z weekly 0.7 https://pharmacountry.com/insights/regulatory/beckman-coulter-iq200-and-dxu-840m850m-analyzers-report-fluid-leak-risk 2026-08-24T15:50:18.841Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-issues-alert-for-aisys-carestation-and-cs²-anesthesia-systems 2026-08-24T15:50:18.663Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-authorizes-temporary-import-of-south-korean-bonky-calcitriol-injection-amid-shortage 2026-08-24T15:50:18.480Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-updated-safety-and-educational-materials 2026-08-24T15:50:18.253Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-to-small-guillainbarré-syndrome-risk-with-rsv-vaccines-abrysvo-and-arexvy-in-adults-60 2026-08-24T15:50:18.082Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-reaffirms-paracetamol-safety-during-pregnancy-no-autism-link-found 2026-08-24T15:50:17.900Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ngpod-ph-testing-device-withdrawn-from-uk-market 2026-08-24T15:50:17.719Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-1721-august-2026 2026-08-24T15:50:17.479Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-announces-medsafetyweek-2025-theme-we-can-all-help-make-medicines-safer 2026-08-24T15:50:17.260Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chm-endorses-updated-isotretinoin-prescribing-guidance-seeks-service-feedback 2026-08-24T15:50:17.105Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-adds-iih-warning-to-mesalazine-product-information 2026-08-24T15:50:16.987Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-of-medication-error-risk-with-new-rybelsus-tablet 2026-08-24T15:50:16.782Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-reviews-addiction-warnings-for-gabapentinoids-benzodiazepines-and-zdrugs 2026-08-24T12:05:23.373Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chm-endorses-updated-riskminimisation-measures-for-isotretinoin 2026-08-24T12:05:23.143Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-updates-glp1-agonist-labels-with-stronger-pancreatitis-warnings 2026-08-24T12:05:22.943Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-warns-of-rare-naion-cases-linked-to-semaglutide-wegovy-ozempic-rybelsus 2026-08-24T12:05:22.725Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-restricts-ixchiq-chikungunya-vaccine-use-in-adults-over-60 2026-08-24T12:05:22.578Z weekly 0.7 https://pharmacountry.com/insights/regulatory/chm-temporarily-restricts-ixchiq-chikungunya-vaccine-for-65-age-group 2026-08-24T12:05:22.379Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-to-falsified-mounjaro-kwikpen-15mg-supplied-via-uk-online-pharmacy 2026-08-24T12:05:22.203Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-on-congestion-from-xylometazolineoxymetazoline-sprays 2026-08-24T12:05:21.990Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-updates-safety-warnings-for-finasteride-and-dutasteride-over-suicide-risk 2026-08-24T12:05:21.762Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-reminds-of-serious-amiodarone-risks-and-need-for-patient-monitoring 2026-08-24T12:05:21.642Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-on-delayed-angioedema-distinguish-bradykinin-vs-histamine-types 2026-08-24T12:05:21.503Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-updated-warning-on-botulinum-toxin-typea-products-over-risk-of-iatrogenic-botulism 2026-08-24T12:05:21.304Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-adds-contraindication-for-domperidone-in-pheochromocytoma-patients 2026-08-24T12:05:21.083Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-safety-notice-incorrect-dose-risks-with-insulinspecific-syringes 2026-08-24T12:05:20.890Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-updates-japanese-pharmacopoeia-with-pdg-harmonized-texts-2 2026-08-24T00:05:32.204Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-updates-atc-learning-videos 2026-08-24T00:05:31.691Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-releases-seven-english-translations-on-pediatric-drug-development-guidance 2026-08-24T00:05:31.483Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-updates-japanese-pharmacopoeia-with-pdg-harmonized-texts 2026-08-24T00:05:31.284Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-launches-new-designation-early-access-website 2026-08-24T00:05:31.087Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-launches-new-overview-of-orphan-drug-designation-website 2026-08-24T00:05:30.868Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-posts-schedule-for-jp19i-publication 2026-08-24T00:05:30.571Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-hokuriku-branch-holds-10th-anniversary-symposium 2026-08-24T00:05:30.382Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-posts-report-on-10th-anniversary-of-pmda-atc-ceremony 2026-08-24T00:05:30.266Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-adds-project-team-for-ai-utilization-guiding-principles 2026-08-24T00:05:30.114Z weekly 0.7 https://pharmacountry.com/insights/reports/pmda-workshop-on-new-approach-methodologies-nams-held-after-iccr20 2026-08-24T00:05:29.946Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-updated-list-of-approved-medical-devices-apr-2004sep-2025 2026-08-24T00:05:29.786Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-announces-pdg-march-2026-news 2026-08-24T00:05:29.646Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-asia-office-gmp-workshop-training-2026-report-published 2026-08-24T00:05:29.511Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-posts-report-from-asia-office-gcp-workshop-2026 2026-08-23T22:05:12.510Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-list-of-approved-drugs-april-2004-feb-2026 2026-08-23T22:05:12.259Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-approves-shinsa-cdx-for-identifying-eligible-patients 2026-08-23T22:05:12.028Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-followup-alert-serious-hypocarnitinemia-and-hypoglycaemia-in-children-treated-with-pivoxilgroup-antibacterials 2026-08-23T22:05:11.817Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-concludes-mou-with-medical-university-of-vienna 2026-08-23T22:05:11.636Z weekly 0.7 https://pharmacountry.com/insights/reports/pmda-concludes-mou-with-london-school-of-hygiene-tropical-medicine 2026-08-23T22:05:11.528Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-releases-safety-information-no429-for-pharmaceuticals-and-medical-devices 2026-08-23T22:05:11.375Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-posts-2026-no2-update 2026-08-23T22:05:11.238Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-issues-press-release-on-international-pharmacopoeia-activities 2026-08-23T22:05:11.094Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-english-translation-of-riheart-review-report 2026-08-23T22:05:10.894Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-issues-early-guidance-on-clinical-evaluation-of-factor-viii-ix-for-pediatric-hemophilia 2026-08-23T22:05:10.688Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-posts-summary-of-8th-asian-network-meeting 2026-08-23T22:05:10.559Z weekly 0.7 https://pharmacountry.com/insights/regulatory/asean-japan-medical-devices-regulatory-seminar-2026-announced 2026-08-23T22:05:10.414Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-opens-applications-for-2026-blood-products-seminar-ppwg 2026-08-23T22:05:10.260Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-report-on-asean-japan-medical-devices-regulatory-symposium-2026 2026-08-23T20:04:54.797Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-updates-information-on-biosimilars 2026-08-23T20:04:54.547Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-list-of-approved-regenerative-medical-products-apr-2015may-2026 2026-08-23T20:04:54.301Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-releases-english-translation-of-review-report-for-optune-lua-and-esprit-btk-scaffold-system 2026-08-23T20:04:54.165Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-publishes-english-review-report-for-beovu-partial-change-approval 2026-08-23T20:04:53.952Z weekly 0.7 https://pharmacountry.com/insights/regulatory/pmda-revises-precautions-for-donanemab-and-other-drugs 2026-08-23T20:04:53.832Z weekly 0.7 https://pharmacountry.com/insights/reports/pmda-updates-one-stop-service-platform-by-ensemblexj 2026-08-23T20:04:53.720Z weekly 0.7 https://pharmacountry.com/insights/regulatory/crescent-pharma-recalls-ramipril-10mg-capsules-batch 2026-08-23T20:04:53.517Z weekly 0.7 https://pharmacountry.com/insights/regulatory/doncaster-pharma-alerts-mhra-over-braille-embossing-error-on-hiprex-1-g-tablets 2026-08-23T20:04:53.288Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-1317-april-2026 2026-08-23T20:04:53.066Z weekly 0.7 https://pharmacountry.com/insights/regulatory/omega-pharma-recalls-napralief-250mg-tablets-over-missing-pil-text 2026-08-23T20:04:52.806Z weekly 0.7 https://pharmacountry.com/insights/regulatory/amarox-limited-recalls-sertraline-100-mg-tablets-batch-over-manufacturing-error 2026-08-23T20:04:52.652Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-april-2026-safety-advice-for-medicines-and-devices 2026-08-23T20:04:52.435Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-2024-april-2026 2026-08-23T20:04:52.196Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-on-1-may-2026 2026-08-23T18:05:07.046Z weekly 0.7 https://pharmacountry.com/insights/regulatory/milpharm-limited-reports-discrepancy-in-pil-for-loperamide-2-mg-orodispersible-tablets 2026-08-23T18:05:06.832Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-48-may-2026 2026-08-23T18:05:06.616Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-27-april1-may-2026 2026-08-23T18:05:06.447Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fresenius-medical-care-deutschland-gmbh-reports-braille-label-error 2026-08-23T18:05:06.320Z weekly 0.7 https://pharmacountry.com/insights/regulatory/risk-of-severe-harm-from-using-incorrect-iv-giving-set-for-blood-transfusion 2026-08-23T18:05:06.195Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-field-safety-notices-for-1115-may-2026 2026-08-23T18:05:06.037Z weekly 0.7 https://pharmacountry.com/insights/regulatory/medline-and-kimal-issue-field-safety-notices-for-namic-syringes-and-manifolds 2026-08-23T18:05:05.911Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-on-rare-complications-from-allurion-gastric-balloon 2026-08-23T18:05:05.650Z weekly 0.7 https://pharmacountry.com/insights/regulatory/crescent-pharma-initiates-precautionary-recall-of-ramipril-25-mg-capsules 2026-08-23T18:05:05.410Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-releases-field-safety-notices-for-2529-may-2026 2026-08-23T18:05:05.274Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-recall-inaccurate-sto2-readings-from-edwards-foresight-oximeter-cable 2026-08-23T18:05:05.108Z weekly 0.7 https://pharmacountry.com/insights/regulatory/beckman-coulter-iq200-and-dxu-840m850m-analyzers-report-fluid-leak-complaints 2026-08-23T18:05:04.934Z weekly 0.7 https://pharmacountry.com/insights/regulatory/health-canada-alert-aisys-anesthesia-systems-to-alternate-o₂-control 2026-08-23T18:05:04.756Z weekly 0.7 https://pharmacountry.com/insights/regulatory/becton-dickinson-uk-recalls-chloraprep-2-applicators-over-sterility-concerns 2026-08-23T16:05:14.550Z weekly 0.7 https://pharmacountry.com/insights/regulatory/teva-uk-reports-labeling-error-on-ponlimsi-denosumab-60mg-carton 2026-08-23T16:05:14.401Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-1822-may-2026 2026-08-23T16:05:14.219Z weekly 0.7 https://pharmacountry.com/insights/regulatory/cadila-pharmaceuticals-reports-barcode-error-on-mirtazapine-30mg-tablets 2026-08-23T16:05:14.018Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-field-safety-notices-for-1519-june-2026 2026-08-23T16:05:13.827Z weekly 0.7 https://pharmacountry.com/insights/regulatory/brancaster-pharma-reports-outdated-pil-on-notified-batches 2026-08-23T16:05:13.652Z weekly 0.7 https://pharmacountry.com/insights/regulatory/flamingo-pharma-uk-ltd-recalls-flucloxacillin-500mg-capsules-due-to-incorrect-pil 2026-08-23T16:05:13.525Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-29-june3-july-2026 2026-08-23T16:05:13.320Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-july-2026-safety-advice-for-medicines-and-medical-devices 2026-08-23T16:05:13.145Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-for-2731-july-2026 2026-08-23T16:05:12.980Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-updated-guidance-on-defects-in-belzer-organ-preservation-solutions 2026-08-23T16:05:12.858Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-alerts-on-medical-devices-lacking-valid-ukcace-markings 2026-08-23T16:05:12.706Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-field-safety-notices-for-37-august-2026 2026-08-23T16:05:12.569Z weekly 0.7 https://pharmacountry.com/insights/regulatory/resmed-field-safety-notice-astral-100150-ventilators-may-interrupt-therapy 2026-08-23T16:05:12.337Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-publishes-field-safety-notices-list-for-1317-july-2026 2026-08-23T16:05:12.088Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-advises-against-use-of-rectal-catheters-for-infants 2026-08-23T15:20:50.233Z weekly 0.7 https://pharmacountry.com/insights/regulatory/zentiva-uk-pharma-recalls-fingolimod-05-mg-capsules-over-metal-contamination-risk 2026-08-23T15:20:50.012Z weekly 0.7 https://pharmacountry.com/insights/regulatory/label-mixup-recall-potential-mislabeling-of-famotidine-20-mg-tablets 2026-08-23T15:17:00.856Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-product-over-sterility-concerns-due-to-gmp-violations 2026-08-23T15:17:00.716Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-recalls-product-due-to-lack-of-assurance-of-sterility 2026-08-23T15:17:00.507Z weekly 0.7 https://pharmacountry.com/insights/analysis/where-to-source-semaglutide-supplier-guide 2026-08-23T14:35:36.048Z weekly 0.7 https://pharmacountry.com/insights/analysis/which-countries-dominate-manufacturing-equipment-utilities-supply 2026-08-23T14:34:45.299Z weekly 0.7 https://pharmacountry.com/insights/news/natural-extracts-herbal-ingredients-price-benchmark-what-sellers-are-asking 2026-08-23T14:28:42.268Z weekly 0.7 https://pharmacountry.com/insights/regulatory/orbit-pharma-recalls-cyclizine-lactate-injection-batch-over-gmp-deficiencies 2026-08-23T13:44:18.964Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-field-safety-notices-for-812-june-2026 2026-08-23T13:44:18.758Z weekly 0.7 https://pharmacountry.com/insights/regulatory/mhra-issues-field-safety-notices-for-15-june-2026 2026-08-23T13:44:18.634Z weekly 0.7 https://pharmacountry.com/insights/reports/mirabegron-study-for-oab-completed 2026-08-23T11:01:26.413Z weekly 0.7 https://pharmacountry.com/insights/news/cidp-and-mmn-immunoglobulin-study 2026-08-23T11:00:20.715Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-issues-field-safety-notices-for-multiple-products-1014-aug-2026 2026-08-23T10:47:23.238Z weekly 0.7 https://pharmacountry.com/insights/news/dräger-expands-field-safety-notice-for-atlan-anaesthesia-workstations-over-ventilator-failure-risk 2026-08-23T10:47:23.108Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-issues-field-safety-notices-for-2024-july-2026 2026-08-23T10:47:22.957Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-alerts-missing-safety-info-for-tuzulby-prolongedrelease-tablets 2026-08-23T10:47:22.811Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-alerts-manufacturing-issue-with-xaggitin-xl-prolongedrelease-tablets 2026-08-23T10:47:22.665Z weekly 0.7 https://pharmacountry.com/insights/news/uk-mhra-issues-field-safety-notices-for-610-july-2026 2026-08-23T10:47:22.503Z weekly 0.7 https://pharmacountry.com/insights/news/becton-dickinson-uk-recalls-chloraprep-1-ml-applicators-over-sterility-concerns 2026-08-23T10:47:22.381Z weekly 0.7 https://pharmacountry.com/insights/news/bristol-laboratories-recalls-phenoxymethylpenicillin-oral-solution-batch-7124002 2026-08-23T10:47:22.236Z weekly 0.7 https://pharmacountry.com/insights/news/relonchem-reports-particulate-contamination-in-gabapentin-oral-solution-bottles 2026-08-23T10:47:22.097Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-issues-field-safety-notices-for-multiple-products-2226-june-2026 2026-08-23T10:47:21.983Z weekly 0.7 https://pharmacountry.com/insights/news/mhra-issues-june-2026-safety-advice-for-medicines-and-medical-devices 2026-08-23T10:47:21.661Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ema-gmp-requirements-advanced-therapy-medicinal-products-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/analysis/biosimilars-market-growth-competitive-dynamics-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/news/who-transparency-pharmaceutical-pricing-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/news/pfizer-expands-api-manufacturing-singapore 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/news/global-pharma-market-1-9-trillion-2027 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/regulatory/fda-guidance-continuous-manufacturing-drug-substances-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/reports/pharma-b2b-platforms-market-analysis-report-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/reports/state-pharma-supply-chain-resilience-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/analysis/contract-manufacturing-asia-pacific-opportunities-2025-2027 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/insights/regulatory/ich-q12-post-approval-change-management-2025 2026-05-22T06:05:52.598Z weekly 0.7 https://pharmacountry.com/knowledge/eu-marketing-authorization-centralized-vs-national-procedure 2026-08-25T05:37:09.462Z monthly 0.6 https://pharmacountry.com/knowledge/tablet-compression-machine-installation-qualification-protocol 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/autoclave-operational-qualification-checklist 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/fluid-bed-dryer-performance-qualification-approach 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/karl-fischer-titrator-calibration-and-maintenance-guide 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/dissolution-apparatus-usp-apparatus-1-2-qualification-requirements 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/blister-packaging-machine-urs-for-new-equipment-purchase 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/freeze-dryer-lyophilizer-process-parameters-and-qualification 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/clean-in-place-cip-systems-validation-approach 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/balance-and-weighing-equipment-calibration-frequency-and-tolerance 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/hygroscopicity-testing-method-and-impact-on-api-storage 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/paracetamol-api-specification-and-impurity-profile 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/particle-size-distribution-analytical-method-and-acceptance-criteria 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/reference-standards-qualification-and-requalification-procedure 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/ibuprofen-polymorphism-and-crystal-form-considerations 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/metformin-hcl-analytical-method-for-assay-by-hplc 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/residual-solvents-in-apis-ich-q3c-classification-guide 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/genotoxic-impurities-control-strategy-per-ich-m7 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/elemental-impurities-ich-q3d-risk-assessment-approach 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/hplc-system-user-requirement-specification-urs-template 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/amorphous-vs-crystalline-api-selection-criteria-for-formulation 2026-08-25T05:26:35.428Z monthly 0.6 https://pharmacountry.com/knowledge/laboratory-sample-management-chain-of-custody-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/analyst-qualification-training-and-competency-assessment 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/out-of-trend-oot-data-detection-and-investigation-approach 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/laboratory-audit-trail-review-requirements-for-electronic-systems 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/reference-standard-management-storage-and-inventory-control 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/laboratory-equipment-calibration-program-frequency-and-documentation 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/retained-sample-program-storage-requirements-and-retention-periods 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/laboratory-investigation-phase-i-ii-oos-investigation-framework 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/process-analytical-technology-pat-implementation-in-pharma-manufacturing 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/continuous-manufacturing-technology-overview-for-solid-dosage-forms 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/spray-drying-technology-application-in-api-and-formulation-processing 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/single-use-technology-application-in-biopharmaceutical-manufacturing 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/3d-printing-in-pharma-manufacturing-current-applications-and-limitations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/digital-twin-technology-application-for-process-optimization 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/freeze-drying-lyophilization-technology-process-design-considerations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/nanotechnology-in-drug-delivery-current-applications-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/automation-in-pharma-manufacturing-benefits-and-implementation-considerations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/artificial-intelligence-in-manufacturing-applications-for-process-control 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/cosmetic-product-safety-report-eu-regulation-1223-2009-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/cosmetic-stability-testing-method-and-design-considerations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/preservative-systems-selection-for-cosmetic-formulations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/cosmetic-ingredient-labeling-inci-nomenclature-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/microbial-testing-for-cosmetics-iso-17516-limits-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/challenge-testing-preservative-efficacy-for-cosmetic-products 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/cosmetic-gmp-iso-22716-requirements-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/sunscreen-testing-spf-determination-method-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/usp-nf-structure-and-how-to-navigate-monographs 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/ich-guidelines-overview-of-quality-q-safety-s-efficacy-e-series 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/iso-13485-quality-management-for-medical-devices-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/eu-gmp-annex-1-2022-revision-key-changes-for-sterile-manufacturing 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/iso-14644-cleanroom-classification-standard-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/who-gmp-guidelines-comparison-with-eu-fda-gmp-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/pharmacopeial-harmonization-usp-ep-jp-convergence-status 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/iso-9001-quality-management-system-requirements-for-pharma-suppliers 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/iso-13485-qms-implementation-for-medical-device-manufacturers 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/medical-device-classification-fda-class-i-ii-iii-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/natural-and-organic-cosmetic-certification-standards-comparison-cosmos-natrue 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/cosmetic-claims-substantiation-testing-requirements-for-efficacy-claims 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/pharmacovigilance-requirements-post-marketing-safety-reporting-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/medical-device-510-k-submission-key-requirements-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/biocompatibility-testing-iso-10993-series-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/medical-device-risk-management-iso-14971-application 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/eu-mdr-medical-device-regulation-key-changes-from-mdd 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/sterilization-validation-for-medical-devices-eo-gamma-and-steam-methods 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/medical-device-design-controls-fda-qsr-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/software-as-a-medical-device-samd-regulatory-classification-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/post-market-surveillance-requirements-for-medical-device-manufacturers 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/anda-submission-key-components-and-common-deficiencies 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/ich-common-technical-document-ctd-module-structure-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/post-approval-changes-fda-variation-classification-type-i-ii-iii 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/drug-master-file-dmf-purpose-and-submission-requirements 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/gmp-inspection-readiness-common-fda-483-observations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/orphan-drug-designation-regulatory-pathway-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/who-prequalification-requirements-for-api-manufacturers 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/regulatory-labeling-requirements-smpc-and-package-insert-content 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/21-cfr-part-210-211-us-gmp-regulation-structure-overview 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/iso-15378-primary-packaging-materials-quality-management 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/laboratory-information-management-system-lims-implementation-considerations 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/data-integrity-alcoa-principles-for-laboratory-records 2026-08-25T00:15:49.882Z monthly 0.6 https://pharmacountry.com/knowledge/temperature-mapping-qualification-approach-for-cold-storage-units 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/performance-qualification-pq-acceptance-criteria-development 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/vendor-qualification-documentation-requirements-from-equipment-suppliers 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/antimicrobial-effectiveness-testing-usp-51-method 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/media-fill-validation-aseptic-process-simulation-requirements 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/microbial-identification-phenotypic-vs-genotypic-methods-comparison 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/objectionable-microorganisms-risk-assessment-for-non-sterile-products 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/water-system-microbial-monitoring-usp-requirements 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/gowning-qualification-personnel-aseptic-technique-assessment 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/bioburden-testing-method-and-acceptance-criteria 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/rapid-microbiological-methods-alternative-to-traditional-culture-based-testing 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/preservative-efficacy-testing-method-and-regulatory-requirements 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/hplc-method-development-systematic-approach-for-assay-methods 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/analytical-method-validation-ich-q2-r2-parameters-overview 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/dissolution-method-development-discriminating-method-design 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/gc-method-for-residual-solvents-ich-q3c-compliant-approach 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/uv-vis-spectrophotometry-method-validation-for-assay-testing 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/mass-spectrometry-in-impurity-identification-lc-ms-approach 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/karl-fischer-titration-water-content-determination-method 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/method-transfer-protocol-and-acceptance-criteria-between-labs 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/forced-degradation-studies-design-for-stability-indicating-methods 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/system-suitability-testing-hplc-requirements-per-usp-621 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/ich-q1a-r2-stability-testing-guideline-overview 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/stability-study-design-zone-based-storage-conditions-zone-i-ivb 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/photostability-testing-ich-q1b-method-overview 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/accelerated-stability-testing-design-and-data-interpretation 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/in-use-stability-study-design-for-multi-dose-products 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/shelf-life-determination-statistical-approach-per-ich-q1e 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/stress-testing-forced-degradation-design-for-new-drug-substances 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/cold-chain-stability-excursion-impact-assessment-approach 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/bracketing-and-matrixing-reduced-stability-study-designs 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/post-approval-stability-commitment-ongoing-stability-program-requirements 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/process-validation-stage-2-ppq-protocol-design 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/cleaning-validation-acceptance-criteria-calculation 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/analytical-method-validation-robustness-testing-approach 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/computer-system-validation-csv-gamp-5-risk-based-approach 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/sterilization-process-validation-steam-autoclave-cycle-development 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/shipping-validation-temperature-excursion-simulation-testing 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/aseptic-process-validation-media-fill-design-and-acceptance-criteria 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/validation-master-plan-vmp-structure-and-required-content 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/concurrent-vs-prospective-validation-when-each-approach-applies 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/revalidation-triggers-criteria-for-re-executing-validation-studies 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/design-qualification-dq-approach-for-new-manufacturing-equipment 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/installation-qualification-iq-protocol-structure-and-content 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/operational-qualification-oq-test-approach-for-process-equipment 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/requalification-frequency-risk-based-approach-for-critical-equipment 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/autoclave-qualification-thermal-distribution-and-penetration-studies 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/hvac-qualification-airflow-and-particle-count-verification 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/computerized-system-qualification-integration-with-csv-lifecycle 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/environmental-monitoring-viable-and-non-viable-particle-sampling 2026-08-24T23:54:40.811Z monthly 0.6 https://pharmacountry.com/knowledge/tamper-evident-packaging-design-requirements-and-verification 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/primary-packaging-compatibility-extractables-and-leachables-study-design 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/child-resistant-packaging-testing-requirements-per-iso-8317 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/blister-packaging-material-selection-for-moisture-sensitive-products 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/cold-chain-packaging-qualification-for-temperature-sensitive-products 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/cleanroom-classification-iso-14644-1-vs-eu-gmp-grade-comparison 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/hvac-system-qualification-approach-for-pharma-manufacturing 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/facility-design-unidirectional-flow-for-aseptic-processing 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/water-for-injection-wfi-system-qualification-requirements 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/environmental-monitoring-program-design-for-grade-a-b-areas 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/compressed-air-system-quality-requirements-per-iso-8573-1 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/facility-qualification-dq-iq-oq-pq-lifecycle-overview 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/pest-control-program-requirements-for-gmp-facilities 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/warehouse-storage-conditions-temperature-mapping-study-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/airlock-design-personnel-and-material-flow-in-aseptic-facilities 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/serialization-and-track-and-trace-regulatory-requirements-overview 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/packaging-material-specification-aluminum-foil-for-blister-packs 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/bottle-and-closure-system-moisture-vapor-transmission-rate-testing 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/label-content-requirements-pharmacopeial-and-regulatory-compliance 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/packaging-validation-shipping-simulation-per-ista-astm 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/tablet-manufacturing-wet-granulation-process-overview 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/sterile-manufacturing-aseptic-processing-requirements 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/batch-record-design-gmp-documentation-requirements 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/process-validation-three-stage-lifecycle-approach-fda-2011-guidance 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/scale-up-manufacturing-considerations-from-lab-to-commercial-batch 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/continuous-manufacturing-regulatory-and-technical-considerations 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/cleaning-validation-approach-for-shared-manufacturing-equipment 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/in-process-controls-design-for-tablet-manufacturing 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/mixing-and-blending-process-parameters-and-homogeneity-verification 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/coating-process-film-coating-parameters-and-common-defects 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/immediate-release-tablet-formulation-development-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/extended-release-formulation-matrix-vs-reservoir-system-comparison 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/orally-disintegrating-tablets-formulation-considerations 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/excipient-compatibility-study-design-and-interpretation 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/bioavailability-enhancement-solid-dispersion-techniques-overview 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/suspension-formulation-stabilizer-selection-and-particle-settling-control 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/softgel-capsule-formulation-fill-material-considerations 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/qbd-quality-by-design-application-to-formulation-development 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/taste-masking-techniques-for-oral-pediatric-formulations 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/preformulation-studies-physicochemical-characterization-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/out-of-specification-oos-investigation-fda-compliant-procedure 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/content-uniformity-testing-usp-905-method-and-acceptance-criteria 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/dissolution-testing-method-development-and-validation-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/microbial-limit-testing-usp-61-62-overview 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/sterility-testing-membrane-filtration-method-per-usp-71 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/related-substances-testing-hplc-method-for-impurity-quantification 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/qc-laboratory-sampling-plan-statistical-approach-ansi-asq-z1-4 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/stability-indicating-method-development-and-validation-requirements 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/endotoxin-testing-lal-method-per-usp-85 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/certificate-of-analysis-coa-required-elements-and-format 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/deviation-management-root-cause-analysis-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/capa-corrective-and-preventive-action-system-design-per-ich-q10 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/change-control-process-for-gmp-manufacturing-facilities 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/quality-risk-management-ich-q9-tools-overview-fmea-haccp 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/supplier-qualification-approach-for-raw-material-vendors 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/annual-product-quality-review-apqr-required-content-and-structure 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/batch-release-procedure-qp-certification-requirements-eu-gmp 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/document-control-system-gmp-requirements-for-sops-and-records 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/self-inspection-program-gmp-internal-audit-approach 2026-08-24T15:56:14.121Z monthly 0.6 https://pharmacountry.com/knowledge/product-recall-procedure-classification-and-notification-requirements 2026-08-24T15:56:14.121Z monthly 0.6